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Abstract 
The first chapter in this thesis includes the design, synthesis, and evaluation of anti-
Alzheimer and anti-norovirus activities of tricyclic pyrones (TPs). Alzheimer’s disease is a major 
cause of dementia and sixth leading cause of death; it is a growing problem all over the world. 
On the other hand, norovirus, a highly contagious agent is responsible for more than 90% of non-
bacterial gastroenteritis causing severity mainly in the closed environments. No drugs exist to 
eradicate the symptoms developed by both of these disorders. 
Studies have shown that the development of Alzheimer’s disease and the infection of 
norovirus are dependent on cholesterol metabolism. More specifically, the inhibition of acyl-
CoA: cholesterol acyltrasferase (ACAT) led to the reduction of plaques in Alzheimer’s disease 
as well as reduced the infection of norovirus. Mimicking the structure of CP2, a TP with 
promising anti-Alzheimer activities, a library of tricyclic pyrones containing phenyl, naphthyl, 
heterocyclic, and dipeptidyl moieties were synthesized and evaluated for their anti-Alzheimer 
and anti-norovirus efficacies. Several TPs containing phenyl and naphthyl groups showed sub-
micromolar to nanomolar potencies for the protection of neuronal MC65 cells from Aβ-
oligomers induced death. Similarly, the TPs containing pyrrolyl, imidazolyl, and quinolinyl 
moieties were effective to inhibit the norovirus replication in low micromolar range. The most 
effective TPs from MC65 cells protection assay were also effective in the inhibition ACAT and 
up-regulation ABCA1 gene.  
The second chapter in this thesis includes the design, synthesis, and anti-norovirus 
activity of thiouridine nucleosides. Many nucleosides have demonstrated effective inhibition of 
viral RNA polymerase, and some are progressing at different level of clinical trials for the 
treatment of hepatitis C virus. Some of the nucleosides, including 2’-C-methyl and 2’-amino 
  
substituted analogs, were found to effectively inhibit the norovirus replication. In the search of 
more potent anti-noroviral compounds, two thiouridine nucleosides were synthesized and 
evaluated as anti-norovirus agents. Both of these analogs were ineffective up to 50 μM for the 
inhibition of norovirus replication in cell based assay. Proposed work of converting these 
nucleosides to their phosphoramidate derivatives is also described.  
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activity of thiouridine nucleosides. Many nucleosides have demonstrated effective inhibition of 
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Chapter 1 - Design, synthesis, and biological evaluation of tricyclic 
pyrones as anti-Alzheimer and anti-norovirus agents 
 1.1 Introduction 
Alzheimer’s disease (AD), a neurodegenerative disorder, is a major cause of dementia 
and sixth leading cause of death affecting around 30 million people all over the world.
1,2
 
Likewise, norovirus (NV) being a highly contagious agent is responsible for non-bacterial 
gastroenteritis outbreaks causing 21 million sicknesses, 70,000 hospitalizations and 800 deaths 
each year in the United States.
3
 No drugs or vaccines are available for the treatment of either 
disorder. Continuous efforts of researches to develop drugs against these disorders are not yet 
successful.
3,4
 Like other cholesterol related disorders,
5,6,7 
the beginning and progress of 
Alzheimer’s disease and the replication of norovirus were found to be dependent on the level and 
distribution of host cholesterol.
8,9
 Therefore, the modulation of cholesterol at different stages of 
its metabolic pathway provides a wide spectrum of targets for the treatment of both disorders. A 
set of tricyclic pyrones synthesized as acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors 
in Dr. Hua’s lab had shown promising anti-Alzheimer activities.10 In the search of stronger 
ACAT inhibitors, several TPs containing phenyl, naphthyl, heterocyclic, and dipeptidyl at C13 
position were synthesized and evaluated for their anti-Alzheimer and anti-norovirus activities.  
 1.2 Background 
 1.2.1 Alzheimer’s disease and its connection with lipid metabolism 
Alzheimer’s disease (AD) is characterized by cognitive and neuronlogical degradation.4 
The symptoms of AD starts with anatomical change in the parts of brain, unnoticed outwardly 
until the disease progresses enough to affect the behavior.
11
 It may take 10 to 20 years to affect 
  2  
 
the physical and mental health of the patients, severely.
11
 Cognitive degradation starts with 
difficulty to remember newly learned things and widens with problems of planning, performing 
usual work, understanding spatial relations, confusions, change in mood, and personality 
degradation.
12
 Anatomically, extracellular amyloid-β (Aβ) plaques and intracellular 
hyperphosphorylated tau (Figure 1.1) identify the brain of AD patients; both of these hamper 
communication and flow of nutrients among the neuronal cells leading to their death.
4
 The 
plaques are formed due to over activity of β secretase (Figure 1.2) generating Aβ oligomers 
from amyloid precursor protein (APP).
4
 Aβ plaques are made up of amyloid-β 42, amyloid-β 40, 
astrocytes, microglia, and dystrophic neurides,
13
 while the neurofibrilly tangles mainly contained 
hyper-phosphorylated tau protein.
14
 Formation of tangles, including other downstream 
symptoms, was reported to be the aftermath from the generation of Aβ plaques.15’16 With the 
progression of disease, the mental and physical power continuously degrades ultimately leading 
to the death of AD patients, mainly due to other infections and/or low immunity.
12
  
 
 
Figure 1.1: Tangles and plaques in Alzheimer affected neurons. 
 Taken from ref 12 with permission 
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 secretase
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Aoligomers
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Figure 1.2: Abnormal β-secretase pathway of amyloid precursor protein (APP).  
 
 
 The increasing abundance of AD compared to other disorders (Figure 1.3) not only requires 
more attention to it, but also indicates challenges associated with the treatments.
11
 Medications 
used for Alzheimer’s disease only provide temporary comfort dealing with individual symptoms 
like memory loss, sleep problem, but do not modify the disease.
11
  
The mechanism of Alzheimer’s disease is yet to be known; however, its development has 
been reported to be multi-factorial (Figure 1.4).
4
 In less than 1% of AD patients, the presence of 
any forms of mutated genes for amyloid precursor protein (APP) or presenilin 1 or presenilin 2 
confirmed the early onset of Alzheimer’s disease.4 Other risk factors associated with the 
development of AD are: age, food, cholesterol,
1,17
 head injury,
18
 and family’s genetic and 
behavioral history.
19
 Several studies have shown strong connection of cholesterol related factors 
to the development and progression of AD.
4,5,8
 Abnormal distribution of cholesterol inside the 
cells, in the membranes, and outside the cells was found to be responsible for the formation, 
accumulation, and removal of Aβ peptideds.4 People with inherited ε4 gene of apolipoprotein E  
Modified from ref 4 
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Figure 1.3: Percent change in the abundance of different diseases from 2000 to 2008. 
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Figure 1.4: Factors associated with the development of Alzheimer’s disease.4,5,8 
 
Taken from ref 11 with permission 
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(APOE) were found to be at high risk for the development of AD.
20,21
 Furthermore, the neurons 
with tangles were found to have higher level of cholesterol compared to the healthy neurons.
22
 
Several cholesterol transporters like ABCA1,
23
 cholesterol hydroxylase,
24
 liver X factor  
receptors,
25
 and ACAT
26
 were also found to be connected to the development of Alzheimer’s 
disease. Therefore, the modulation of these factors towards the avoidance or eradication of 
Alzheimer’s disease has been persued.4  
 1.2.2 Norovirus infection and effects of lipid modulation 
Norovirus, a category B bioterrorism pathogen, is responsible for more than 90% of non-
bacterial gastroenteritis. The outbreaks mainly occurs in the closed environments like 
dormitories, cruise ships, hospitals, and care facilities.
27,28 
Norovirus is mainly transmitted 
through fecal to oral route and only 10 virions can develop the sickness.
3
  The major symptoms 
of norovirus infection include diarrhea, throwing, nausea, stomach pain, fever, headache, and 
body aches.
28
 In most of the people, it is recovered within 1-3 days; however, it becomes life 
threatening to children, elderly people, and people with weakened immune system.
3
 People with 
certain histo-blood group antigens receptors were found to be more susceptible to certain strains 
of norovirus.
29,30
  
 
  
Figure 1.5: X-ray crystallographic structure of Norwalk virus. 
 Taken from ref 35 with permission 
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Figure 1.6: Schematic representation of norovirus genome.
32
  
 
            Norovirus is one of the four genera in family caliciviridiae with an icosahedral shaped 
capsid (Figure 1.5). It contains a non-enveloped, positive sense, single-strand RNA 
approximately 7.7 kb in length.
31,32
 The genome of norovirus (Figure 1.6) has three open reading 
frames (ORFs). The ORF-1 encodes seven non-structural proteins, while ORF-2 and ORF-3 
encode a major structural protein VP1 and a minor structural protein VP2 respectively.
33
 
Depending on the sequence of capsid genes, the norovirus that infects human is classified into 
main three genogroups (GI, GII, and GIV) and 26 genetic clusters, which further include several 
strains.
34
 The capsid of Norwalk virus contains 90 dimers of casid protein forming S and P 
domains.
35
 The S domain forms the icosahedral pattern and the P domain projects out from the 
dimeric junctions. The P domain of the NV capsid was found be responsible for its strain 
variations and virulence.
36,37,38 
Drug or vaccine development for norovirus infection has faced challenges due to its 
variations in strains, less infective to small animals, and being not able to grow in cell culture.
3
 
DNA microarray studies of the NV replicon-bearing cells demonstrated a strong dependency of 
norovirus replication with cellular cholesterol.
9
 Moreover, the entry of murine NV in murine 
macrophages was controlled by host cholesterol.
39,40 
These reports indicate the possibility of 
using cholesterol modulating compounds as anti-noroviral drugs. 
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 1.2.3 Acyl-CoA: cholesterol acyltransferase (ACAT), a target for the treatment of 
Alzheimer’s disease and norovirus infection 
Cholesterol is essential for normal body functions; the requirement of cholesterol is 
fulfilled from both the dietary intake and continuous synthesis in the body.
41
 Several enzymes 
are responsible for the maintenance of cholesterol homeostasis at different stages of its metabolic 
pathway. Endoplasmic reticulum/cell membrane is the center of intracellular and extracellular 
cholesterol balance.
42
 Acyl-CoA: cholesterol acyltrasferase (ACAT)
43
 (Figure 1.7) is a 
membrane bound enzyme, and uses long chain fatty acid as its substrate to convert cholesterol to 
cholesterol ester maintaining intracellular cholesterol homeostasis.
44
  
Well known ACAT inhibitors like avasimibe (1) and CP113818 (2) (Figure 1.8) used for 
the treatment of atherosclerosis were also found effective to reduce the Aβ plaque formation in 
AD.
47,45
 According to the studies from cell and animal models, the reduction of Aβ plaques was 
positively correlated with the inhibition ACAT.
45,46
 Similarly, genes responsible for ACAT were 
significantly changed in DNA microarray analysis of the NV replicon cells.
9
 Furthermore,  
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Figure 1.7: A. Schematic representation of enzyme ACAT.  B. Role of ACAT and ABCA1 
in the maintenance of intracellular cholesterol balance.
43
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Figure 1.8: ACAT inhibitors effective to reduce Aβ plaques.47,45 
 
ACAT inhibitors like CI976 (3), Sandoz 58-035 (4), and YIC-C8-434 (5) (Figure 1.9) 
significantly reduced the replication of norovirus mRNA.
9
 Therefore, the modulation of 
intracellular cholesterol homeostasis by altering the role of ACAT provides an effective pathway 
for the treatment of Alzheimer’s disease and norovirus infection.9,47 
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Figure 1.9: ACAT inhibitors effective for NV inhibition.
9
  
 
 1.2.4 Motivation to synthesize tricyclic pyrones as ACAT inhibitors  
Pyripyropene A (6)
48
 (Figure 1.10), a tetracyclic pyrone, was reported as a strong ACAT 
inhibitor. Tricyclic pyrone 7
49
 being structurally similar to 6 encouraged for the synthesis of TP 
analogs as ACAT inhibitors. Among the TP analogs synthesized by modifying different parts in 
the structure of 7 in Dr. Hua’s lab, compounds 8 and 9 (Figure 1.10) showed encouraging 
potency for the protection of MC65 cells.
10
 Moreover, compound 9 (CP2) effectively prevented 
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the formation and enhanced the clearance of Aβ plaques in vitro and in vivo.50,51 Therefore, the 
TPs similar in structure with compound 9 can have better anti-Alzheimer activities. So, the 
further exploration of similar analogs by modifying C13 position in compound 7 to find more 
potential candidates was desired. 
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Figure 1.10: Structural resemblance of pyripyropene A and tricyclic pyrones. 
 
 1.3 Design and synthesis of tricyclic pyrones (TPs) as anti-Alzheimer and 
anti-norovirus agents 
To find more effective ACAT inhibitors by mimicking the structure of CP2, several 
analogs (10 – 36) of TP (Figure 1.11 & 1.12) containing aryl-amino, -amide, -ester, -imine, and 
-dipeptidyl functionalities at C13 position were synthesized. Compounds 10 – 35 were obtained 
as a mixture of diastereomers at C12 from the coupling of amine 39 or alcohol 40 with 
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corresponding aldehydes or acids. The diastereomers were not separable through silica gel 
column chromatography. 
Though initially targeted for anti-Alzheimer activity, tricyclic pyrones were also 
evaluated for their anti-noroviurs activity as several well known ACAT inhibitors were found to 
inhibit norovirus.
9
 Most of the TP compounds listed here were evaluated for the protection of  
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Figure 1.11: Tricyclic pyrones containing phenyl and naphthyl moieties. 
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Figure 1.12: Tricyclic pyrones with aryl heterocyclic, phenyl, and dipeptidyl moieties. 
 
neuronal cells as well as for the inhibition of norovirus. However, for the purpose of this 
dissertation, the compounds containing phenyl and naphthyl moieties are reported for anti-
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Alzheimer potencies, while the compounds with aryl heterocylclic functionalities are reported for 
anti-norovirus activity. Nevertheless, compounds 34 and 35 with phenyl moieties are reported for 
anti-norovirus activity. Motivated by promising anti-norovirus potency of dipeptidyl aldehydes,
52
 
the dipeptidyl analog 36 was made through a series of oxidation, hydrolysis and coupling 
reactions starting from alcohol 40. Compound 36 could not be obtained with satisfactory purity 
through silica gel column or from recrystalization. Therefore, compound 36 was not tested for its 
anti-noroviral efficacy. 
 1.3.1 Synthesis of tricyclic pyrones amine 39 and alcohol 40 
The synthesis of precursors amine 39
10
 and alcohol 40
10
 was performed through a 
sequence of condensation and hydroboration-amination or hydroboration-hydroxylation 
(Scheme 1.1) reactions respectively, from 4-hydroxypyrone 37 by using reported procedures. 
Hence, tricyclic pyrone 7 was obtained as a single isomer with excellent yield from condensation 
of hydroxypyrone 37 with perillaldehyde (38) in ethyl acetate at reflux.
49
 Then hydroboration-
amination
53
 of compound 7 by treating with BH3·THF in dry tetrahydrofuran (THF) at 0 °C 
followed by refluxing with hydroxylamine-O-sulfonic acid (HSA) provided tricyclic pyrone 
amine 39 in 50% yiled.
54
 During basic work up, the treatment of amine 39 with (aq) 1N NaOH 
gave trace amount of hydrolyzed byproduct, and the problem of hydrolysis was solved by using 
milder base (aq) K2CO3. Similarly, tricyclic pyrone alcohol 40 was obtained in 82% yield via 
hydroboration-hydroxylation reactions from tricyclic pyrone 7.
10
 Previously, in Dr. Hua’s lab, 
amine 39 was synthesized through a sequence of mesylation, azidation, and reduction reactions 
(Scheme 1.1) starting from alcohol 40.
10
 Both TP amine 39 and alcohol 40 were obtained as a 
1:1 mixture of two diastereomers at C12 center.  
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Scheme 1.1: Synthesis of tricyclic pyrones amine 39 and alcohol 40.
10,54
 
 
 1.3.2 Design and synthesis of tricyclic pyrones with phenyl and naphthyl moieties as 
anti-Alzheimer agents 
The synthesis of tricyclic pyrones (TPs) 10 – 14 containing phenylmethyl and 
naphthylmethyl -amino and -amide functionalities are shown in Schemes 1.2 & 1.3. Motivated 
with the activity of 3-methoxy-4-hydroxybenzylamino analog 10A for the protection of MC65 
cells, several benzyl and naphthylmethyl –amino groups at C13 position of tricyclic pyrone (TP) 
were synthesized as anti-Alzheimer compounds. 3,4-Disubstituted phenyl analogs with different 
functionalities (10B – 10G) as well as 3,4,5-trisubstituted analog (10H) were synthesized. Due to 
higher efficacy of p-hydroxyphenyl analog (10D) for the protection of MC65 cells, 
corresponding monosubstituted aryl analogs with hydroxyl at ortho, meta, and para (11A – 11C) 
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were explored. Superior potency of p-hydroxy analog (11C) compared to ortho and meta analogs 
(11A – 11B) led to the synthesis of TPs with varying length of hydroxyl chains (11D – 11E) as 
well as several other substituents of -methoxy, -formyl, -methyl ester, -chloro, -cyano, and -
dimethyl amino (11G – 11L) at para position of aryl moiety. Further derivatization of the potent 
analog 11C was done by making differently substituted naphthylmethyl amino analogs (12 - 13).  
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Figure 1.13: Phenyl and naphthyl aldehydes and acids used to synthesize tricyclic pyrones. 
 
 
Tricyclic pyrone compounds 10A – 11G, 11I – 13 were synthesized (Scheme 1.2) by 
reductive amination
55
 of amine 39 with corresponding aldehydes 43 – 46 (Figure 1.13) with the 
yields ranging from 50% to 77%.
56
 The reductive amination reaction was conducted in two steps. 
The formation of imine was achieved by stirring a mixture of amine 39 and an aldehyde in dry 
MeOH, and then the imine functionality was reduced with NaBH3CN in the presence of acetic 
acid. The reaction also proceeded well in EtOH and tetrahydrofuran (THF). The intermediate 
imine was stable enough to be observed by 
1
H NMR, and in some cases was purified through 
silica gel column. In the absence of CH3COOH, the reduction was slower and in case of 12B, 
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was very reluctant. Higher amounts of NaBH3CN, CH3COOH, and longer time were needed to 
complete the reduction to get tricyclic pyrone 12B from its intermediate imine. Formation of the 
hydrogen bond between imine functionality and ortho hydroxyl in naphthyl moiety could have 
made a stable, five or six-membered structure. This intermediate imine was stable enough to be 
purified through silica gel column. Interestingly, compound 12A decomposed while  
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Scheme 1.2: Synthesis of tricyclic pyrones 10 – 13.   
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Scheme 1.3: Synthesis of tricyclic pyrones 11E, 11H, and 14. 
 
concentrating the organic layer in reduced pressure, but its trifluoroacetic acid (TFA) salt was 
found to be more stable. Therefore, 1.2 equivalents TFA was added before concentration of the 
organic layer, so compound 12A was obtained in the form of its TFA salt. Synthesis of tricyclic 
pyrones 11E, 11H, and 14 was achieved via desilylation, oxidation, and 3-(3-
dimethylaminopropyl)-1-ethylcarbodiimide (EDC) coupling reactions (Scheme 1.3). Hence, the 
p-hydroxyethyl ether analog 11E was obtained after the removal of silyl protecting group from 
compound 11E’ and the 4-formyl analog 11H was obtained by benzylic oxidation of compound 
11D with 2-iodoxybenzoic acid (IBX) and dimethyl sulfoxide (DMSO)
57
 in 71% and 64% yields, 
respectively. With encouraging MC65 cells protection results of tricyclic pyrones with 2° amine 
functionality, the comparison of potency with amide analogs was desired. Therefore, tricyclic 
pyrone amides 14A and 14B were synthesized in reasonable yields from the coupling reaction of 
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amine 39 with aryl acids 47A and 47B in DMF in the presence of EDC and N-
hydroxysuccinimide (NHS). 
Aryl aldehdydes 43A, 43B, 43E, 43G – 44C, 44F, 44G, 44J – 45B, and carboxylic acids 
47A, 47B were obtained from commercial sources. While, aldehydes 43C, 43D, 43F, 44D, 44E, 
44I, 45C, and 45D were prepared according to the literature methods (Schemes 1.4 & 1.5) with 
the yields ranging 66% - 100%. Hence, the monobromination of p-hydroxybenzaldehyde  
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Scheme 1.4: Synthesis of aldehydes 43C, 43D, 43F, 44D, 44E, 44I, and 45C.
61-69
 
 
(44C) with bromine was achieved in 70% yield in a mixture of chloroform and dimethoxyehtane 
(4:1) to get aldehyde 43C.
58
 The reduction of 4-cyano-2-fluorophenol (48) with platinum oxide 
in formic acid provided 3-fluorinated adehyde 43D
59
 in 80% yield.
60
 The reduction of 
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terephthalaldehyde (49) with NaBH4 in a mixture of dichloromethane and methanol at 0 °C gave 
aldehyde 44D in 75% yield.
61
 Aldehyde 44E was obtained from the substitution of bromide in 
(2-bromoehtoxy)(t-butly)dimethylsilane (50) with phenolic hydroxyl of aldehyde 44C in the 
presence of K2CO3 in DMF.
62
 Esterification of p-carboxybenzaldehyde (51) with methyl iodide 
in DMF provided aldehyde 44I
63
 in quantitative yield.
64
 Aldehyde 45C
65
 was obtained in 
quantitative yield by methylation of 4-hydroxy-1-naphthylcarboxaldehyde (45A) with methyl 
iodide in the presence of K2CO3.
66
  Dibenzylated aldehyde 43F
67
 was obtained from 3-methoxy-
4-hydroxybenzaldehyde (43A) through a two steps process of demethylation and benzylation.
68
 
Thus, demethylation of aldehyde 43A with BBr3
69
 in dichloromethane gave 3,4-
dihydroxybenzaldehyde (52), which was then benzylated with benzyl bromide and potassium 
carbonate in acetone to get aldehyde 43F. Aldehyde 45D was obtained in 70% yield from 
metalation/Vilsmeier-Haack reaction of 4-bromo-2-naphthol (56) in diethyl ether with NaH, n-
BuLi and DMF.
70
 Compound 56 in turn was obtained from 1-aminonaphthlene (53) in a three 
steps process of bromination, oxidative azotization, and reduction reactions.
71
 Thus, the  
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Scheme 1.5: Synthesis of aldehydes 45D and 46.
70,71
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bromination of compound 53 with bromine in acetic acid provided compound 54, which then 
was oxidatively azotized
72
 with NaNO2/AcOH to get compound 55. Finally, compound 55 was 
reduced with NaBH4 followed by aqueous workup to provide compound 56 in 28% overall yield 
from compound 53.
71
 Similarly, aldehyde 46 was obtained by metalation/Vilsmeier-Haack 
reaction of 6-bromo-2-naphthol (57) with 66% yield.
70
  
 
 1.3.3 Design and synthesis of tricyclic pyrones with heterocyclic, benzyl, and dipeptidyl 
moieties as anti-norovirus agents 
Several TP analogs containing different aryl heterocycles (15 - 33), phenyl (34 , 35), and 
dipeptidyl aldehyde (36) groups were synthesized (Schemes 1.6, 1.7, 1.8, & 1.9) to find potent 
anti-norovirus compounds. TPs containing 5-membered heterocycles with furanyl, thiophenyl, 
pyrrolyl, imidadolyl, and thiazolyl groups in mono and bicyclic systems were synthesized.   
Encouraged with low micromolar efficacy of some of the 5-membered aryl heterocycle 
containing analogs to inhibit norovirus inhibition, the TPs with six-membered aryl heterocycles 
were also explored with pyridinyl, quinolinyl, and benzoquinolinyl moieties.  Like TPs bearing 
phenyl analogs, the synthesis of TPs 15 – 31 (Scheme 1.6 & 1.7) was achieved via the reductive 
amination of amine 39 with respective aldehydes 58 – 74 (Figure 1.14) in 41% to 75% yields. 
As in the case of phenyl or naphthylmethyl -amino analogs the reduction of intermediate imine 
was slower in the absence of acetic acid. Observation of relatively low yields of some 
heterocyclic TP analogs is due to the loss associated to their higher polarity, during purification 
through silica gel column. Among the aryl heterocyclic containing TPs, 2-quinolinyl analog 27A 
showed improved potency for norovirus inhibition. Therefore, further derivatization of the TPs 
containing quinolinyl group was carried out by using differently substituted 2-quinolinyl and 4-
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quinolinyl aldehydes 70A – 71F to get their corresponding TP analogs 27A – 28F. Use of more 
than one equivalents of aldehydes provided a mixture of monoalkylated and dialkylated products   
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Figure 1.14: Heterocyclic and benzyl, aldehydes and acids used to synthesize tricylic 
pyrones. 
 
21 - 23 (Scheme 1.7), but in the case of analog 23 even the use of less than one equivalent of 
aldehyde 66 provided a mixture of mono and di-alkylated products 23A and 23B. This indicates 
the possibility of reversal of the reductive amination reaction in some analogs. The formation of 
dialkylated product was discouraged by addition of higher equivalents of acetic acids, probably 
due to the protonation of secondary amine lowering its nucleophilicity. Syntheses of the TPs 
containing quinolinyl -amide 32, -ester 33, phenyl ester 34, and benzyl imine 35 (Scheme 1.8) 
were also performed to further explore the anti-norovirus activity of TPs. By mimicking the 
structure of the most active TP amine 28A to inhibit norovirus, the corresponding amide and  
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Scheme 1.6: Synthesis of tricyclic pyrones 15 – 20 and 24 – 31. 
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Scheme 1.8: Synthesis of tricyclic pyrones -amide 32, –esters 33, 34, and –imine 35. 
 
ester analogs 32 and 33 were made by EDC coupling reactions of amine 39 and alcohol 40 
respectively, with acid 75. Thus, the treatment of amine 39 and alcohol 40 separately with acid 
75 in dichloromethane in the presence of EDC and DMAP provided 62% and 57% yields of 
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compounds 32 and 33, respectively. Similarly, TP ester 34 was obtained in 53% overall yield 
from the EDC coupling of amine 39 and phenyl acid 76 followed by the removal of silyl 
protecting group. Tricyclic pyrone imine 35 was obtained in an attempt to prepare an analog 
containing four membered ring analogous to the dialkylated product from the reductive 
amination of amine 39 and dialdehyde 77. However, the reduction of imine 35 was not achieved 
even with higher equivalents of NaBH3CN and acetic acid. Imine 35 was found stable for the 
chromatographic separation and purified through silica gel column. It was obtained as a 1:1 
mixture of E and Z isomers. 
The encouraging anti-norovirus activity of the tricyclic pyrones and the reported NV 
inhibitory efficacy of dipeptidyl surrogate aldehydes
52
 motivated to synthesize the dipeptidyl 
aldehyde analog 36 as an anti-noroviral agent. The synthesis of compound 36 was achieved 
through a series of oxidations, coupling, and reduction reactions (Scheme 1.9) starting from 
alcohol 40. Thus, the treatment of alcohol 40 with IBX/DMSO provided aldehyde 78 with 
excellent yield. Aldehyde 78 was further oxidized by oxone in DMF to get the corresponding 
carboxylic acid analog 79 with 80% yield.
73
  An attempt to oxidize aldehyde 78 to acid 79 with 
pyridinium dichromate (PDC)
74
 was not successful. The coupling of TP acid 79 with alanine 
methyl ester (80) in the presence of EDC and DMAP in dichloromethane provided the alanine 
ester analog 81 in 66% yield. The ester functionality in compound 81 was hydrolyzed with (aq) 
LiOH in a mixture of THF/MeOH (1:1) to get the corresponding carboxylic acid 82 in 90% 
yield. Similar EDC coupling reaction of acid 82 with glutamine surrogate hydrochloric salt 83
52
 
in a mixture of DCM and DMF (10:1) gave dipeptidyl ester analog 84. Glutamine surrogate HCl 
salt 83 was synthesized by Dr. Keshar Prasain and Sahani M. Weerasekara by following the 
literature methods.
52,75
 Compound 84 was obtained as a mixture of four isomers indicating the  
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Scheme 1.9: Synthesis of TP 36. 
 
possibility of stable rotational conformations. The origination of four isomers due to 
epimerization of α-H in compound 82 during hydrolysis with (aq) LiOH is less likely as only two 
diastereomers were observed by NMRs. The hydrolysis of compound 84 with LiBH4 in a 
mixture of DCM and THF (1:1) at 0 °C followed by oxidation of the resulted alcohol with Dess-
Martin periodinane in DCM provided desired compound 36.  Though the TLC observation of 
compound 36 from reaction mixture was good, some unidentified problems occurred while 
purifying the compound 36 through silica gel column and could not be obtained with satisfactory 
purity.  
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Scheme 1.10: Synthesis of aldehydes 61, 62, 70B, 70C, 71B, 71F, and 74.
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Heterocyclic aldehydes 58 – 60, 63 – 69, 70A, heterocyclic acid 75, and benzylic 
dialdehyde 77 were purchased from commercial sources, while heterocyclic aldehydes 61, 62, 
70B, 70C, 71 - 74, and phenyl acid 76 were prepared in our lab. Synthesis of aldehydes 61, 62, 
70B, 70C, 71B, 71F, and 74 was done by aromatic ring formylation of the corresponding 
heterocycles (Scheme 1.10). 2-Formyl pyrrole (61)
76
 and 3-formyl pyrrole (62)
77
 were obtained 
from N-silylation followed by formylation reactions. Hence, the treatment of pyrrole (85) with 
NaH and isopropylsilyl chloride in DMF provided intermediate 86, which was then formylated 
with oxalyl dichloride and DMF in dichloromethane followed by hydrolysis to get 2-formyl  
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Scheme 1.11: Synthesis of aldehydes 71B, 71C, 71D, and 71E.
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pyrrole (61) and 3-formyl pyrrole (62) in 29% and 37% yields, respectively.
77
  Aldehydes 70B, 
70C, 71B, 71F, and 74 were obtained through a sequence of oxidation and hydrolysis 
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reactions.
78,79 
Thus, the reflux of protonated forms of the quinolines 87, 88, 89 and 
benzo[h]quinoline (90) separately, with t-butylhydroperoxide and catalytic amount of ferrous  
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Scheme 1.12: Synthesis of aldehydes 71A, 72, 73, and acid 76.
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sulfate in a mixture of acetonitrile and trioxane (1:1) for 6 h, at 80 °C  followed by acidic 
hydrolysis provided the aldehydes 70B, 70C,
80
 71F, 71B, and 74,
81
  respectively, with the yields 
ranging 16% to 50%. A mixture of both 2- and 4-formylated analogs were obtained from 6-
methylquinoline (88) and benzo[h]quinoline (90) indicating exclusive formylation only in 2 and 
4 positions of the quinoline nitrogen. Synthesis of aldehydes 71C, 71D, and 71E (Scheme 1.11) 
was possible by isolating the intermediates of trioxanylated quinolines 92 and 94. The trioxanyl 
moiety in these analogs was found stable enough for the benzlic oxidation of 2- and 4-methyl 
substituents with SeO2.
78,82
 Thus, the trioxanylation of 4-methylquinoline (87) with TFA, FeSO4, 
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t-butylhydroperoxide, and trioxane provided intermediate 92
79
 in 43% yield along with small 
amount of hydrolyzed product 70B. Then the benzylic oxidation of methyl in the intermediate 92 
with selenium dioxide, in toluene, at 85 °C gave the aldehyde 71E in 50% yield.
82
 Trace amount 
of dialdehyde analog 93 was also observed by the hydrolysis of the trioxanyl moiety. Similarly, 
trioxanylation of 2-methylquinoline (89) provided 2-methyl-4-trioxanylquinonline (94) in 51% 
yield. Isolation of intermediate 94 also provided an alternate and stepwise route for the formation 
of aldehyde 71B. Benzylic oxidation of intermediate 94 with selenium dioxide at 80 °C followed 
by acidic hydrolysis provided dialdehyde 93 in 68% overall yield from 94. The benzylic 
oxidation of 2-methyl intermediate 94 with selenium dioxide was found more conducive than 4-
methyl analog 92. Reduction of dialdehyde 93 with NaBH4 in a mixture of ethanol and 
dichloromethane at 0 °C gave desired aldehyde 71C along with aldehyde 96 and dialcohol 97 
with 32%, 35%, and 16% yields, respectively. Acetylation of hydroxyl functionality in aldehyde 
71C with Ac2O and ZnO provided aldehyde 71D in 85% yield.
83
 
Synthesis of aldehydes 71A, 72, 73, and acid 76 was possible by benzylic oxidation with 
SeO2, bromination followed by hydrolysis, and silylation reactions (Scheme 1.12). Aldehyde 
71A was obtained in 73% yield along with small amount of quinoline-4-carboxylic acid (75) 
from the oxidation of 4-methylquinoline (87) with selenium dioxide in toluene.
82
 The oxidation 
of 6-methylquinoline (88) in similar conditions provided very low yield of aldehyde 72, but 
refluxing in xylene provided 54% yield.
82
 Benzylic oxidation of 8-methylquinoline (98) in 
toluene did not work in above conditions. Therefore, aldehyde 73 was obtained from a two steps 
process of benzylic bromination followed by hydrolysis.
84
 Hence, the bromination of compound 
98 with N-bromosuccinimide (NBS) and azobisisobutyronitrile (AIBN) in dichloromethane 
provided a mixture of mono and di –brominated intermediates; then the hydrolysis of these 
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intermediates by refluxing in water gave a mixture of aldehyde 73 and alcohol 99  in 37% and 
54% yields, respectively. The oxidation of alcohol 99 with IBX/DMSO also provided aldehyde 
73 in 79% yield. Carboxylic acid 76 was synthesized from p-hydroxybenzoic acid (100) using 
silylation followed by hydrolysis reactions by Jianyu Lu, in our lab. So, the treatment of 
compound 100 with imidazole and TBSCl in DMF followed by hydrolysis with potassium 
carbonate provided compound 76 in 60% yield.
85
  
 
1.4 Anti-Alzheimer and anti-norovirus activities of tricyclic pyrones 
As mentioned earlier, most of the TP compounds were tested for both anti-Alzheimer and 
anti-norovirus activities. However, for the purpose of this dissertation, TPs 10 – 14 (Figure 1.11) 
with phenyl and naphthyl moieties are reported for anti-Alzheimer activity;
86
 while, TPs 15 – 33 
(Figure 1.12) with heterocyclic moieties and TPs 34, 35 (Figure 1.12) with phenyl moieties are 
reported for anti-norovirus activity.
87
 The most effective compounds (10D, 11C, 11D, and 12A) 
from MC65 cells protection assay were also evaluated for ACAT inhibition and ABCA1 gene 
modulation potencies.   
MC65 cells protection assay was carried out by Dr. Izumi Maezawa in Dr. Lee Way 
Jin’s lab at M. I. N. D. Institute and the Department of Pathology, University of California Davis 
Health System. ACAT inhibition, ABCA1 modulation, and Norovirus inhibitory study was 
performed by Yungeong Kim and Kyeong-Ok, Chang at the Department of Diagnostic 
Medicine and Pathology, College of Vetenary Medicine, Kansas State University.  
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 1.4.1 Anti-Alzheimer activities of tricyclic pyrones 
Anti-Alzheimer activity of TPs was accessed by observing the potency to protect MC65 
cells against intracellular amyloid-β oligomers induced toxicity. MC65 cells are neuroblastoma 
cells
86
, which are readily generated in cell culture. In MC65 cells, the generation of intracellular 
Aβ oligomers from C99 fragment of amyloid precursor protein (APP) leads to cell death after 3 
days. Efficacy of TP compounds 10 – 14 to prevent neuronal cell death was observed 
quantitatively by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
Tetracline (TC) prevents the formation of C99 fragment of APP; therefore, it also prevents the 
death of neuronal cells by supressing the Aβ formation. The efficacy of TPs to protect MC65 
cells was determined in the absence of tetracline, while in the presence of tetracline the toxicity 
of TP compounds was observed. The median effective concentration (EC50), median toxic 
concentration (TD50), and therapeutic index (TI, ratio of TD50 and EC50) of tricyclic pyrones (10 
- 14) are listed in Table 1.1.  
The results from MC65 cells protection assay showed that the compounds containing p-
hydroxy -phenyl, and -naphthyl groups have higher anti-Alzheimer potency than others. 3-
Methoxy-4-hydroxy aryl analog 10A showed submicromolar potency, and the substitution of 3-
methoxy in 10A with nitro or bromo (10B, 10C) led to the reduction of potency, while 
substitution with fluoro (10D) provided a compound with nanomolar activity.  Other 3,4-
disubstituted (10E – 10G) as well as 3,4,5-trisubstituted (10H) analogs were found inferior to 
compound 10A. Replacement of 3-methoxy with hydrogen in 10A also provided a candidate 
(11C) with nanomolar efficacy. Among monosubstituted aryl analogs, TPs with phenolic 
hydroxyl at ortho and meta (11A and 11B) showed low micromolar potency but were inferior to 
p-hydroxyl analog 11C. Conversion of the hydroxyl in 11C to the methyhydroxyl (11D) slightly  
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Table 1.1: MC65 cells protection assay of tricyclic pyrones 10 – 14. 
Compounds EC50 
(µM) 
TD50 
(µM) 
TI Compounds EC50 
(µM) 
TD50 
(µM) 
TI 
CP2 (9) 0.120 39.0 325 11F 3.24 37.3 11.5 
10A 0.242 26.3 109 11G 2.77 >50 >18.1 
10B 3.85 >50 >13.0 11H 6.41 39.4 6.15 
10C 0.639 >50 >78.2 11I 0.769 >50 >65.0 
10D 0.067 >50 >746 11J 4.36 38.2 8.76 
10E 1.56 >50 >32.1 11K 2.79 48 17.2 
10F 0.662 9.38 14.2 11L >50 >50 ---- 
10G 1.18 >50 >42.4 12A 0.145 13.7 94 
10H 1.26 >50 >39.7 12B 0.198 26.4 133 
11A 2.44 30.7 12.6 12C 0.621 15.3 24.6 
11B 4.66 >50 >10.7 12D 0.586 18.2 31.1 
11C 0.070 49.3 704 13 0.459 24.1 52.5 
11D 0.101 >50 >495 14A 6.25 6.69 1.07 
11E 24.50 >50 >2.04 14B >50 8.35 ---- 
 
diminished the potency.  While, further lengthening of the hydroxyl in the form of ethyl ether 
(11E) significantly decreased the MC65 cells protection efficiency. Replacing the hydroxyl part 
in analog 11C by hydrogen, methoxy, aldehdye, methyl ester, dimethyl amino, and chloro groups 
(11F – 11K) provided less potent analogs. Moreover, placement of cyano group (11L) 
significantly reduced the anti-Alzheimer potency. Analogous to the TPs with phenyl moieties, 
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the p-hydroxyl naphthyl analog 12A showed highest potency among the compounds 12A – 12D. 
Tricyclic pyrone amides 14A and 14B were significantly less effective than the amines analogs. 
Structure activity relationship of TPs indicated the necessity p-hydroxy aryl groups with 2° 
amine functionality for anti-Alzheimer activity.   
 
Table 1.2: ACAT inhibition and ABCA1 gene modulation activity of tricyclic pyrones. 
Compounds IC50 ACAT inhibition (µM) EC50 ABCA1 gene 
expression (µM) 
 
CP2 1.2 ± 0.2 1.9 ± 0.1 
10D 1.8 ± 0.03 2.2 ± 0.2 
11C 0.3 ± 0.08 1.1 ± 0.1 
11D 1.4 ± 0.2 2.5 ± 0.4 
12A 0.8 ± 0.06 1.3 ± 0.1 
CI-976 0.2 ± 0.1 0.6 ± 0.07 
   
TP compounds 10D, 11C, and 11D were identified more potent than earlier candidate 
CP2 in MC65 cells protection assay, and compound 12A also showed comparable activity with 
CP2. The most active analogs to protect MC65 cells along with CI-976, a well known ACAT 
inhibitor, were evaluated for ACAT inhibitory and ABCA1 modulation activities (Table 1.2) in 
MC65 cells. The ACAT inhibitory activity of the TPs was evaluated by measuring the intensity 
of fluorescence obtained from staining of cells incubated with mock-medium, TPs, and CI-976 in 
the presence of 22-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-23,24-bisnor-5-cholen-3-ol 
(NBD-cholesterol).
88
  NBD-cholesterol fluoresces with lipids containing cholesterol ester (CE); 
inhibitory activity of the TPs was measured by comparing intensities of fluorescence of the mock 
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treated cells without the TPs. TP compounds showed low micromolar to submicromolar (0.3 to 
1.8 µM) effectiveness, comparable with CI-976 to inhibit ACAT. The inhibition of ACAT will 
reduce the formation of cholesterol ester increasing the level of free cholesterol inside the cells, 
which then requires cholesterol efflux by increasing the cholesterol transporter gene ABCA1. 
Therefore, the observation of ABCA1 gene provides complementary information for the 
inhibition of ACAT. The modulation of ABCA1 gene by TPs was measured using gene 
expression assay.
89
 TP analogs 10D, 11C, 11D, 12A, and CP2 were also effective to upregulate 
the ABCA1 gene in low micromolar range. The ability of TPs to inhibit ACAT and upregulate 
ABCA1 gene was correlated with MC65 cells protection activity, but the inability of CI-976 to 
protect MC65 cells up to 50 µM indicates possibility of other mechanisms. Like CP2, other TP 
compounds may also disaggregate or/and block the formation of Aβ-oligomers leading to the 
protection of neuronal cells.
51
 TPs may also be effective by promoting the efflux of cholesterol 
increasing the efficiency of cholesterol transporters. Other possible pathways of TPs for the 
neuronal cells protection are reduction of APOE ε4 or inhibition of β-secratase.  
 1.4.2 Anti-norovirus activity of tricyclic pyrones 
Anti-norovirus activity was performed with quantitative reverse transcription-PCR (qRT-
PCR) method with one-step Platinum qRT-PCR kit by observing norovirus genome in norovirus 
replicon harboring cells.
87,90
 One day old norovirus harboring cells (HG23) were treated with 
different concentrations of each tricyclic pyrone compounds (0 [mock-DMSO] - 10 µM). 
Effective dose (EC50) for reducing 50% of NV genome was analyzed with real time qRT-PCR 
after 24 h of treatment. Similarly, the toxic dose (TD50) for for killing 50% of HG23 cells at 48 
hours of post treatment was analyzed by using cytotoxicity assay kit (Promega, Madison, WI). 
The NV inhibitory activity of the TPs 15 – 35 along with their precursor amine 39, 
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corresponding toxicities, and therapeutic indexes is listed in Table 1.3. Among TPs 15 – 24 
containing 5-membered aryl heterocycles, compounds 19 and 23A with pyrrolyl and imidazolyl 
moieties, respectively showed higher efficacy in low micromolar range. Similar potency was 
observed for 3-pyridinly analog 25, while 4-pyridinyl analog 26 was found less active. 
Dialkylated analogs 21B – 23B were found to have similar potency with corresponding mono 
alkylated analogs 21A – 23A. 2-Quinolinyl and 4-quinolinyl analogs 27A, 28A, and 28F were 
found to have increased anti-NV activity, compound 28A being the most potent. Addition of 
methyl substituent at 6-position (28F) in 4-quinolinyl TP 28A slightly reduced the activity, while 
addition of methyl, hydroxymethyl, acetoxymethyl, and trioxanyl moieties at 2-positions (28B – 
28E) diminished the efficacy significantly. Similarly, addition of the methyl substituents at 4 and 
6 -positions (27B, 27C) in 2-quinolinly analog 27A also lowered the efficacy. Other TPs with 6-
quinolinyl analog 29 only showed moderate potency, while 8-quinolinyl analog 30 was found 
inactive. TP containing benzo[h]quinolinyl moiety 31 showed less potency than its quinolinyl 
analog 28A. Conversion of the amine functionality in 28A to its amide or ester analogs also 
provided the inferior candidates 32 and 33, respectively. p-Hydroxyphenyl ester analog 34 was 
even inferior to 4-quinolinyl ester analog 33, while p-methoxybenzyl imine analog 35 showed 
comparable efficacy with ester 33. Tricyclic pyrone amine 39 was also found ineffective to 
inhibit NV replication. From structure activity relationships, the TPs containg pyrrolyl, 
imidazolyl, pyridinly, and quinolinyl moieties showed NV inhibitory activity in low micromolar 
range. Similar to the case in anti-Alzheimer activity, the 2° amine functionality was found more 
effective than amide and ester functionalities for anti-norovirus activity. The NV inhibitory 
activity of TPs may have been effective by inhibiting the cellular ACAT.  
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Table 1.3: Norovirus inhibitory activity of tricyclic pyrones. 
Compounds EC50 
(µM) 
TD50 
(µM)  
Therapeutic 
index (TI) 
Compounds EC50 
(µM) 
TD50 
(µM)  
Therapeutic 
index (TI) 
15 5.00 ---- ---- 27B 5.3 >200 >40 
16 5.00 >200 >40 27C 8.1 83.7 10.3 
17 7.00 >200 >28.5 28A 2.4 96.4 40.2 
18 7.00 >200 >28.5 28B 8.2 ND ---- 
19 4.00 >200 >50 28C 9.5 ND ---- 
20 8.00 >200 >25 28D 9.7 ND ---- 
21A 5.00 >200 >40 28E 8.4 ND ---- 
21B 5.00 >200 >40 28F 3.4 61.2 18 
22A >10 >200 ---- 29 8.1 ND ---- 
22B 7.00 >200 >28.5 30 >10 >160 ---- 
23A 4.00 >200 >50 31 5.3 >200 >40 
23B 5.00 >200 >40 32 5.5 103.5 18.8 
24 7.00 >200 >28.5 33 6.00 80 13.3 
25 4.1 >200 >50 34 8.00 80 10 
26 9.6 ND ---- 35 6.00 >200 >33.3 
27A 3.4 >200 >58.8 39 >10 >200 ---- 
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 1.5 Conclusions 
Tricyclic pyrones containing phenyl, naphthyl, heterocyclic, and dipeptidyl moieties were 
synthesized and evaluated for anti-Alzheimer and anti-norovirus activities.  
Several TPs with p-hydroxy -phenyl and -naphthyl showed sub-micromolar to nanomolar 
efficacy to protect MC65 cells against Aβ oligomers induced toxicity. The most active TPs in 
MC65 assay were also effective to inhibit ACAT and upregulate ABCA1 gene. Similarly, the 
tricyclic pyrones containing pyrrolyl, imidazolyl, pyridinyl, and quinolinyl moieties 
demonstrated effective inhibition of norovirus genome in low micromolar range. The secondary 
amine functionality was more effective than amide functionality for the efficacy against both 
disorders. High therapeutic index of tricyclic pyrones indicates higher potentiality of TPs to 
develop as drugs. Further pharmacokinetic studies or modifications of active TPs could generate 
drugs with required properties for the treatment of Alzheimer or/and norovirus. 
 
 
 
 
 
 
 
 
 
 
 
  37  
 
1.6 References
                                               
1. Puglielli, L.; Tanzi, R. E.; Kovacs, D. M. Alzheimer’s disease: the cholesterol connection, 
Nature Neuroscience, 2003, 6, 345-351. 
2. Wolfe, M. S. Introduction to special issue on Alzheimer’s disease , J. Med. Chem., 2012, 55, 
8977-8978. 
3. Center for Disease Control and Prevention, 
http://www.cdc.gov/norovirus/about/overview.html, 
http://www.cdc.gov/norovirus/about/treatment.html 
4. Maulik, M.; Westaway, D.; Jhamandas, J. H.; Kar, S. Role of cholesterol in APP metabolism 
and its significance in Alzheimer’s disease pathogenesis, Mol. Neurology, 2013, 47, 37-63. 
5. Herman, G. E. Disorders of cholesterol biosynthesis: prototypic metabolic malformation 
syndromes, Human Molecular Genetics, 2003, 12, R75-R88. 
6. Chang, C.; Dong, R.; Miyazaki, A.; Sakashita, N.; Zhang, Y.; Liu, J.; Guo, M.; Li, B.-L.; 
Chang, T.-Y. Human acyl-CoA: cholesterol acyltransferase (ACAT) and its potential as a target 
for pharmaceutical intervention against atherosclerosis, Acta Biochimica et Biophysica Sinica, 
2006, 38, 151-156. 
7. Young, S. G.; Fielding, C. J. The ABCs of cholesterol efflux, Nature Genetics, 1999, 22, 316-
318. 
8. Wolozin, B. Cholesterol and the biology of Alzheimer’s disease, Neuron, 2004, 41, 7-10. 
9. Chang, K.-Ok. Role of cholesterol pathways in norovirus replication, Journal of Virology, 
2009, 83, 8587-8597.  
10. Hua, D. H.; Huang, X.; Tamura, M.; Chen, Y.; Woltkamp, M.; Jin, L.-W.; Perchellet, E. M.; 
Perchellet, J. P.; Chiang, P. K.; Namatame, I.; Tomoda, H. Synthesis and bioactivities of tricyclic 
pyrones, Tetrahedron, 2003, 59, 4795-4803. 
11. Alzheimer Association, 2012 Alzheimer’s disease facts and figures (Alzheimer’s Association 
Report), Alzheimer’s and Dementia, 2012, 8, 131-168. 
12. http://www.alz.org/10 signs, http://www.alz.org/braintour/plaques_tangles.asp 
13. Clippingdale, A. B.; Wade, J. D.; Barrow, C. J. The amyloid-beta peptide and its role in 
Alzheimer’s disease, Journal of Peptide Science, 2001, 7 (5), 227-249. 
14. Lee, V. M. Regulation of tau phosphorylation in  Alzheimer’s disease, Annals of New York 
Academy of Sciences, 1996, 777, 107-113. 
  38  
 
                                                                                                                                                       
15. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and 
problems on the road to therapeutics, Science, 2002, 297, 353-356.  
16. St George-Hyslop, P. H.; Agnes, P. Molecular biology and genetics of Alzheimer’s disease, 
Comptes Rendus Biologies, 2005, 328, 119-130. 
17. Kivipelto, M.; Ngandu, T.; Fratiglioni, L.; Viitanen, M.; Kareholt, I.; Winblad, B.; Helkala, 
E. L.; Tuomilehto, J.; Soininen, H.; Nissinen, A. Obesity and vascular risk factors at midlife and 
the risk of dementia and Alzheimer disease, Arch Neural, 2005, 62, 1556-1560. 
18. Plassman, B. L.; Havlik, R. J.; Steffens, D. C.; Helms M. J.; Newman, T. N.; Drosdic, D.; 
Phillips, C.; Gau, B. A.; Welsh-Bohmer, K. A.; Burke, J. R.; Guralnik, J. M.; Breitner, J. C. 
Documented head injury in early adulthood and risk of Alzheimer’s disease and other demetias, 
Neurology, 2000, 55, 1158-1166. 
19. Mayeux, R.; Sano, M.; Chen, J.; Tatemichi, T.; Stem, Y. Risk of dementia in first-degree 
relatives of patients with Alzheimer’s disease and related disorders, Arch Neurol, 1991, 48, 269-
273. 
20. Mahley, R. W.; Weisgraber, K. H.; Huang, Y. Apolipoprotien ε4: A causative factor and 
therapeutic target in neuropathology including Alzheimer’s disease PNAS, 2006, 103, 5644-
5651. 
21. Wisniewski, T.; Castano, E. M.; Golabek, A.; Vogel, T.; Frangione, B. Acceleration of 
Alzheimer’s fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 1994, 145, 1030-1035. 
22. Distl, R.; Meske, V.; Ohm, T. G.; Tangle-bearing neurons contain more free cholesterol than 
adjacent tangle-free neurons, Acta Neuropathol., 2001, 101, 547-554. 
23. Katzov, H.; Chalmers, K.; Palmgren, J.; Anderson, N.; Johansson, B.; Cairns, N. J.; Gatz, M.; 
Wilcock, G. K.; Love, S.; Pedersen, N. L.; Brookes, A. J.; Blennow, R.; Kehoe, P. G.; Prince, J. 
A.  Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to 
beta-amyloid metabolism, Human Mutation, 2004, 23, 358-367. 
24. Kolsch, H.; Lutjohann, D.; Ludwig, M.; Schulte, A.; Ptok, U.; Jessen, F. Polymorphism in 
the cholesterol 24S-hydroxylase gene is associated with Alzheimer’s disease, Mol. Psychiatry, 
2002, 7, 899-902. 
25. Kang, J.; Rivest, S. Lipid metabolism and neuroinflamation in Alzheimer’s disease: A role 
for liver X receptors, Endocrine Reviews, 2012, 33, 715-746.  
26. Bertram, L.; McQueen, M. B.; Mullin, K.; Blacker, D.; Tanzi, R. E. Systematic meta-analysis 
of Alzheimer’s disease genetic association studies: the AlzGene database,  Nature, 2007, 39, 17-
23. 
27. Widdowson, M. A.; Sukla, A.; Bulens, S. N.; Beard, R. S.; Chaves, S. S.; Hammond, R.; 
Salehi, E. D. P.; Swabson, E.; Totaro, J.; Woron, R.; Mead. P. S.; Bresee, J. S.; Stephan, S. M.; 
  39  
 
                                                                                                                                                       
Glass, R. I. Norovirus and Foodborne Disease, United States, 1991-2000, Emerging Infectious 
Diseases, 2005, 11, 95-102.   
28. Goodgame, R. Norovirus Gastroenteritis, Current Gastroenterology Reports, 2006, 8, 401-
408.  
29. Houston, A. M.; Atmar, R. L.; Marcus, D. M.; Estes, M. K. Norwalk virus-like particle 
hemagglutination by  binding to H histo-blood group antigens, J. Virol., 2003, 77, 405-415. 
30. Lindesmith, L.; Moe, C.; Marionneau, S.; Ruvoen, N.; Jiang, X.; Lindblad, L.; Stewart, P.; 
Lependu, J.; Baric, R. Human susceptibility and resistance to Norwalk virus infection, Nature 
Medicine, 2003, 9, 548-553. 
31. Grren, K. Y.; Ando, T.; Balayan, M. S.; Berke, T.; Clarke, I. N.; Estes, M. K.; Matson, D. O.; 
Nakata, S.; Neill, J. D.; Studdert, M. J.; Thiel, H. J. Taxonomy of the caliciviruses, J. Infect. Dis., 
2000, 181, (suppl): S322-S330.  
32. Hardy, M. E. Norovirus protein structure and function, FEMS Microbiology Letters, 2005, 
253, 1-8. 
33. Clarke, I. N.; Lambden, P. R. Organization and expression of calicivirus genes, J. Infect. 
Dis., 2000, 181, (Suppl 2):S309-S316. 
34. Zheng, D.-P.; Ando, T.; Fankhauser, R. L.; Beard, R. S.; Glass, R. I.; Monroe, S. S.  
Norovirus classification and proposed strain nomenclature, Virology, 2006, 346, 312-323. 
35. Prasad, B. V. V.; Hardy, M. E.; Dokland, T.; Bella, J.; Rossmann, M. G.; Estes, M. K. X-ray 
crystallographic structure of the Norwalk virus capsid, Science, 1999, 286, 287-290. 
36. Lochridge, V. P.; Jutila, K. L.; Graff, J. W.; Hardy,  M. E. Epitopes in the P2 domain of 
norovirus VP1 recognized by monoclonal antibodies that block cell interactions, J. Gen. Virol. 
2005, 86, 2799-2806. 
37. Harrington, P. R.; Vinje, J.; Moe, C. L.; Baric, R. S. Norovirus capture with histo-blood 
group antigens reveals novel virus-ligand interactions, J. Virol, 2004, 78, 3035-3045. 
38. Prasad, B. V.; Rothnagel, R.; Jiang, X.; Estes, M. K. Three-dimensional structure of 
baculovirus-expressed Norwalk virus capsids, J. Virol., 1994, 68, 5117-5125. 
39. Gerondopoulos, A.; Jackson, T.; Monaghan, P.; Doyle, N.; Roberts, L. O. Murine norovirus-
1 cell entry is mediated through a non-clathrin, non-caveolae, dynamin, and cholesterol-
dependent pathway, J. Gen. Virol., 2010, 91, 1428-1438. 
40. Perry, J. F.; Wobus, C. E. Endocytosis of murine norovirus 1 into Murine Macrophages is 
dependent on Dynamin II and cholesterol, Journal Virol., 2010, 84, 6163-6176. 
  40  
 
                                                                                                                                                       
41. Charlton-Menys, V.; Durrington, P. N. Human cholesterol metabolism and therapeutic 
molecules, Exp. Physiol., 2007, 93, 27-42. 
42. Anderson, R. G.; Goldstein J.; Brown, M. From cholesterol homeostasis to new paradigms in 
membrane biology, Trends in Cell Biology, 2003, 13, 534-539. 
43. Chang, T.-Y.; Li, B.-L.; Chang, C. C. Y.; Urano, Y. Acyl-coenzyme A: cholesterol 
acyltransferases,  Am. J. Physiol. Endocrinol. Metab., 2009, 297, E1-E9. 
44. Hofmann, K. A superfamily of membrane-bound O-acyltrasferases with implications for Wnt 
signaling, Trends Biochem. Sci., 2000, 25, 111-112.  
45. Hutter-Paier, B.; Huttunen, H. J.; Puglielli, L.; Eckman, C. B.; Kim, D. Y.; Hofmeister, A.; 
Moir, R. D.; Domnitz, S. B.; Frosch, M. P.; Windish, M.; Kovacs, D. M. The ACAT inhibitor 
CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer’s disease, 
Neuron, 2004, 44, 227-238. 
46. Puglielli, L.; Konopka, G.; Pack-Chung, E.; Ingano, L. A. M.; Berezovska, O.; Hyman, B. T.; 
Chang, T. Y.; Tanzi, R. E.; Kovacs, D. M. Acyl-coenzyme A: cholesterol acyltransferase 
modulates the generation of amyloid-β peptide, Nature Cell Biology, 2001, 3, 905-912. 
47. Huttunen, H. J.; Kovacs, D. M. ACAT as a drug target for Alzheimer’s disease,  
Neurodegerative Dis., 2008, 5, 212-214. 
48. Omura, S.; Tomoda, H.; Kim, Y. K.; Nishida, H. Pyripyropenes, highly potent inhibitors of 
acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigates, Journal of Antibiotics, 
1993, 46, 1168-1169. 
49. Hua, D. H.; Chen, Y.; Sin, H.-S.; Maroto, M. J.; Robinson, P. D.; Newell, S. W.; Perchellet, 
E. M.; Ladesich, J. B.; Freeman, J. A.; Perchellet, J.-P.; Chiang, P. K. A one-pot condensation of 
pyrones and enals, synthesis of 1H, 7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans, 
J.  Org.  Chem., 1997, 62, 6888-6896. 
50. Maezawa, I.; Hong, H.-S.; Wu, H.-C.; Battina, S. K.; Rana, S.; Iwamoto, T.; Radke, G. A.; 
Pettersson, E.; Martin, G. M.; Hua, D. H.; Jin, L.-W. A novel tricyclic pyrone compound 
ameliorates cell death associated with intracellular amyloid-β oligomeric complexes, Journal of 
neurochemistry, 2006, 98, 57-67.  
51. Hong, H.-S.; Rana, S.; Barrigan, L.; Shi, A.; Zhang, Y.; Zhou, F.; Jin, L.-W.; Hua, D. H. 
Inhition of Alzheimer’s amyloid toxicity with a tricyclic pyrone in vitro and in vivo, Journal of 
neurochemistry, 2009, 108, 1097-1108. 
52. Tiew, K.-C.; He, G.; Aravapalli, S.; Mandadapu, S. R.; Gunnam, M. R.; Alliston, K. R.; 
Lushington, G. H.; Kim, Y.; Chang, K.-Ok.; Groutas, W. C. Design, synthesis, and evaluation of 
inhibitors of Norwalk virus 3C protease,  Bioorg. Med. Chem. Lett., 2011, 21, 5315-5319. 
  41  
 
                                                                                                                                                       
53. Brown, H. C.; Wetherill, R. B. Organoboranes for synthesis. 7. An improved general 
synthesis of primary amines from alkenes via hydroboration-organoborane chemistry, 
Tetrahedron, 1987, 43, 4071-4078. 
54. Pokhrel, L.; Kim, Y.; Nguyen, T. D. T.; Prior, A. M.; Lu, J.; Chang, K.-Ok.; Hua, D. H. 
Synthesis and anti-norovirus activity of pyranobenzopyrone compounds, Biorg. & Med. Chem. 
Lett., 2012, 22, 3480-3484. 
55. Borch, R. F.; Bernstein, M. D.; Durst, H. D. Cyanohydridoborate anion  as a selective 
reducing agent,  J. Am. Chem. Soc., 1971, 93, 2897-2904. 
56. Pokhrel, L.; Maezawa, I.; Nguyen, T. D. T.; Chang, K.-Ok.; Jin, L.-W.; Hua, D. H. Inhibition 
of Acyl-CoA: cholesterol acyltransferase (ACAT), overexpression of cholesterol transporter 
gene, and protection of amyloid β (Aβ) oligomers-induced neuronal cell death by tricyclic 
pyrone molecules, J. Med. Chem., 2012, 55, 8969-8973.  
57. Nicolaou, K. C.; Montagonon, T.; Baran, P. S.; Zhong, Y. – L.; Iodine (V) reagents in 
organic synthesis. Part 4. O-iodoxybenzoic acid as a chemospecific tool for single electron 
transfer-based oxidation process, J. Am. Chem. Soc., 2002, 124, 2245.  
58. Silva, P. L.; Pires, P. A. R.; Trassi, M. A. S.; El Seoud, O. A. Solvation in pure liquids: what 
can be learned from the use of pairs of indicators?, J. Phys. Chem. B, 2008, 112, 14976-14984.  
59. Rao, J. M. R.; Arumugam, N.; Ansari, M. M.; Gudla, C.; Pachiyappan, S.; Ramalingam, M.; 
George, J.; Arul, G. F.; Bommegowda, Y. K.; Angupillai, S. K.; Kottamalai, R.; Jidugu, P.; Rao, 
D. S. Preparation of methoxyiminophenylethyloxybenzyloxyphenylpropanoic acid derivatives 
and analogs use as GPR40 agonists, PCT Int. Appl. WO 2012011125 A1 20120126, 2012.  
60. Xi, F.; Kamal, F.; Schenerman, M. A. A novel and convenient transformation of nitriles to 
aldehydes, Tetrahedron Letters, 2002, 43, 1395-1396. 
61. Mak, C. C.; Bampos, N.; Darling, S. L.; Montalti, M.; Prodi, L.; Sanders, J. K. M. A strategy 
for the assembly of multiple porphyrin arrays based on the coordination chemistry of Ru-
centered porphyrin pentamers, J. Org. Chem., 2001, 66, 4476-4486. 
62. Kemp, S. J.; Storey, L. J.; Storey, J. M. D.; Richard, J.; Harrington, C. R.; Wischik, C. M.; 
Clunas, S.; Heinrich, T. K. Preparation of benzothiazole, imidazothiazole, imidazopyrimidine 
and imidazopyride compounds as ligands for aggregated tau molecules useful in diagnosis, 
prognosis, and treatment of diseases. PCT Int. Appl. WO 2010034982 A1 20100401, 2010. 
63. Pradin, C.; Pelletier, J. N.; Lubell, W. D.; Keillor, J. W. Cinnamoyl inhibitors of tissue 
transglutaminase, J. Org. Chem., 2008, 73, 5766-6775. 
64. Meyer, E.; Joussef, A. C.; Gallardo, H.; de Souza, L. B. P. Synthesis of new 4,5-dihydro-
3(2H)-pyridazinone derivatives, Synth. Commun., 2004, 34, 783-793. 
  42  
 
                                                                                                                                                       
65. Smith, W. B.; Deavenport, D. L.; Ihrig, A. M. Substituent effects on aromatic proton 
chemical shifts. VIII. Conformational effects of the carbonyl group in benzenes and 
naphthalenes, J. Am. Chem. Soc., 1972, 94, 1959-1965. 
66. Goel, M.; Jayakannan, M. Supramolecular liquid crystalline π-conjugates: the role of 
aromatic π-stacking and van der Waals forces on the molecular self-assembly of 
oligophenylenevinylenes, J. Phys. Chem. B., 2010, 114, 12508-12519. 
67. Acura, A. U.; Amat-Guerri, F.; Morcillo, P.; Liras, M.; Rodriguez, B. Structure and 
formation of the fluorescent compound of lignum nephriticum,  Org. Lett., 2009, 11, 3020-3023. 
68. Hua, D. H.; Huang, X.; Chen. Y.; Battina, S. K.; Tamura, M.; No, S. K.; Koo, S. I.; Tomoda, 
H.; Perchellet, E. M.; Perchellet, J. P. Total syntheses of (+)-chloropuupehenone and (+)-
chloropuupehenol, and their analogs, and evaluation of their bioactivities, J. Org. Chem., 2004, 
69, 6065-6078. 
69. McOmie, J. F. W.; Watts, M. L.; West, D. E. Demethylation of aryl methyl ethers by boron 
tribromide, Tetrahedron, 1968, 24, 2289-2292. 
70. Chamontin, K.; Lokshin, V.; Rossollin, V.; Samat, A. Synthesis and reactivity of formyl-
substituted photochromic 3,3-diphenyl-[3H]-naphtho[2, 1-b]pyrans, Tetrahedron, 1999, 55, 
5821-5830. 
71. Newman, M. S.; Sankaran, V.; Olson, D. R. Phenolic and ketonic tautomers in polycyclic 
aromatic hydrocarbons, J. Am. Chem. Soc., 1976, 98, 3237-3242. 
72. Hodgson, H. H.; Birtwell, S. The diazotization of 1-amino-2-hydroxy-4-cyanonaphthalene 
and the preparation of 4-cyano-2-naphthol, J. Chem. Soc. 1944, 539-540. 
73. Travis, B. R.; Sivakumar, M.; Hollist, G. O.; Borhan, B. Facile oxidation of aldehydes to 
acids and esters with oxone, Org. Lett., 2003, 5, 1031-1034.  
74. Corey, E. J.; Schmidt, G. Useful procedures for the oxidation of alcohols involving 
pyridinium dichromate in approtic media, Tetrahedron Letters, 1979, 20, 399-402. 
75. Mou, K.; Xu, B.; Ma, C.; Yang, X.; Zou, X.; Yang, L.; Xu, P. Novel CADD-based peptidyl 
vinyl ester derivatives as potential proteasome inhibitors, Bioorg. Med. Chem. Lett.,  2008, 18, 
2198-2202.  
76. Rivero, I. A.; Espinoza, K. A.; Ochoa, A.  The use of solid-phase supported 1-N-piperazine-
4-N-carboxaldehyde in Vilsmeier reactions, Journal of Combinatorial Chemistry, 2004, 4, 270-
274.  
77. Masahiro, K.; Atsushi, H.; Haruyuki, H. Preparation of substituted 1-heterocyclysulfonyl-2-
aminomethyl-5-(hetero)aryl-1H-pyrrole derivatives as acid secretion inhibitors for treating ulcer 
and related disorders, PCT Int. Appl. WO 2007026916 A1, 20070308, 2007.  
  43  
 
                                                                                                                                                       
78. Gardini, G. P. Homolytic aromatic substitution: simple route to the aldehydes of 
heteroaromatic bases, Tetrahedron Letters, 1972, 40, 4113-4116. 
79. Giordano, C.; Minisci, F.; Vismara, E.; Levi, S. A general, selective, and convenient 
procedure of homolytic formylation of heteroaromatic bases, J. Org. Chem., 1986, 51, 536-537. 
80. Fakhfakh, M. A.; Fournet, A.; Prina, E.; Mouscadet, J.-F.; Franck, X.; Hocquemiller, R.; 
Figadere, B. Synthesis and biological evaluation of substituted quinolines: potential treatment of 
protozoal and retroviral co-infections, Bioorg. Med. Chem., 2003, 11, 5013-5023. 
81. Gobeil, R. J.; Hamilton, C. S. Derivatives of benzo[h]quinoline, J. Am. Chem. Soc., 1945, 67, 
511-513. 
82. Perez-Melero, C.; Maya, A. B. S.; del Rey, B.; Pelaez, R.; Caballero, E.; Medarde, M. A new 
family of quinoline and quinoxaline analogues of combretastatins, Bioorg. Med. Chem. Lett., 
2004, 14, 3771-3774.  
83. Tamaddon, F.; Amrollahi, M. A.; Sharafat, L. A green protocol for selective O-acylation in 
the presence of zinc oxide, as a heterogeneous, reusable, and eco-friendly catalyst, Tetrahedron 
Letters, 2005, 46, 7841-7844.  
84. Anklin, C. G.; Pregosin, P. S. Cyclic acyl complexes of palladium (II). Synthesis and NMR 
spectroscopy of acyl complexes derived from quinoline-8-carboxaldehyde and 2-
(dimethylamino)benzaldehyde, J. Organomet. Chem., 1983, 243, 101-109. 
85. Zhao, Y.; Zhang, W.; Li, J.; Yu, F.; Pu, J. Synthesis and performance of a novel coumarin-
containing side-chain liquid crystalline polymer, Solid State Phenomena, 2012, 181-182, 197-
200. 
86. Hong, H.-S.; Mawzawa, I.; Yao, N.; Diaz-Avalos, R.; Rana, S.; Hua, D. H.; Cheng, R. H.; 
Lam, K. S.; Jin, L.-W. Combining the rapid MTT formazan extocytosis assay and the MC65 
protection assay let to the discovery of the carbozole analogs as small molecule inhibitors of Aβ 
oligomer-induced cytotoxicity, Brain Res., 2007, 1130, 223-234. 
87. Chang, K.-Ok.; Sosnovtsev, S. V.; Balliot, G.; King, A. D.; Green, K. Y. Stable expression of 
a Norwalk virus RNA replicaon in a human hepatoma cell line, Virology, 2006, 353,  463-473. 
88. Lada, A. T.; Davis, M.; Kent, C.; Chapman, J.; Tomoda, H.; Omura, S.; Rudel, L. L. 
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence 
assay: individual ACAT uniqueness, J. Lipid Res., 2004, 45, 378-386. 
89. Chawala, A.; Boisvert, W. A.; Lee, C. H.; Laffitte, B. A.; Barak, Y.; Joseph, S. B.; Liao, D.; 
Nagy, L.; Edwards, P. A.; Curtiss, L. K.; Evans, R. M.; Tontonoz, P. A PPAR gamma-LXR-
ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis, Molecular 
Cell, 2001, 7, 161-171. 
  44  
 
                                                                                                                                                       
90. Chang, K.-Ok.; George, D. W. Interferons and ribavirin effectively inhibit Norwalk virus 
replication in replicon-bearing cells, J. virol., 2007, 81, 12111-12118. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  45  
 
 1.7 Experimental 
General Methods: NMR spectra were obtained from 400-MHz and 200-MHz spectrometers 
(Varian Inc.), in CDCl3, unless otherwise indicated, and reported in ppm.  Infrared spectra were 
taken from a Nicolet 380 FT-IR instrument (Thermo Scientific) in solid forms and reported in 
cm
-1
.  Low-resolution mass spectra were taken from an API 2000-triple quadrupole ESI-MS/MS 
mass spectrometer (from Applied Biosystems).  High-resolution Mass spectra were obtained 
from a LCT Premier (Waters Corp., Milford MA) time of flight mass spectrometer.  The 
instrument was operated at 10,000 resolution (W mode) with dynamic range enhancement that 
attenuates large intensity signals.  The cone voltage was 60 eV.  Spectra were acquired at 16666 
Hz pusher frequency covering the mass range 100 to 1200  and accumulating data for 2 seconds 
per cycle.  Mass correction for exact mass determinations was made automatically with the lock 
mass feature in the MassLynx data system.  A reference compound in an auxiliary sprayer is 
sampled every third cycle by toggling a “shutter” between the analysis and reference needles.  
The reference mass is used for a linear mass correction of the analytical cycles.  Chemicals were 
purchased from Fisher Scientific, Aldrich Chemical Co., Chem-Impex International, and VWR.  
CI-976 was purchased from Sigma Chemical Company.   
MC65 cell assay:
50
 MC65 cells were grown in the presence of 1 g/mL tetracycline (TC), and 
cell toxicity was induced via the formation of APP in the absence of tetracycline (TC) by 
generating C99, a precursor of APP. Cells were washed extensively, and plated at a density of 
1.2 to 1.5 x 10
5
 cells/cm
2
 in Opti-minimal essential medium (MEM; without phenol-red) from 
Gibco/BRL (Carlsbad, CA, USA) without serum and without TC. Different concentrations of 
each TP compound were added and cell viabilities were assessed using a colorimetric MTT 
assay. The cytotoxicity was determined using MTT assay in the presence of TC, the results of 
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which were comparable with data obtained using counts of viable cells based on trypan blue 
exclusion and the live/dead assay. 
Assay for ACAT activity:
88
 Intracellular ACAT activity by the treatment with each compound 
was measured using staining of lipid droplets with NBD-cholesterol. MC65 or Huh-7 cells 
grown in 96-well plates were treated with each compound at the concentration ranging 0.01 to 20 
µg/ml or mock-medium for 20 min. After initial incubation, the medium was replaced with 200 
µl of medium containing
 
1 µg/ml NBD-cholesterol and the same treatment. Cells were further 
incubated for 48 hr, the lipid droplets were measured by the intensity of fluorescence on a 
fluorescent
 
plate reader (FLx800, Bioteck) equipped with 485 nm excitation and 535 nm 
emission
 
filters. Relative ACAT activity by each treatment was calculated by the comparison of 
fluorescence signals to mock-medium treatment. CI-976, a known ACAT inhibitor, was used as 
a control.  
Detection of ABCA1 mRNA levels:
89
 The inhibition of ACAT increases the level of free 
cholesterol, subsequently induce oxidation of cholesterol (oxycholesterol) and activate the LXR 
pathway. Therefore, the induction of cholesterol efflux-related proteins such as ABCA1 in MC65 
and Huh-7 cells was examined. Cells grown in 6-well plates were incubated with the same 
compounds or mock-medium as above for 24 hr, and the expression of ABCA1 gene was 
assessed with the Gene Expression Assay (Applied Biosystems) after total RNA was extracted. 
The mRNA levels by each treatment were compared to those by mock-medium treatment. The 
known ACAT inhibitor, CI-976 was also used as a control in this study. 
Anti-norovirus activity of tricyclic pyrones:
87,90
 The anti-noroviral effects of each compounds 
were examined in NV replicon-harboring cells (HG23 cells). Briefly, One-day old, 80 - 90% 
confluent HG23 cells were treated with varying concentrations of each compound (0 [mock-
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DMSO] - 10 µM) to examine their effects on the replication of NV.  At 48 hrs of treatment, the 
NV genome was analyzed with real time qRT-PCR. The EC50 of each compound for NV genome 
levels was determined at 48 hrs post-treatment. HG23 cells were also treated with varying 
concentrations (0 [mock-DMSO] - 200 µM) of each compound to assess the cytotoxic effects.  
Cell cytotoxicity assay kit (Promega, Madison, WI) was used to calculate the median toxic dose 
(TD50) at 48 hrs of treatment. 
 
(5aS,7S)-7-Isoprepenyl-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-
b][1]benzopyran (7) 
O
O
O
H
 
A mixture of 10 g (79.36 mmol) of 4-hydroxypyrone 37 and 4.56 g (39.68 mmol) of L-proline, 
and 11.9 g (79.36 mmol) of perillaldehyde (38) in 500 mL of ethyl acetate was refluxed for 30 h. 
Then the mixture was diluted with ethyl acetate (400 mL), washed with brine (300 mL x 4), 
concentrated to 300 mL, and crystallized at -0 °C to get 15.9 g (78%) of compound 7, whose 
1
H 
and 
13
C NMR spectra are identical to that reported.
49  
(5aS,7S)-7-[(1R) and (1S)-2-Amino-1-methylethyl)-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (39) 
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O
O
O
NH2
H
 
10 mL (10 mmol) of BH3•THF complex (1.0 M in THF) was added dropwise to a cold (0 
o
C) 
solution of 5.0 g (19.4 mmol) of compound 7 in 100 mL of THF, under argon.  After stirring the 
solution at 0 
o
C for 2 h and 25 
o
C for 12 h, the borane solution was added to 3.3 g (29.2 mmol) of 
hydroxylamine-O-sulfonic acid via a cannula followed by the addition of 20 mL of chloroform.  
The reaction mixture was heated to reflux for 7 h, cooled to 25 
o
C, diluted with 300 mL of ethyl 
acetate, and extracted with 2 N HCl (100 mL x 2).  The combined HCl layer was washed three 
times with ethyl acetate (100 mL each), basified carefully with 5% sodium carbonate until pH = 
9 ~ 10, and extracted three times with dichloromethane. The combined dichloromethane layer 
was washed with brine, dried (anhydrous Na2SO4), and concentrated to give 2.7 g (50% yield) of 
compound 39, whose 
1
H and 
13
C NMR spectra are identical to that reported.
10 
(5aS,7S)-7-[(1R) and (1S)-2-hydroxy-1-methylethyl)-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (40) 
O
O
O
OH
H
 
7.5 mL (7.5 mmol) of BH3•THF complex (1.0 M in THF) was added dropwise to a cold (0 
o
C) 
solution of 4.1 g (14.8 mmol) of compound 7 in 50 mL of THF, under argon.  After stirring the 
solution at 0 
o
C for 2 h and 25 
o
C for 12 h, solutions of 40 mL of 0.5% NaOH and 15 mL of 30% 
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H2O2 were added at 0 °C. After stirring for 2 h at 0 °C, the mixture was diluted with ethyl acetate 
(300 mL), washed with a solutions of NaHCO3 and brine, separately; dried with MgSO4, 
concentrated, and purified through silica gel column eluting with a gradient mixture of hexanes 
and ethyl acetate to get 3.6 g (82% yield) of alcohol 40, whose 
1
H and 
13
C NMR spectra are 
identical to that reported.
10
   
General procedure to synthesize tricyclic pyrones 10A – 11G, 11I – 1356 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-hydroxy-3-methoxy)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10A) 
O
O
O
H
N
H
OMe
OH
 
A mixture of 250 mg (0.9 mmol) of amine 39 and 138 mg (0.9 mmol) of aldehyde 43A in 10 mL 
of dry methanol was stirred for overnight. To this was added 10 drops of acetic acid followed by 
a solution of 141 mg (2.25 mmol) of NaBH3CN in methanol. After stirring for 1 h, the mixture 
was diluted with 50 mL of 5% NH4OH and extracted in dichloromethane (100 x 3). The 
combined organic layer was washed with brine, dried with MgSO4, concentrated, and purified 
through silica gel column using a gradient mixture of dichloromethane and methanol as eluent to 
get 236 mg (63% yield) of 10A as a solid. M.p. 71 – 74 oC;  FTIR (solid)  3600 - 3100 (b, w), 
2900, 2866, 1693, 1560, 1506, 1443, 1263, 1224, 1142, 807;  
1
H NMR δ   6.81 (s, 1 H),  6.73 (d, 
J = 8.4 Hz, 1 H), 6.68 (d, J = 8.4 Hz, 1 H), 5.95 (s, 1 H), 5.64 (s, 1 H), 4.99 – 4.90 (m, 1 H), 3.71 
(s, 3 H),   3.67 (s, 2 H), 2.58 (dd, J = 11.3, 4.0 Hz, 1 H), 2.47 - 2.37 (m, 1 H), 2.33 (d, J = 13.6 
Hz, 1 H), 2.10 (s, 3 H), 1.99 – 1.81 (m, 2 H), 1.69 – 1.36 (m, 4 H), 1.20 – 0.95 (m, 1 H), 0.83 and 
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0.82 (2 d, J = 6.6 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.31, 163.29, 162.6, 161.5, 
147.1, 145.3, 132.7, 130.3, 121.1, 114.8, 111.3, 108.9, 99.8, 97.2, 79.5, 79.4, 55.6, 55.6, 53.7, 
52.6, 52.5, 39.0, 38.5, 38.4, 37.0, 36.9, 36.5, 32.2, 32.1, 30.8, 28.2, 20.0, 14.5, 14.4; MS 
(electrospray ionization) m/z 412.1 (M+H
+
), 276.5, 137.3; HRMS calcd for C24H30NO5
+
 (M+H
+
) 
412.2124, found 412.2124 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-hydroxy-3-nitro)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10B) 
O
O
O
H
N
H
NO2
OH
 
From 85 mg (0.31 mmol) of amine 39 and 52 mg (0.31 mmol) of aldehyde 43B, 89 mg (68% 
yield) of 10B was obtained as a solid. M.p. 76 – 78 oC;  FTIR (solid)  3400 - 3200 (b, w), 2932, 
1693, 1615, 1566, 1534, 1509, 1447, 1334, 1232, 1143, 819, 761;  
1H NMR  δ 8.04 (d, J = 1.4 
Hz, 1 H), 7.56 (dd, J = 8.6, 2.0 Hz, 1 H), 7.09 (d, J = 8.6 Hz, 1 H), 6.02 (s, 1 H), 5.68 (s, 1 H), 
5.11 – 4.95 (m, 1 H), 3.74 (s, 2 H), 2.64 – 2.49 (m, 1 H), 2.49 – 2.33 (m, 2 H), 2.16 (s, 3 H), 2.09 
– 1.86 (m, 2 H), 1.77 – 1.37 (m, 4 H), 1.33 – 1.02 (m, 1 H), 0.89 and 0.88 (2 d, J = 6.6 Hz, 3 H, 
CH3 of two diastereomers); 
13C NMR δ 163.4, 163.3, 162.7, 161.6, 154.3, 137.7, 133.4, 133.2, 
132.8, 123.9, 120.1, 109.2, 99.9, 97.4, 79.7, 79.6, 53.1, 53.0, 52.7, 39.3, 38.7, 38.5, 37.9, 37.7, 
36.8, 32.5, 32.3, 31.1, 28.6, 20.2, 14.9, 14.6; MS (electrospray ionization) m/z 427.5 (M+H
+
), 
276.3, 139.1; HRMS calcd for C23H27N2O6
+
 (M+H
+
) 427.1869, found 427.1880 (100%). 
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(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(3-bromo-4-hydroxy)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10C) 
O
O
O
H
N
H
Br
OH
 
From 85 mg (0.31 mmol) of amine 39 and 62 mg (0.31 mmol) of aldehyde 43C, 80 mg (56% 
yield) of 10C was obtained as a solid. M.p. 67 – 68 oC;  FTIR (solid)  3550 - 3150 (b, w), 2925, 
1681, 1564, 1513, 1447, 1422, 1293, 1232, 1147, 1047, 822, 763, 669;  
1H NMR δ 7.45 (s, 1 H), 
7.16 (d, J = 8.0 Hz, 1 H), 6.95 (d, J = 8.2 Hz, 1 H), 6.07 (s, 1 H), 5.71 (s, 1 H), 5.10 – 5.02 (m, 1 
H), 3.71 (s, 2 H), 2.64 – 2.56 (m, 1 H), 2.50 – 2.41 (m, 2 H), 2.19 (s, 3 H), 2.08 – 1.93 (m, 2 H), 
1.74 – 1.46 (m, 4 H), 1.30 – 1.05 (m, 1 H), 0.91 and 0.90 (2 d, J = 6.8 Hz, 3 H, CH3 of two 
diastereomers); 
13C NMR δ 163.50, 163.47, 162.8, 161.7, 151.9, 133.0, 132.0, 129.1, 116.4, 
110.5, 109.3, 100.0, 97.6, 79.8, 79.7, 53.2, 53.1, 39.4, 38.8, 38.7, 37.8, 37.7, 36.9, 32.6, 32.4, 
31.2, 28.6, 20.3, 14.9, 14.7; MS (electrospray ionization) m/z 462.1 (M+2), 459.9 (M+H
+
), 
276.3, 115.1; HRMS calcd for C23H27NO4Br
+
 (M+H
+
) 460.1123, found 460.1146. 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(3-fluoro-4-hydroxy)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10D) 
O
O
O
H
N
H
F
OH
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From 85 mg (0.31 mmol) of amine 39 and 44 mg (0.31 mmol) of aldehyde 43D, 80 mg (65% 
yield) of 10D was obtained as a solid. M.p. 90 – 92 oC;  FTIR (solid)  3500 - 3100 (b, w), 2929, 
1686, 1566, 1517, 1447, 1289, 1233, 1203, 1146, 1007, 860, 763;  
1H NMR δ 6.98 (dd, J = 11.6, 
1.6 Hz, 1 H), 6.94 – 6.84 (m, 2 H), 6.07 (s, 1 H), 5.71 (s, 1 H), 5.10 – 4.99 (m, 1 H), 3.67 (s, 2 
H), 2.66 – 2.59 (m, 1 H), 2.51 – 2.41 (m, 2 H), 2.19 (s, 3 H), 2.08 – 1.92 (m, 2 H), 1.73 – 1.44 
(m, 4 H), 1.30 – 1.06 (m, 1 H), 0.92 and 0.91 (2 d, J = 6.8 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.52, 163.49, 162.8, 161.8, 152.9, 150.5, 143.9, 143.7, 132.9, 124.8, 118.4, 116.1, 
115.9, 109.4, 100.0, 97.6, 79.8, 79.7, 53.5, 53.2, 53.1, 39.3, 38.9, 38.8, 37.5, 37.4, 36.9, 32.5, 
32.4, 31.1, 28.5, 20.3, 14.8, 14.7; MS (electrospray ionization) m/z 400.1 (M+H
+
), 276.2, 147.4, 
139.0; HRMS calcd for C23H27NO4F
+
 (M+H
+
) 400.1924, found 400.1924 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(3-hydroxy-4-methoxy)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10E) 
O
O
O
H
N
H
OH
OMe
 
From 85 mg (0.31 mmol) of amine 39 and 47 mg (0.31 mmol) of aldehyde 43E, 89 mg (70% 
yield) of 10E was obtained as a solid. M.p. (TFA salt) 85 – 87 oC;  FTIR (TFA salt; solid)  
3500 - 3200 (b, w), 2939, 1671, 1567, 1513, 1444, 1278, 1198, 1181, 1134, 1028, 810, 720;  
1
H 
NMR  δ 6.95 (s, 1 H), 6.82 – 6.72 (m, 2 H), 6.00 (s, 1 H), 5.67 (d, J = 4.4 Hz, 1 H), 5.01 (td, J = 
10.4, 4.7 Hz, 1 H), 3.82 (s, 3 H), 3.74 (s, 2 H), 2.62 (dd, J = 11.9, 6.0 Hz, 1 H), 2.51 – 2.43 (m, 1 
H), 2.38 (d, J = 14.4 Hz, 1 H), 2.15 (s, 3 H), 2.03 – 1.88 (m, 2 H), 1.78 – 1.37 (m, 4 H), 1.31 – 
0.99 (m, 1 H), 0.88 and 0.87 (2 d, J = 6.4 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.4, 
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162.7, 161.6, 146.6, 146.1, 132.8, 130.9, 120.2, 115.3, 110.9, 109.1, 99.9, 97.4, 79.6, 79.5, 56.0, 
55.98, 53.0, 52.1, 52.0, 39.2, 38.4, 38.2, 36.9, 36.8, 36.4, 32.4, 32.2, 31.0, 28.0, 20.2, 14.5, 14.4; 
MS (electrospray ionization) m/z (negative Mode) 410.3 (M-1), 274.3, 121.3; HRMS calcd for 
C24H30NO5
+
 (M+H
+
) 412.2124, found 412.2115 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(3,4-di(benzyloxy)benzylamino]propan-2-yl}-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10F) 
O
O
O
H
N
H
OBn
OBn
 
From 85 mg (0.31 mmol) of amine 39 and 99 mg (0.31 mmol) of aldehyde 43F, 117 mg (66% 
yield) of 10F was obtained as a solid. M.p. (TFA salt) 83 – 85 oC;  FTIR (solid)  3400 (b, w), 
2870, 1674, 1530, 1405, 1265, 1200, 1173, 1008, 821, 797, 719, 737, 696;  
1H NMR δ 7.46 (d, J 
= 7.6 Hz, 2 H), 7.43 (d, J = 7.6 Hz, 2 H), 7.39 - 7.26 (m, 6 H), 7.09 (d, J = 6.4 Hz, 1 H), 690 – 
683 (m, 2 H), 6.05 (s, 1 H), 5.66 and 5.62 (2d, 1 H, two diastereomers), 5.18 (s, 2 H), 5.11 (s, 2 
H), 5.09 – 4.99 (m, 1 H), 381 - 3.71 (m, 2 H), 2.63 – 2.53 (m, 1 H), 2.49 – 2.35 (m, 2 H), 2.13 (s, 
3 H), 2.04 – 1.88 (m, 2 H), 1.78 – 1.40 (m, 4 H), 1.27 – 1.00 (m, 1 H), 0.90 and 0.88 (2 d, J = 6.8 
Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.3, 263.3, 162.6, 161.6, 149.0, 148.4, 
148.37, 137.3, 132.6, 128.5, 128.5, 127.8, 127.4, 127.3, 121.7, 115.2, 115.1, 114.8, 109.2, 99.8, 
97.3, 79.5, 79.4, 71.2, 71.1, 53.1, 53.0, 52.0, 39.1, 38.4, 38.1, 36.9, 36.7, 36.3, 32.3, 32.1, 30.9, 
28.2, 20.1, 14.6, 14.3;  MS (electrospray ionization) m/z 578.7 (M+H
+
), 181.2; HRMS calcd for 
C37H40NO5
+
 (M+H
+
) 578.2906, found 578.2921 (100%). 
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(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[( benzo[d][1,3]dioxol-5-
ylmethylamino)benzylamino]propan-2-yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-
b][1]benzopyran (10G) 
O
O
O
H
N
H
O
O
 
From 85 mg (0.31 mmol) of amine 39 and 46.5 (0.31 mmol) of aldehyde 43G, 90 mg (71% 
yield) of 10G was obtained as a solid. M.p. (HCl salt) 107 – 110 oC;  FTIR (HCl salt; solid)  
3367 (b, w), 2928, 1682, 1564, 1446, 1250, 1035, 923, 810, 723;  
1H NMR δ 6.84 (s, 1 H), 6.75 
(s, 2 H), 6.05 (s, 1 H), 5.93 (s, 2 H), 5.69 (s, 1 H), 5.08 – 4.99 (m, 1 H), 3.69 (s, 2 H), 2.62 – 2.54 
(m, 1 H), 2.48 – 2.38 (m, 2 H), 2.18 (s, 3 H), 2.06 – 1.87 (m, 2 H), 1.73 – 1.44 (m, 4 H), 1.37 - 
1.03 (m, 1 H), 0.89 and 0.88 (2 d, J = 7.0 Hz, 3 H, CH3 for two diastereomers); 
13C NMR δ 
163.4, 163.36, 162.7, 161.6, 147.9, 146.7, 134.1, 133.0, 132.93, 121.42, 121.41, 109.3, 108.8, 
108.2, 101.1, 99.9, 97.5, 79.8, 79.7, 54.0, 52.93, 52.85, 39.4, 38.8, 38.6, 37.8, 37.7, 36.8, 32.5, 
32.4, 31.2, 28.5, 20.3, 14.8, 14.7; MS (electrospray ionization) m/z 410.3 (M+H
+
), 315.0, 214.4, 
115.1; HRMS calcd for C24H28NO5
+
 (M+H
+
) 410.1967, found 410.1958 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-hydroxy-3,5-dimethoxy)benzylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (10H) 
O
O
O
H
N
H
OMe
OH
OMe
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From 85 mg (0.31 mmol) of amine 39 and 56 mg (0.31 mmol) of aldehyde 43H, 103 mg (76% 
yield) of 10H was obtained as a solid. M.p. (TFA salt) 108 – 110 oC;  FTIR (TFA salt; solid)  
3500 - 314 (b, w), 2836, 1677, 1566, 1521, 1450, 1431, 1332, 1200, 1115, 831, 720;  
1H NMR  δ 
6.59 (s, 2 H), 6.01 (s, 1 H), 5.67 (s, 1 H), 5.02 (d, J = 9.4 Hz, 1 H), 3.83 (s, 6 H), 3.73 (s, 2 H), 
2.72 – 2.55 (m, 1 H), 2.55 – 2.29 (m, 2 H), 2.15 (s, 3 H), 2.07 – 1.80 (m, 2 H), 1.80 – 1.36 (m, 4 
H), 1.32 – 1.00 (m, 1 H), 0.89 (d, J = 6.2 Hz, 3 H, CH3); 
13C NMR δ 163.33, 163.32, 162.6, 
161.6, 147.3, 134.2, 132.7, 129.4, 109.2, 105.3, 99.9, 97.4, 79.6, 79.5, 56.4, 54.0, 52.5, 39.2, 
38.7, 38.5, 37.1, 37.0, 36.7, 32.4, 32.2, 31.0, 28.4, 20.2, 14.8, 14.6; MS (electrospray ionization) 
m/z (Negative Mode) 440.3 (M-1), 274.3, 230.2; HRMS calcd for C25H32NO6
+
 (M+H
+
) 
442.2230, found 442.2236 (100%). 
 (5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(2-hydroxybenzylamino)propan-2-yl]-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11A) 
O
O
O
H
N
H
OH  
From 85 mg (0.31 mmol) of amine 39 and 38 mg (0.31 mmol) of aldehyde 44A, 75 mg (64% 
yield) of 11A was obtained as a solid. M.p. 73 – 75 oC;  FTIR (solid)  3500 - 3090 (b, w), 2852, 
1701, 1638, 1566, 1448, 1419, 1256, 1232, 1146, 817, 754; 
1H NMR δ 7.18 (t, J = 7.6 Hz, 1 H), 
7.00 (d, J = 7.2 Hz, 1 H), 6.84 (d, J = 8.4 Hz, 1 H), 6.79 (t, J = 7.4 Hz, 1 H), 6.08 (s, 1 H), 5.71 
(t, J = 0.8 Hz, 1 H), 5.11 – 5.02 (m, 1 H), 3.99 (s, 2 H), 2.73 - 2.64 (m, 1 H), 2.60 – 2.51 (m, 1 
H), 2.46 (d, J = 14.0 Hz, 1 H), 2.19 (s, 3 H), 2.09 – 1.92 (m, 2 H), 1.73 – 1.45 (m, 4 H), 1.31 – 
1.05 (m, 1H), 0.95 and 0.94 (2 d, J = 6.8 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.4, 
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162.7, 161.7, 158.3, 132.6, 129.0, 128.5, 122.7, 119.2, 116.5, 109.5, 99.9, 97.5, 79.6, 79.5, 53.2, 
52.9, 52.9, 39.3, 38.8, 38.7, 37.6, 37.57, 36.8, 32.4, 32.3, 31.1, 28.5, 20.3, 14.8, 14.7; MS 
(electrospary ionization) m/z 382.4 (M+H
+
), 276.5, 247.4, 139.1; HRMS calcd for C23H28NO4
+
 
(M+H
+
) 382.2018, found 382.2033 (100%). 
(5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(3-hydroxybenzylamino)propan-2-yl]-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11B) 
O
O
O
H
N
H
OH  
From 85 mg (0.31 mmol) of amine 39 and 38 mg (0.31 mmol) of aldehyde 44B, 59 mg (50% 
yield) of 11B was obtained as a solid. M.p. (TFA salt) 55 - 57
o
C;  FTIR (TFA salt; solid)  3500 
- 3100 (b, w), 2941, 2871, 1671, 1590, 1564, 1450, 1197, 1134, 797, 720, 695;  
1H NMR δ 7.14  
(t, J = 8.0 Hz, 1 H), 6.78 (d, J = 7.2 Hz, 1 H), 6.77 (s, 1 H), 6.73 (d, J = 8.8 Hz, 1 H), 6.03 (s, 1 
H), 5.71 (d, J = 2 Hz, 1 H), 5.05 – 4.96 (m, 1 H), 3.71 (s, 2 H), 2.68 – 2.60 (m, 1 H), 2.52 – 2.44 
(m, 1 H), 2.40 (d, J = 13.2 Hz, 1 H), 2.18 (s, 3 H), 2.05 - 1.87 (m, 2 H), 1.74 – 1.40 (m, 4 H), 
1.34 - 1.02 (m, 1 H), 0.88 (d, J = 6.6, Hz, 3 H, CH3); 
13C NMR δ 163.62, 163.60, 163.0, 161.8, 
157.2, 140.7, 132.9, 129.8, 120.0, 115.7, 115.0, 109.2, 100.1, 97.5, 79.8, 79.7, 53.9, 53.0, 52.9, 
39.3, 38.7, 38.6, 37.3, 37.2, 36.7, 32.5, 32.3, 31.1, 28.3, 20.3, 14.7, 14.6; MS (electrospray 
ionization) m/z 404.3 (M+Na
+
), 382.2 (M+H
+
), 139.1, 107.1; HRMS calcd for C23H28NO4
+
 
(M+H
+
) 382.2018, found 382.2000 (100%). 
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(5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(4-hydroxybenzylamino)propan-2-yl]-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11C) 
O
O
O
H
N
H
OH
 
From 85 mg (0.31 mmol) of amine 39 and 38 mg (0.31 mmol) of aldehyde 44C, 80 mg (68% 
yield) of 11C was obtained as a solid. M.p. 75 – 78 oC; FTIR (solid)  3276 (b, w), 1682, 1637, 
1565, 1514, 1446, 1231, 1146, 879, 762; 
1H NMR δ 7.16 (d, J = 8.0 Hz, 2 H), 6.76 (d, J = 8.4 
Hz, 2 H), 6.06 (s, 1 H), 5.71 (s, 1 H), 5.09 – 4.99 (m, 1 H), 3.70 (s, 2 H), 2.66 – 2.57 (m, 1 H), 
2.51 – 2.39 (m, 2 H), 2.19 (s, 3 H), 2.07 – 1.90 (m, 2 H), 1.73 – 1.47 (m, 4 H), 1.29 – 1.08 (m, 1 
H), 0.90 and 0.89 (2 d, J = 6.4 Hz, 3 H, CH3 of two diastereomers); 
13
C NMR δ 163.7, 163.6, 
163.0, 161.8, 156.5, 133.0, 129.9, 129.7, 115.9, 109.1, 100.1, 97.5, 79.7, 79.65, 53.5, 52.8, 52.7, 
39.2, 38.8, 38.7, 37.2, 37.1, 36.8, 32.4, 32.3, 31.0, 28.4, 20.2, 14.7, 14.6; MS (electrospray 
ionization) m/z 382.4 (M+H
+
), 276.5; HRMS calcd for C23H28NO4
+
 (M+H
+
) 382.2018, found 
382.2013. 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-hydroxymethyl)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11D) 
O
O
O
H
N
OH
H
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From 170 mg (0.62 mmol) amine 39 and 84 mg (0.62 mmol) of aldehyde 44D, 150 mg (61% 
yield) of 11D was obtained as a solid. M.p. (TFA salt) 85 – 87 oC;  FTIR (TFA salt; solid)  
3376 (b, w), 2909, 1670, 1563, 1443, 1424, 1197, 1172, 1134, 797, 719, 702; 
1
H NMR δ 7.36 – 
7.28 (m, 4 H), 6.05 (s, 1 H), 5.70 (s, 1 H), 5.08 – 4.98 (m, 1 H), 4.67 (s, 2 H), 3.77 (s, 2 H), 2.65 
– 2.54 (m, 1 H), 2.49 – 2.39 (m, 2 H), 2.18 (s, 3 H), 2.06 – 1.90 (m, 2 H), 1.72 – 1.44 (m, 4 H), 
1.36 – 1.04 (m, 1 H), 0.89 and 0.88 (2 d, J = 6.8 Hz, 3 H, CH3 of two diastereomers); 
13
C NMR δ 
163.4, 163.4, 162.8, 161.7, 140.1, 139.6, 133.0, 132.95, 128.5, 128.5, 127.3, 109.3, 100.0, 97.6, 
79.9, 79.7, 65.2, 54.0, 53.9, 53.1, 53.1, 39.4, 38.9, 38.7, 37.8, 37.7, 36.9, 32.6, 32.4, 31.2, 28.5, 
20.3, 14.8, 14.7; MS (electrospray ionization) m/z 418.5 (M+Na
+
), 396.3 (M+H
+
), 378.6, 245.2; 
HRMS calcd for C24H30NO4
+
 (M+H
+
) 396.2175, found 396.2183 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[4-(2-hydroxyethoxy)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11E) 
O
O
O
H
N
H
O
OH
 
From 85 mg (0.31 mmol) of amine 39 and 87 mg (0.31 mmol) of aldehyde 44E, 72 mg (55% 
overall yield in two steps) of 11E was obtained as a solid. (Note: To product 11E’ obtained from 
reductive amination, deprotection of TBDMS with n-Bu4NF was done in THF at 25 
o
C). M.p. 
(TFA salt) 68 – 72 oC; FTIR (TFA salt; solid)  3370 (b, w), 1668, 1559, 1508, 1417, 1253, 
1197, 1173, 1136, 831, 798, 720; 
1H NMR δ 7.19 (d, J = 8.4 Hz, 2 H), 6.83 (d, J = 8.4 Hz, 2 H), 
6.01 (s, 1 H), 5.68 (s, 1 H), 5.06 – 4.95 (m, 1 H), 4.02 (t, J = 4.4 Hz, 2 H), 3.89 (t, J = 4.2 Hz, 2 
H), 3.67 (s, 2 H), 2.62 – 2.50 (m, 1 H), 2.46 – 2.34 (m, 2 H), 2.14 (s, 3 H), 2.03 – 1.87 (m, 2 H), 
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1.69 – 1.42 (m, 4 H), 1.33 – 1.01 (m, 1 H), 0.85 (d, J = 6.8 Hz, 3 H, CH3); 
13CNMR  δ 163.4, 
163.3, 162.6, 161.5, 157.9, 132.9, 132.7, 129.4, 114.5, 109.1, 99.9, 97.4, 79.7, 79.6, 69.4, 61.2, 
53.5, 53.0, 52.9, 39.2, 38.7, 38.6, 37.6, 37.5, 36.8, 32.4, 32.3, 31.0, 28.4, 20.1, 14.7, 14.6; MS 
(electrospray ionization) m/z 427.2 (M+2), 426.3 (M+H
+
), 151.1, 107.1; HRMS calcd for 
C25H32NO5
+
 (M+H
+
) 426.2280, found 426.2260. 
(5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(benzylamino)propan-2-yl]-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11F) 
O
O
O
H
N
H
 
 From 85 mg (0.31 mmol) of amine 39 and 33 mg (0.31 mmol) of aldehyde 44F, 70 mg (62% 
yield) of 11F was obtained as a solid. M.p. (TFA salt) 86 – 90 oC; FTIR (solid)  3340 (w), 
1658, 1572, 1161 (s), 1133, 719, 702;  
1
H NMR δ 7.45 – 7.20 (m, 5 H), 6.05 (s, 1 H), 5.70 (s, 1 
H), 5.15 – 4.95 (m, 1 H), 3.78 (s, 2 H), 2.65 – 2.55 (m, 1 H), 2.52 – 2.38 (m, 2 H), 2.18 (s, 3 H), 
2.08 – 1.89 (m, 2 H), 1.77 – 1.45 (m, 4 H), 1.37 – 1.05 (m, 1 H), 0.89 (d, J = 7.2 Hz, 3 H, CH3); 
13
C NMR δ 163.4, 163.4, 162.8, 161.6, 140.5, 133.0, 132.97, 128.6, 128.2, 127.1, 109.2, 100.0, 
97.5, 79.8, 79.7, 54.3, 53.3, 53.2, 39.4, 38.8, 38.6, 37.8, 37.7, 36.8, 32.5, 32.4, 31.1, 28.4, 20.3, 
14.8, 14.7; MS (electrospray ionization) m/z 388.4 (M+Na
+
), 366.4 (M+H
+
), 139.1; HRMS calcd 
for C23H28NO3
+ 
(M+H
+
) 366.2069, found 366.2078 (100%). 
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(5aS,7S)-3-Methyl-7-[ (1R) and (1S)-1-(4-methoxybenzylamino)propan-2-yl]-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11G) 
O
O
O
H
N
H
OMe
 
From 85 mg (0.31 mmol) of amine 39 and 42 mg (0.31 mmol) of aldehyde 44G, 82 mg (67% 
yield) of 11G was obtained as a solid. M.p. (TFA salt) 90 - 92
o
C; FTIR (TFA salt; solid)  3350 
(w), 1667, 1563, 1252, 1197, 1177, 1135, 829, 798, 719; 
1H NMR δ 7.23 (d, J = 8.4 Hz, 2 H), 
6.85 (d, J = 8.8 Hz, 2 H), 6.04 (s, 1 H), 5.69 (d, J = 0.8 Hz, 1 H), 5.08 – 4.96 (m, 1 H), 3.79 (s, 3 
H), 3.71 (s, 2 H), 2.62 – 2.51 (m, 1 H), 2.48 – 2.36 (m, 2 H), 2.17 (s, 3 H), 2.05 – 1.86 (m, 2 H), 
1.71 – 1.44 (m, 4 H), 1.27 – 1.04 (m, 1 H), 0.88 and 0.87 (2 d, J = 6.6 Hz, 3 H, CH3 of two 
diastereomers); 
13C NMR δ 163.4, 163.37, 162.7, 161.6, 158.8, 132.9, 132.2, 129.5, 113.9, 109.1, 
99.9, 97.4, 79.8, 79.7, 55.4, 53.6, 53.0, 52.9, 39.3, 38.7, 38.6, 37.7, 37.6, 36.8, 32.5, 32.4, 31.1, 
28.4, 20.3, 14.8, 14.6; MS (electrospray ionization) m/z 396.4 (M+H
+
), 121.1; HRMS calcd for 
C24H30O4N
+
 (M+H
+
) 396.2175, found 396.2180 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-methoxycarbonyl)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11I) 
O
O
O
H
N
O
MeO
H
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From 85 mg (0.31 mmol) of amine 39 and 51 mg (0.31 mmol) of aldehyde 44I, 88 mg (67% 
yield) of 11I was obtained as a solid. M.p. (HCl salt) 117 – 120 oC;  FTIR (HCl salt; solid)  
3329 (b, w), 2925, 1716, 1566, 1434, 1280, 1107, 761; 
1H NMR δ 7.98 (d, J = 8.0 Hz, 2 H), 7.38 
(d, J = 8.0 Hz, 2 H), 6.04 (s, 1 H), 5.69 (s, 1 H), 5.07 – 4.98 (m, 1 H), 3.90 (s, 3 H), 3.82 (s, 2 H), 
2.62 – 2.53 (m, 1 H), 2.48 – 2.38 (m, 2 H), 2.17 (s, 3 H), 2.06 – 1.89 (m, 2 H), 1.72 – 1.44 (m, 4 
H), 1.35 – 1.04 (m, 1 H), 0.89 and 0.88 (2 d, J = 6.6 Hz, 3 H, CH3 of two diastereomers); 
13
C 
NMR δ 167.2, 163.4, 163.35, 162.7, 161.6, 146.1, 132.9, 129.8, 129.0, 128.0, 109.3, 99.9, 97.5, 
79.8, 79.7, 53.9, 53.3, 53.2, 52.2, 39.3, 38.8, 38.7, 37.9, 37.8, 36.9, 32.5, 32.4, 31.1, 28.6, 20.2, 
14.8, 14.7; MS (electrospray ionization) m/z 424.4 (M+H
+
), 139.1; HRMS calcd for C25H30NO5
+
 
(M+H
+
) 424.2124, found 424.2114 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-dimethylamino)benzylamino]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11J) 
O
O
O
H
N
N
H
 
From 85 mg (0.31 mmol) of amine 39 and 46 mg (0.31 mmol) of aldehyde 44J, 80 mg (63% 
yield) of 11J was obtained as a solid. M.p. (HCl salt) 132 – 136 oC;  FTIR (HCl salt; solid)  
3398 (b, w), 2928, 1701, 1635, 1560, 1439, 1236, 1138, 825, 669; 
1H NMR δ 7.29 (d, J = 8.4 Hz, 
2 H), 6.69 (d, J = 8.4 Hz, 2 H), 6.05 (s, 1 H), 5.68 (s, 1 H), 5.16 – 4.98 (m, 1 H), 3.81 (s, 2 H), 
2.92 (s, 6 H), 2.72 – 2.60 (m, 1 H), 2.58 – 2.46 (m, 1 H), 2.41 (d, J = 14.0 Hz, 1 H), 2.18 (s, 3 H), 
2.06 – 1.92 (m, 2 H), 1.88 – 1.67 (m, 2 H), 1.67- 1.40 (m, 2 H), 1.35 – 1.03 (m, 1 H), 0.93 and 
0.92 (2 d, J = 6.4 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.4, 162.7, 161.7, 150.5, 
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132.7, 130.3, 112.7, 109.4, 99.9, 97.5, 79.6, 79.5, 52.6, 51.3, 40.7, 40.4, 39.3, 38.3, 38.1, 36.5, 
36.3, 32.4, 32.2, 31.1, 28.0, 20.3, 14.5, 14.4; MS (electrospray ionization) m/z 409.6 (M+H
+
), 
365.3, 207.1; HRMS calcd for C25H33N2O3
+
 (M+H
+
) 409.2491, found 409.2510 (100%). 
(5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(4-chlorobenzylamino)propan-2-yl]-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11K) 
O
O
O
H
N
Cl
H
 
From 85 mg (0.31 mmol) of amine 39 and 43.5 mg (0.31 mmol) of aldehyde 44K, 69 mg (56% 
yield) of 11K was obtained as a solid.  
1H NMR δ 7.32 – 7.24 (m, 4 H), 6.06 (s, 1 H), 5.71 (s, 1 
H), 5.09 - 5.00 (m, 1 H), 3.75 (s, 2 H), 2.62 – 2.54 (m, 1 H), 2.49 – 2.39 (m, 2 H), 2.19 (s, 3 H), 
2.06 – 1.91 (m, 2 H), 1.71 – 1.46 (m, 4 H), 1.30 – 1.05 (m, 1 H), 0.90 and 0.89 (2 d, J = 6.6 Hz, 3 
H, CH3 of two diastereomers); 
13
C NMR  δ 163.43, 163.40, 162.7, 161.7, 139.0, 132.9, 132.8, 
132.2, 129.6, 128.7, 109.3, 100.0, 97.6, 79.9, 79.7, 53.6, 53.2, 53.1, 39.4, 38.9, 38.7, 37.9, 37.8, 
36.9, 32.6, 32.4, 31.2, 28.6, 20.3, 14.9, 14.7; MS (electrospray ionization) m/z 400.1 (M+H
+
), 
139.2, 124.9; HRMS calcd for C23H27NO3Cl
+
 (M+H
+
) 400.1679, found 400.1667 (100%). 
(5aS,7S)-3-Methyl-7-[(1R) and (1S)-1-(4-cyanobenzylamino)propan-2-yl]-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11L) 
O
O
O
H
N
CN
H
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From 85 mg (0.31 mmol) amine 39 and 41 mg (0.31 mmol) of aldehyde 44L, 76 mg (63% yield) 
of 11L was obtained as a solid. M.p. (TFA salt) 127 – 129 oC;  FTIR (TFA salt; solid)  3300 (b, 
w), 2930, 2848, 2231, 1712, 1655, 1562, 1446, 1420, 1195, 1169, 1137, 827, 798, 719;
  1
H NMR 
δ 7.58 (d, J = 8.2 Hz, 2 H), 7.43 (d, J = 8.0 Hz, 2 H), 6.02 (s, 1 H), 5.69 (s, 1 H), 5.06 – 4.97 (m, 
1 H), 3.82 (s, 2 H), 2.60 – 2.51 (m, Hz, 1 H), 2.45 – 2.37 (m, 2 H), 2.16 (s, 3 H), 2.04 – 1.89 (m, 
2 H), 1.70 – 1.45 (m, 4 H), 1.26 – 1.06 (m, 1 H), 0.89 and 0.88 (2 d, J = 6.8 Hz, 3 H, CH3 of two 
diastereomers); 
13C NMR δ 163.3, 163.3, 162.6, 161.6, 146.5, 132.8, 132.2, 128.7, 119.1, 110.7, 
109.2, 99.9, 97.4, 79.7, 79.6, 53.7, 53.7, 53.3, 53.2, 39.2, 38.8, 38.6, 37.9, 37.8, 36.8, 32.5, 32.3, 
31.1, 28.6, 20.2, 14.9, 14.6; MS (electrospray ionization) m/z 413.2 (M+Na
+
), 391.5 (M+H
+
), 
247.3, 139.0; HRMS calcd for C24H27N2O3
+
 (M+H
+
) 391.2022, found 391.2031 (100%). 
 (5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-hydroxynaphthalen-1-yl)methylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran•TFA salt (12A) 
O
O
O
H
N
H
OH
 
From 85 mg (0.31 mmol) of amine 39 and 53.5 mg (0.31 mmol) of aldehyde 45A, 130 mg (77% 
yield) of 12A•TFA was obtained as a solid. (Note: compound 12A decomposes during 
concentration (removal of solvents), therefore 1.2 equivalents of trifluoroacetic acid was added 
to make the stable salt before concentration). M.p. (TFA salt) 80 – 82 oC;  FTIR (TFA salt; solid) 
 3440 - 3100 (b, w), 2958, 1667, 1564, 1446, 1198, 1177, 1131, 824, 762, 719;  1H NMR 
(Acetone–d6) δ 8.30 (d, J = 8.4 Hz, 1 H), 8.17 (d, J = 8.4 Hz, 1 H), 7.64 (d, J = 7.2 Hz, 1 H), 
7.56 (t, J = 7.6 Hz 1 H), 7.49 (t, J = 7.6 Hz 1 H), 7.00 (d, J = 7.2 Hz, 1 H), 5.88 (s, 1 H), 5.82 (s, 
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1 H), 512 – 4.98 (m, 1 H), 4.71 (s, 2 H), 3.36 – 3.22 (m, 1 H), 3.14 – 3.00 (m, 1 H), 2.38 (d, J = 
14.0 Hz, 1 H), 2.15 (s, 3 H), 2.11 – 1.40 (m, 6 H), 1.30 – 1.02 (m, 1 H), 0.98 and 0.97 (2 d, J = 
6.8 Hz, 3 H, CH3 of two diastereomers); 
13
C NMR (Acetone–d6) δ 164.0, 163.0, 162.4, (161.4, 
161.0, 160.7, 160.3 are from TFA), 155.9, 134.0, 133.7, 132.0, 128.0, 126.1, 125.8, 124.0, 123.9, 
(121.9, 119.0 are from TFA), 118.7, (116.1, 113.2 are from TFA), 109.7, 108.4, 100.1, 97.7, 
97.6, 79.9, 79.8, 51.9, 49.2, 39.6, 38.7, 38.6, 36.7, 35.7, 35.65, 32.7, 32.4, 31.4, 28.5, 20.0, 14.1, 
14.0; MS (electrospray ionization) 432.2 (M+H
+
), 276.2; HRMS calcd for C27H30NO4
+
 (M+H
+
) 
432.2175, found 432.2165. 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(2-hydroxynaphthalen-1-yl)methylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (12B) 
O
O
O
H
N
H
HO
 
From 790 mg (2.87 mmol) of amine 39 and 495 mg (2.87 mmol) of aldehyde 45B, 750 mg (61% 
yield) of 12B was obtained as a solid. (Note: the reduction of intermediate imine required higher 
amounts of CH3COOH and NaBH3CN and the product decomposed gradually during column 
chromatographic purification, but its intermediate imine was stable; therefore, the imine was 
purified through silica gel column and reduced to get the pure product.) M.p. (TFA salt) 113 – 
115 
o
C;  FTIR (TFA salt; solid)  3400 - 3070 (b, w), 2933, 1674, 1629, 1566, 1442, 1199, 1135, 
818, 720;   
1H NMR δ 7.80 (d, J = 8.4 Hz, 1 H), 7.77 (d, J = 8.0 Hz, 1 H), 7.69 (d, J = 9.2 Hz, 1 
H), 7.44 (t, J = 7.6 Hz, 1 H), 7.29 (t, J = 7.6 Hz, 1 H), 7.10 (d, J = 9.2 Hz, 1 H), 6.06 (s, 1 H), 
5.69 (s, 1 H), 5.10 – 5.02 (m, 1 H), 4.44 (s, 2 H), 2.80 – 2.72 (m, 1 H), 2.67 – 2.58 (m, 1 H), 2.45 
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(d, J = 14.4 Hz, 1 H), 2.18 (s, 3 H), 2.09 – 1.93 (m, 2 H), 1.76 – 1.46 (m, 4 H), 1.33 – 1.06 (m, 1 
H), 0.98 and 0.97 (2 d, J = 6.8 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.3, 162.6, 
161.6, 156.9, 132.5, 132.47, 129.2, 128.9, 128.4, 126.4, 122.5, 121.0, 119.4, 112.1, 109.2, 99.8, 
97.3, 79.4, 79.3, 53.2, 53.1, 47.9, 39.1, 38.7, 38.6, 37.5, 37.4, 36.6, 32.3, 32.1, 30.9, 28.3, 20.1, 
14.7, 14.6; MS (electrospray ionization) m/z 432.2 (M+H
+
), 276.2; HRMS calcd for C27H30NO4
+
 
(M+H
+
) 432.2175, 432.2184. 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-methoxynaphthalen-1-yl)methylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (12C) 
O
O
O
H
N
H
OMe
 
From 110 mg (0.4 mmol) of amine 39 and 75 mg (0.4 mmol) of aldehyde 45C, 134 mg (75% 
yield) of 12C was obtained as a solid. M.p. 76 – 78 oC;  FTIR (solid)  3300 (b, w), 2927, 1681, 
1583, 1568, 1448, 1390, 1273, 1231, 1155, 1091, 816, 760;  
1H NMR δ 8.30 (d, J = 8.0, Hz, 1 
H), 8.08 (d, J = 8.4 Hz, 1 H), 7.53 (t, J = 7.2 Hz, 1 H), 7.47 (t, J = 7.2 Hz, 1 H), 7.33 (d, J = 7.6 
Hz, 1 H), 6.73 (d, J = 7.6 Hz, 1 H), 6.03 (s, 1 H), 5.68 (s, 1 H), 5.02 – 4.87 (m, 1 H), 4.12 (s, 2 
H), 3.98 (s, 3 H), 2.71 – 2.62 (m, 1 H), 2.60 – 2.51 (m, 1 H), 2.39 (dd, J = 13.9, 1.9 Hz, 1 H), 
2.17 (s, 3 H), 2.02 – 1.82 (m, 2 H), 1.71 – 1.42 (m, 4 H), 1.35 – 1.02 (m, 1 H), 0.88 and 0.87 (2 
d, J = 6.6 Hz, 3 H, CH3 of two diastereomers); 
13C NMR δ 163.4, 163.3, 162.7, 161.5, 155.1, 
133.0, 132.98, 132.8, 128.0, 126.6, 126.5, 126.1, 125.1, 123.8, 122.7, 109.02, 109.00, 103.0, 
99.9, 97.4, 79.79, 79.75, 79.67, 79.63, 55.6, 55.5, 53.5, 53.1, 52.0, 39.3, 38.5, 38.4, 37.7, 37.6, 
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36.6, 32.5, 32.3, 31.1, 28.3, 20.2, 14.8, 14.6; MS (electrospray ionization) m/z 446.3 (M+H
+
), 
171.1; HRMS calcd for C28H32NO4
+
 (M+H
+
) 446.2331, found 446.2343 (100%). 
 (5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(3-hydroxynaphthalen-1-yl)methylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (12D) 
O
O
O
H
N
H
OH
 
From 85 mg (0.31 mmol) of amine 39 and 53 mg (0.31 mmol) of aldehyde 45D, 80 mg (60% 
yield) of 12D was obtained as a solid. M.p. (TFA salt) 115 – 117 oC;  FTIR (TFA salt; solid)  
3500 - 3200 (b, w), 2927, 1672, 1604, 1565, 1449, 1236, 1199, 1136, 829, 720; 
1H NMR δ 7.92 
(d, J = 8.0 Hz, 1 H), 7.62 (d, J = 7.6 Hz, 1 H), 7.38 (t, J = 7.6 Hz, 1 H), 7.31 (t, J = 7.6 Hz, 1 H), 
7.16 (s, 1 H), 7.05 (s, 1 H), 6.02 (s, 1 H), 5.68 (s, 1 H), 5.01 – 4.90 (m, 1 H), 4.18 (s, 2 H), 2.75 
(dd, J = 11.6, 5.6 Hz, 1 H), 2.66 – 2.55 (m, 1 H), 2.37 (d, J = 13.6 Hz, 1 H), 2.17 (s, 3 H), 2.05 – 
1.80 (m, 2 H), 1.76 – 1.42 (m, 4 H), 1.33 – 1.02 (m, 1 H), 0.89 (d, J = 6.6 Hz, 3 H, CH3); 
13
C 
NMR δ 163.64, 163.62, 163.0, 161.7, 154.1, 136.8, 135.7, 133.0, 127.5, 126.8, 126.4, 123.6, 
123.2, 119.3, 109.7, 109.1, 100.1, 97.5, 79.8, 79.7, 53.6, 53.5, 51.3, 39.3, 38.6, 38.5, 37.4, 37.3, 
36.7, 32.5, 32.3, 31.1, 28.2, 20.3, 14.72, 14.66; MS (electrospray ionization) m/z 432.6 (M+H
+
), 
157.1; HRMS calcd for C27H30NO4
+
 (M+H
+
) 432.2175, 432.2170 (100%). 
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 (5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(6-hydroxynaphthalen-2-yl)methylamino]propan-2-
yl}-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (13) 
O
O
O
H
N
H
OH
 
From 85 mg (0.31 mmol) of amine 39 and 53.5 (0.31 mmol) of aldehyde 46, 98 mg (70% yield) 
of 13 was obtained as a solid. M.p. 100 – 102 oC;  FTIR (solid)  3500 - 3100 (b, w), 2924, 2867, 
1681, 1639, 1605, 1565, 1447, 1232, 1147, 860, 811, 763;  
1H NMR δ 7.63 (s, 1 H), 7.62 (d, J = 
7.6 Hz 1 H), 7.57 (d, J = 8.6 Hz, 1 H), 7.37 (d, J = 8.2 Hz, 1 H), 7.05 (s, 1 H), 7.04 (d, J = 8.0 
Hz, 1 H), 6.06 (s, 1 H), 5.70 (s, 1 H), 5.09 – 4.99 (m, 1 H), 3.91 (s, 2 H), 2.68 (dd, J = 11.1, 4.9 
Hz, 1 H), 2.58 – 2.49 (m, 1 H), 2.43 (d, J = 13.3 Hz, 1 H), 2.19 (s, 3 H), 2.09 – 1.90 (m, 2 H), 
1.75 – 1.43 (m, 4 H), 1.30 – 1.06 (m, 1 H), 0.93 and 0.92 (2 d, J = 6.4 Hz, 3 H, CH3 of two 
diastereomers); 
13C NMR δ 163.68, 163.65, 163.0, 161.7, 154.9, 134.2, 134.0, 133.02, 133.00, 
129.3, 128.4, 127.0, 126.8, 119.0, 109.6, 109.1, 100.1, 97.5, 79.8, 79.7, 54.3, 53.1, 53.0, 39.2, 
38.9, 38.8, 37.5, 37.4, 36.9, 32.5, 32.3, 31.0, 28.5, 20.2, 14.8, 14.7; MS (electrospray ionization) 
m/z 432.1 (M+H
+
); HRMS calcd for C27H30NO4
+
 (M+H
+
) 432.2175, found 432.2163 (100%). 
(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[(4-formyl)benzylamino]propan-2-yl}-1H,7H-
5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (11H) 
O
O
O
H
N
O
H
H
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A solution of 100 mg (0.25 mmol) of 11D and 84 mg (0.30 mmol) of IBX in 2 mL of DMSO 
was stirred at 25 
o
C for 2 h.  The reaction mixture was poured into water (300 mL) and extracted 
twice with CH2Cl2 (200 mL). The combined organic layer was washed with brine, dried 
(MgSO4), concentrated, and column chromatographed on silica gel using a gradient mixture of 
CH2Cl2 and MeOH as eluant to get 64 mg (64% yield) of 11H as a solid. M.p. (HCl salt) 140 – 
142 
o
C;  FTIR (HCl salt; solid)  3407 (b, w), 2930, 1686 (s), 1566, 1448, 1418, 1215, 1002, 
821, 764;  
1H NMR δ 9.99 (s, 1 H), 7.84 (d, J = 8.0 Hz, 2 H), 7.49 (d, J = 8.0 Hz, 2 H), 6.05 (s, 1 
H), 5.69 (s, 1 H), 5.07 – 4.99 (m, 1 H), 3.86 (s, 2 H), 2.63 - 2.56 (m, 1 H), 2.49 – 2.40 (m, 2 H), 
2.18 (s, 3 H), 2.06 – 1.91 (m, 2 H), 1.72 – 1.45 (m, 4 H), 1.33 – 1.06 (m, 1 H), 0.91 and 0.90 (2 
d, J  = 6.8 Hz, 3 H, CH3 of two diastereomers); 
13
C NMR δ 192.1, 163.4, 163.35, 162.7, 161.7, 
148.0, 135.6, 132.8, 130.1, 128.7, 109.3, 99.9, 97.5, 79.8, 79.7, 54.0, 53.4, 53.3, 39.3, 38.9, 38.7, 
38.0, 37.9, 36.9, 32.5, 32.4, 31.1, 28.7, 20.3, 14.9, 14.7; MS (electrospray ionization) m/z 394.6 
(M+H
+
), 242.6; HRMS calcd for C24H28NO4
+
 (M+H
+
) 394.2018, found 394.2006 (100%). 
 
General procedure for the synthesis of amides 14A and 14B 
2-Hydroxy-N-{(2R) and (2S)-2-[(5aS,7S)-3-methyl-(N-(2-(1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran-7-yl]propyl}benzamide (14A) 
O
O
O
H
N
O OH
H
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A mixture of 45 mg (0.33 mmol) of salicylic acid (47A), 100 mg (0.36 mmol) of amine 39, 56 
mg (0.36 mmol) of EDC, and 13 mg (0.1 mmol) of NHS in 2 mL of dry DMF, under argon, was 
stirred for 16 h at 25 
o
C. Then the reaction solution was diluted with 50 mL of ethyl acetate, 
washed twice with water (10 mL each) followed by brine, dried (MgSO4), concentrated, and 
column chromatographed on silica gel using a gradient mixture of hexane and ethyl acetate as 
eluent to give 78 mg (55% yield) of compound 14A as a solid. M.p. 110 – 112 oC;   FTIR (solid) 
 3336 (b, w), 2929, 2850, 1686, 1638, 1591, 1566, 1543, 1491, 1447, 1365, 1232, 1147, 818, 
754;  
1H NMR δ 12.33 (s, 1 H), 7.42 - 7.37 (m, 2 H), 7.00 (d, J = 7.8 Hz, 1 H), 6.85 (t, J = 7.4 
Hz, 1 H), 6.46 (br s, 1 H), 6.08 (s, 1 H), 5.72 (s, 1 H), 5.06 (t, J = 5.2 Hz, 1 H), 3.58 - 3.47 (m, 1 
H), 3.33 - 3.25 (m, 1 H), 2.47 (d, J = 8.0 Hz, 1 H), 2.20 – 2.11 (m, 1 H), 2.19 (s, 3 H), 2.10 – 
1.95 (m, 1 H), 1.86 – 1.54 (m, 4 H), 1.36 – 1.14 (m, 1 H), 0.98 and 0.97 (2 d, J = 7.2 Hz, 3 H, 
CH3 of two diastereomers); 
13C NMR δ 170.3, 163.6, 163.5, 162.8, 161.8, 161.7, 134.5, 132.5, 
125.4, 118.9, 118.8, 114.4, 109.6, 100.0, 97.5, 79.6, 79.4, 43.5, 43.47, 39.3, 38.7, 38.5, 38.1, 
38.0, 36.7, 32.4, 32.3, 31.2, 28.5, 20.3, 14.4, 14.3. MS (electrospray ionization) m/z 418.6 
(M+Na
+
, 100%); HRMS calcd for C23H25NO5Na
+
 (M+Na
+
) 418.1630, found 418.1613 (100%). 
2-Acetoxy-N-{(2R) and (2S)-2-[(5aS,7S)-3-methyl-(N-(2-(1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran-7-yl]propyl}benzamide (14B) 
O
O
O
H
N
O OAc
H
 
From 65 mg (0.36 mmol) of acetylsalicylic acid 47B and 0.10 g (0.36 mmol) of amine 39, 75 mg 
(47 % yield) of 14B was obtained as a solid. M.p. 98 – 100 oC;   FTIR (solid)  3297 (b, w), 
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2928, 2862, 1766, 1696, 1640, 1567, 1532, 1447, 1367, 1193, 1008, 816, 752;  
1H NMR δ 7.70 
(dd, J = 7.8, 1.6 Hz, 1 H), 7.48 (td, J = 7.6, 1.2 Hz, 1 H), 7.32 (td, J = 7.6, 1.2 Hz, 1 H), 7.11 (dd, 
J = 8.2, 1.2 Hz, 1 H), 6.23 (br. s, 1 H), 6.08 (s, 1 H), 5.71 (s, 1 H), 5.07 (t, J = 6.2 Hz, 1 H), 3.56 
- 3.45 (m, 1 H), 3.31 - 3.19 (m, 1 H), 2.48 (dd, J = 14.0, 2.2 Hz, 1 H), 2.34 (s, 3 H), 2.22 - 2.10 
(m, 1 H),  2.19 (s, 3 H), 2.08 – 1.95 (m, 1 H), 1.84 - 1.53 (m, 4 H), 1.35 - 1.12 (m, 1 H), 0.96 and 
0.95 (2 d, J = 6.8 Hz, 3 H, CH3 of two diastereomers);
 13C NMR δ 169.5, 166.2, 163.5, 162.8, 
161.8, 148.0, 132.5, 132.0, 129.6, 128.9, 126.6, 123.4, 109.5, 100.0, 97.5, 79.5, 79.4, 43.83, 
43.80, 39.4, 38.6, 38.4, 38.1, 38.1, 36.7, 32.4, 32.3, 31.2, 28.5, 21.4, 20.3, 14.4, 14.2; MS 
(electrospray ionization) m/z 460.2 (M+Na
+
; 100%), 400.1; HRMS calcd for C25H27NO6Na
+
 
(M+Na
+
) 460.1736, found 460.1729 (100%). 
3-bromo-4-hydroxybenzaldehyde (43C) 
OH
OH
Br
 
To a solution of 500 mg (4.1 mmol) of aldehyde 44C in 15 mL of a mixture of chloroform and 
dimethoxyethane (4:1) at -40 °C was added 159.8 mg (4.1 mmol) of bromine through a syringe. 
After stirring for 4 h, the mixture was diluted with dichloromethane (300 mL), washed with 
water (100 mL x 4) followed by brine, dried (MgSO4), and concentrated to get 595 (70% yield) 
of aldehyde 43C as a solid whose 
1
H spectrum was in agreement to that reported.
58
  
3-fluoro-4-hydroxybenzaldehyde (43D)  
OH
F
OH
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A mixture of 300 mg (2.19 mmol) of 4-cyano-2-fluorophenol (48), 50 mg (0.22 mmol) of PtO2, 
and 10 mL of 88% formic acid was stirred at 75 °C, for 5 h. The mixture was diluted with water 
(200 mL) and extracted in dichloromethane. The organic layer was washed with brine, dried 
(MgSO4), and concentrated to get 240 mg (80% yield) of aldehyde 43D as a solid, whose 
1
H 
spectrum was in agreement to that reported.
59
 
3,4-bis(benzyloxy)benzaldehyde (43F)  
OBn
OBn
OH
 
Step 1: 1.81 g (7.23 mmol) of BBr3 was added to a solution of 1 g (6.57 mmol) of aldehyde 43A 
in 50 mL of dichloromethane at 0 °C. After stirring for 0.5 h at 0 °C and 4 h at 25 °C, diluted 
with MeOH (40 mL) and concentrated in reduced vacuum. This process of dilution and 
concentration with methanol was repeated for 3 times. Diluted with dichloromethane, filtered 
and the residue was washed with dichloromethane to get 3,4-dihydroxybenzaldehyde (52) as a 
solid. 
Step 2: To a mixture of 300 mg (2.17 mmol) of aldehyde 52, and 138.21 mg (6.5 mmol) of 
K2CO3 in 20 mL of acetone was added 928.5 mg (5.42 mmol) of benzyl bromide followed by 
108 mg (0.65 mmol) of potassium iodide. After refluxing for 25 h, the mixture was filtered 
through celite, concentrated, and purified through silica gel column using a gradient mixture of 
hexanes and ether to get 605 mg (85% yield) of compound 43F, whose 
1
H and 
13
C NMR were in 
agreement with that of reported.
67
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(hydroxymethyl)benzaldehyde (44D) 
OH
HO  
To a solution of 1g (7.45 mmol) of terepthaldehyde (49), in a mixture of 10 mL of 
dichloromethane and 5 mL of methanol, at 0 °C was added 70 mg (1.86 mmol) of NaBH4. After 
stirring for 4 h, diluted with dichloromethane (200 mL), washed with brine, dried (MgSO4), 
concentrated, and purified through silica gel column using a gradient mixture of hexanes and 
ether as eluent to get 750 mg (75% yield) of aldehyde 44D, whose 
1
H and 
13
C NMR spectra were 
in agreement to that reported.
61 
 
4-(2-(t-butyldimethylsilyloxy)ethoxy)benzaldehyde (44E) 
OH
O
OTBS
 
A mixture of 300 mg (2.6 mmol) of aldehyde 44C, 750 mg (3.4 mmol) of (2-bromoethoxy) (t-
butyl)dimethylsilane (50), and 1 g (7.8 mmol) of K2CO3 in 10 mL of dry DMF was stirred at 100 
°C for 12 h. The mixture was acidified with 2N HCl and extracted with dichloromethane. The 
organic layer was washed with brine, dried (MgSO4), and concentrated to get 612.8 mg (93% 
yield) of aldehyde 44E, whose 
1
H and 
13
C NMR spectra were in agreement to that reported.
62 
 
Methyl 4-formylbenzoate (44I) 
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OH
O OMe  
To a mixture of 150 mg (0.99 mmol) of p-carboxybenzaldehyde (51), and 413.6 mg (2.99 mmol) 
of K2CO3 in 5 mL of dry DMF was added 425.4 mg (2.99 mmol) of MeI. After stirring for 12 h, 
the mixture was diluted with dichloromethane (300 mL), washed with brine, dried (MgSO4), and 
concentrated to get 274.5 mg (100% yield) of compound 44I, whose 
1
H and 
13
C NMR spectra 
were in agreement to that reported.
63
  
4-methoxy-1-naphthaldehyde (45C) 
OMe
OH
 
185 mg (1.3 mmol) of MeI was added to a mixture of 150 mg (0.87 mmol) aldehyde 12A, and 
180 mg (1.3 mmol) of K2CO3, in 5 mL of acetone. After stirring for 10 h, the mixture was 
diluted with water (30 mL) and extracted in diethyl ether. The ether layer was washed with brine, 
dried with MgSO4, and concentrated to get 140 mg (100% yield) of aldehyde 45C whose 
1
H 
NMR spectrum was in agreement to that reported.
65
  
3-hydroxy-1-naphthaldehyde (45D)  
OH
OH
 
Step 1:
71
: A solution of 5 g (34.91 mmol) of 1-aminonaphthalene (53) in 20 mL of AcOH, was 
added to a solution of 12.3 g (76.8 mmol) of Br2 in AcOH at 0 °C. The mixture was stirred at 60 
°C for 45 min and filtered; the residue was mixed with 1N NaOH and filtered. The residue was 
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washed with water and recrystalized from ethanol to get 5.2 g (50% yield) of 2,4-dibromo-1-
aminonaphthalene (54).  
Step 2:
71
: 1.27 g (18.48 mmol) of NaNO2 (solid) was added to a solution of 4 g (13.2 mmol) of 
2,4-dibromo-1-aminonaphthalene (54) in a mixture of 200 mL of acetic acid and 20 mL of 
propanoic acid at 0 °C. After stirring for 1 h at 0 °C, the mixture was poured into 300 mL of ice 
water and filtered. To the filtrate, 3 L of water was added and filtered again; the residue was 
washed with water and recrystalized from ethanol to get 2.5 g (76% yield) of compound 55. 
Step 3:
71
: 189 mg (4.99 mmol) of NaBH4 (solid) was added to a solution of 2.5 g (9.99 mmol) of 
intermediate 55 in 150 mL of EtOH at 0 °C. After stirring for 3.5 h at 0 °C, the mixture was 
diluted with water (300 mL) and conc. H2SO4 (4 mL), basified with 10% NaOH and extracted 
with dichloromethane. This organic portion was discarded. Aqueous layer was acidified with 4N 
HCl and extracted with dichloromethane. The organic layer was washed with brine, dried 
(MgSO4), and concentrated to get 1.6 g (72% yield) of 4-bromo-2-naphthol (56).  
Step 4
70
: 1 g (4.48 mmol) of 4-bromo-2-naphthol (56) in 15 mL of diethyl ether was added to a 
slurry of 140 mg (5.82 mmol) of NaH in 10 mL of diethyl ether, under argon, at 0 °C. After 
stirring for 1.5 h at 0 °C, 5 mL (8.96 mmol) of n-BuLi (1.6 M in hexanes) was added dropwise. 
After stirring for 1 h, 556 mg (8.96 mmol) of DMF was added and stirring was continued for 3 h. 
The mixture was acidified with 2N HCl and extracted with diethyl ether. The organic layer was 
washed with brine, dried (MgSO4), concentrated, and purified through silica gel column using a 
gradient mixture of hexanes and ether to get 325 mg (70% yield, on the basis of recovered 
starting material) of aldehyde 12D as a solid. 400 mg of starting material 56 was also recovered.  
1
H and 
13
C spectra of aldehyde 12D were in agreement to that reported.
70
 
6-hydroxy-1-naphthaldehyde (46)  
  75  
 
OH
O
H
 
A solution of 1 g (4.48 mmol) of 6-bromo-2-hydroxynaphthlene (57) in 35 mL of diethyl ether, 
under argon, at 0 °C was added to slurry of 140 mg (5.82 mmol) of NaH in 15 mL of diethyl 
ether. After stirring for 2 h, at °C, 4.7 mL (7.62 mmol) of n-BuLi (1.6 M, in hexanes) was added 
dropwise and stirred for 1 h. To this mixture was added 556 mg (7.62 mmol) of DMF and the 
stirring was continued for 2 h. Then the mixture was cooled to 0 °C, acidified with 2N HCl and 
extracted with diethyl ether. The ether layer was washed with brine, dried with MgSO4, 
concentrated, and purified through silica gel column to get 278 mg (66% yield on the basis of 
recovered 57) of aldehye 46 and 450 mg of starting material 57 was also recovered. 
1
H and 
13
C 
spectra of aldehyde 46 were in agreement to that reported.
70
  
 
 General procedure for the syntheses of tricyclic pyrones 15 -31   
(5aS,7S)-3-Methyl-7-(1-(furan-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (15) 
O
O
O
H
N
O
H
 
A mixture of 50 mg (0.18 mmol) of amine 39, 17.5 mg (0.18 mmol) of aldehyde 58, in 5 mL of 
distilled MeOH, under argon was stirred for 12 h. Acetic acid (5 drops) was added followed by a 
solution of 34 mg (0.54 mmol) of NaBH3CN in MeOH. After stirring for 1 h, the mixture was 
diluted with 30 mL of 5% NH4OH solution and extracted in dichloromethane. The organic layer 
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was washed with brine, dried (MgSO4), concentrated, and purified through silica gel column 
using a gradient mixture of dichloromethane and methanol as eluent to get 35.5 mg (55% yield) 
of compound 15, as a solid. 
1
H NMR   7.36 (s, 1 H), 6.32 (d, J = 2.1 Hz, 1 H), 6.17 (d, J = 2.7 
Hz, 1 H), 6.06 (s, 1 H), 5.70 (s, 1 H), 5.10 – 4.99 (m, 1 H), 3.77 (s, 2 H), 2.63 – 2.55 (m, 1 H), 
2.48 - 2.40 (m, 2 H), 2.18 (s, 3 H), 2.08 - 1.92 (m, 2 H), 1.70 - 1.46 (m, 4 H), 1.28 - 1.05 (m, 1 
H), 0.89 (d, J = 6.6 Hz, 3 H); 
13
C NMR  163.42, 163.38, 162.72, 161.65, 154.10, 141.96, 
132.96, 110.30, 109.29, 107.10, 99.94, 97.55, 79.85, 79.72, 53.01, 52.93, 46.61, 39.39, 38.80, 
38.69, 37.84, 37.76, 36.91, 32.56, 32.43, 31.18, 28.48, 20.28, 14.79, 14.71; MS (electrospray 
ionization) m/z 356.4 (M+H
+
), 100%). 
        (5aS,7S)-3-Methyl-7-(1-(thiophen-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (16) 
O
O
O
H
N
S
H
       
 From 100 mg (0.36 mmol) of amine 39 and 41 mg (0.36 mmol) of aldehyde 59, 81 mg of 
compound 16 (60% yield) was obtained as a solid. 
1
H NMR  7.21 (d, J = 5.1 Hz, 1 H), 6.95 (t, J 
= 4.0 Hz, 1 H), 6.91 (d, J = 3.1 Hz, 1 H), 6.06 (s, 1 H), 5.70 (s, 1 H), 5.05 (dt, J = 10.7, 5.2 Hz, 1 
H), 3.98 (s, 2 H), 2.63 (ddd, J = 11.7, 6.1, 3.7 Hz, 1 H), 2.53 – 2.41 (m, 2 H), 2.18 (s, 3 H), 2.09 
– 1.91 (m, 2 H), 1.73 – 1.47 (m, 4 H), 1.28 – 1.06 (m, 1 H), 0.90 and 0.89 (2 d, J = 6.8 Hz, 3 H, 
CH3 of two diastereomers); 
13
C NMR  

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
MS (electrospray ionization) m/z 372.5 (M+H+, 100%). 
(5aS,7S)-3-Methyl-7-(1-(5-phenylthiophen-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (17) 
O
O
O
H
N
S
H
Ph
 
From 80 mg (0.29 mmol) of amine 39 and 55 mg (0.29 mmol) of aldehyde 60, 98 mg (75% 
yield) of compound 17 was obtained as a solid. 
1
H NMR (200 MHz)  7.62 - 7.52 (m, 2 H), 7.42 
- 7.24 (m, 3 H), 7.16 (d, J = 3.7 Hz, 1 H), 6.89 (d, J = 3.7 Hz, 1 H), 6.06 (s, 1 H), 5.67 and 5.65 
(2 s, 1 H, two diastereomers), 3.99 (s, 2 H), 2.73 – 2.61 (m, 1 H), 2.59 – 2.38 (m, 2 H), 2.17 (s, 3 
H), 2.11 – 1.96 (m, 2 H), 1.76 – 1.40 (m, 4 H), 1.31 – 1.05 (m, 1 H), 0.91 and 0.90 (2 d, J = 7.0 
Hz, 3 H, CH3 of two diastereomers);
 13
C NMR  (200 MHz) 163.44, 162.77, 161.62, 144.15, 
143.41, 134.17, 133.00, 132.98, 129.16, 129.02, 127.45, 126.07, 126.01, 125.72, 122.70, 109.23, 
99.96, 97.52, 79.87, 79.72, 52.91, 52.83, 49.05, 39.39, 38.74, 38.52, 37.83, 37.72, 36.78, 32.56, 
32.42, 31.20, 28.56, 20.26, 14.85, 14.63; MS (electrospray ionization) m/z 448.3 (M+H
+
). 
(5aS,7S)-3-Methyl-7-(1-(1H-pyrrol-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (18) 
O
O
O
H
N
N
H
H
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From 80 mg (0.29 mmol) of amine 39 and 28 mg (0.29 mmol) of aldehyde 61, 58 mg (56% 
yield) of compound 18 was obtained as a solid. 
1
H NMR (200 MHz)  10.44 (br. s, 1 H, NH), 
6.84 (s, 1 H), 6.20 (s, 1 H), 6.10 (s, 1 H), 6.01 (s, 1 H), 5.68 (s, 1 H), 5.24 – 4.85 (m, 1 H), 4.17 
(s, 2 H), 2.98 - 2.52 (m, 2 H), 2.39 (d, J = 12.5 Hz, 1 H), 2.16 (s, 3 H), 2.07 - 1.05 (m, 7 H), 0.96 
(d, J = 6.6 Hz, 3 H); 
13
C NMR   163.50, 162.75, 161.88, 132.15, 120.85, 120.29, 112.04, 
109.51, 108.38, 99.96, 97.35, 79.09, 79.05, 49.28, 44.63, 38.85, 37.79, 37.65, 35.88, 35.17, 
35.08, 32.10, 31.85, 30.76, 27.60, 20.25, 14.21, 14.10; MS m/z (electrospray ionization) 355.5 
(M+H
+
).  
(5aS,7S)-3-Methyl-7-(1-(1H-pyrrol-3-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (19)         
O
O
O
H
N
NH
H
 
From 80 mg (0.29 mmol) of amine 39 and 28 mg (0.29 mmol) of aldehyde 62, 44 mg (43% 
yield) of compound 19 was obtained as a solid.
 1
H NMR  8.60 (br. s, 1 H, NH), 6.73 (d, J = 2.3 
Hz, 1 H), 6.70 (s, 1 H), 6.17 (s, 1 H), 6.05 (s, 1 H), 5.70 (s, 1 H), 5.10 - 4.98 (m, 1 H), 3.68 (s, 2 
H), 2.64 (ddd, J = 11.6 5.6 3.9 Hz, 1 H), 2.55 – 2.37 (m, 2 H), 2.18 (s, 3 H), 2.11 – 1.90 (m, 2 H), 
1.75 – 1.38 (m, 4 H), 1.32 – 1.05 (m, 1 H), 0.89 (d, J = 6.6 Hz, 3 H); 13C NMR   163.46, 
143.43, 162.77, 161.62, 133.09, 133.07, 122.66, 118.23, 116.16, 109.14, 109.13, 108.31, 99.97, 
97.51, 79.88, 79.75, 53.38, 53.29, 46.90, 46.89, 39.39, 38.89, 38.78, 37.75, 37.67, 36.91, 32.56, 
32.43, 31.17, 28.47, 20.22, 14.82, 14.73; MS (electrospray ionization) m/z 355.5 (M+H
+
). 
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(5aS,7S)-3-Methyl-7-(1-(1H-indol-3-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (20)  
 
O
O
O
H
N
NH
H
 
From 80 mg (0.29 mmol) of amine 39 and 42 mg (0.29 mmol) of aldehyde 63, 66 mg (56% 
yield) of compound 20 was obtained as a solid. 
1
H NMR  9.53 (br. s, 1 H, NH), 7.71 (s, 1 H), 
7.64 (d, J = 8.0 Hz, 1 H), 7.42 (d, J = 8.0 Hz, 1 H), 7.21 – 7.11 (m, 2 H), 5.93 (s, 1 H), 5.63 and 
5.60 (2 s, 1 H, two diastereomers), 5.11 – 5.03 and 4.99 – 4.91 (2 m, 1 H, two diastereomers), 
4.33 (s, 2 H), 2.98 – 2.86 (m, 1 H), 2.81 – 2.71 (m, 1 H), 2.32 (d, J = 12.4 Hz, 1 H), 2.16 and 
2.15 (2 s, 3 H), 2.12 – 1.03 (m, 7 H), 0.95 (d, J = 6.8 Hz, 3 H); 13C NMR   163.58, 163.54, 
162.90, 161.82, 136.09, 132.29, 127.63, 127.28, 122.72, 120.64, 118.05, 112.18, 109.45, 104.71, 
100.02, 97.48, 79.09, 79.05, 50.06, 42.65, 38.93, 37.61, 37.50, 35.71, 35.06, 32.13, 31.80, 30.79, 
27.29, 20.28, 14.14.  
 
 
(5aS,7S)-3-Methyl-7-(benzofuran-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (21A) and (5aS,7S)-3-Methyl-7-
(bis(benzofuran-2-ylmethyl)amino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (21B) 
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O
O
O
H
N
O
H
O
O
O
N
O
O
H
21A 21B     
From 100 (0.36 mmol) of amine 39 and 69.1 mg (0.47 mmol) of aldehyde 64, 89 mg (60% yield) 
of compound 21A and 32 mg (16% yield) of compound 21B were obtained as solids. Compound 
21A: 
1
H NMR  7.53 (d, J = 7.8 Hz, 1 H), 7.45 (d, J = 8.2 Hz, 1 H), 7.28 – 7.18 (m, 2 H), 6.57 
(s, 1 H), 6.06 (s, 1 H), 5.69 (s, 1 H), 5.10 – 4.97 (m, 1 H), 3.93 (s, 2 H), 2.69 – 2.60 (m, 1 H), 
2.54 – 2.47 (m, 1 H), 2.43 (d, J = 14.0 Hz, 1 H), 2.18 (s, 3 H), 2.07 – 1.92 (m, 2 H), 1.70 - 1.46  
(m, 4 H), 1.31 – 1.06 (m, 1 H), 0.91 and 0.90 (2 d,  J = 6.4 Hz, 3 H, CH3 of two diastereomers);
 
13
C NMR   163.43, 163.40, 162.75, 161.66, 156.85, 155.09, 132.92, 128.58, 123.99, 122.85, 
120.90, 111.23, 109.30, 104.05, 99.96, 97.54, 79.81, 79.69, 53.06, 52.96, 47.04, 39.37, 38.79, 
38.66, 37.88, 37.79, 36.87, 32.53, 32.39, 31.17, 28.52, 20.27, 14.81, 14.67; MS (electrospray 
ionization) m/z 406.3 (M+H
+
, 100%). Compound 21B:
 1
H NMR  7.61 - 7.42 (m, 4 H), 7.37 – 
7.17 (m, 4 H), 6.61 (s, 2 H), 6.01 (s, 1 H), 5.70 and 5.59 (2 s, 1 H, two diastereomers), 5.17 – 
5.00 and 4.88 – 4.80 (2 m, 1H), 4.01 – 3.79 (m, 4 H), 2.61 – 2.41 (m, 1 H), 2.40 – 2.23 (m, 2H), 
2.20 (s, 3 H), 2.17 – 1.45 (m, 5 H), 1.54 – 1.19 (m, 2 H), 0.84 and 0.83 (2 d, 3 H, CH3 of two 
diastereomers); 
13
C NMR   163.43, 162.79, 161.58, 161.52, 155.54, 155.20, 155.19, 133.16, 
128.48, 128.46, 124.13, 122.89, 120.95, 120.92, 111.37, 111.31, 109.15, 105.76, 99.99, 99.96, 
97.58, 79.91, 79.79, 56.93, 51.36, 39.70, 37.83, 37.43, 35.69, 35.39, 35.18, 32.66, 32.34, 31.48, 
27.47, 20.31, 14.31, 14.02; MS (electrospray ionization) 536.5 m/z (M+H
+
, 100%).  
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 (5aS,7S)-3-Methyl-7-(benzo[b]thiophen-3-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (22A) and (5aS,7S)-3-Methyl-7-
(bis(benzo[b]thiophen-3-ylmethyl)amino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (22B)    
22A 22B
O
O
O
H
N
S
H
O
O
O
N
S
S
H
             
From 110 mg (0.4 mmol) of amine 39, and 84 mg (0.52 mmol) of aldehyde 65, 100 mg (60% 
yield) of compound 22A and 19 mg of (8% yield) of 22B were obtained as solids. Compound 
22A: 
1
H NMR (200 MHz)  7.92 - 7.80 (m, 2 H), 7.41 - 7.33 (m, 2 H), 7.30 (s, 1 H), 6.04 (s, 1 
H), 5.70 (s, 1 H), 5.09 – 4.89 (m, 1 H), 4.03 (s, 2 H), 2.77 – 2.27 (m, 3 H), 2.18 (s, 3 H), 2.10 - 
1.80 (m, 2 H), 1.76 – 1.40 (m, 4 H), 1.36 – 1.04 (m, 1 H), 0.90 (d, J = 6.6 Hz, 3 H); 13C NMR 
(200 MHz) 163.43, 162.76, 161.64, 140.87, 138.55, 135.40, 132.97, 124.53, 124.11, 123.15, 
123.06, 122.05, 109.18, 99.96, 97.50, 79.82, 79.70, 53.55, 53.49, 48.14, 39.40, 38.66, 38.53, 
37.86, 37.76, 36.81, 32.53, 32.38, 31.17, 28.43, 20.27, 14.85, 14.72; MS (electrospray 
ionization) m/z 422.4 (M+H
+
). Compound 22B: 
1
H NMR  7.91 - 7.81 (m, 2 H), 7.61 (t, J = 8.6 
Hz, 2 H), 7.45 – 7.28 (m, 4 H), 7.23 – 7.14 (m, 2 H), 5.90 and 5.86 (2 s, 1 H, two diastereomers), 
5.70 and 5.64 (2 s, 1 H), 4.96 (d, J = 4.8 Hz, 1 H), 4.74 and 3.38 (2 dd, J = 11.2, 4.2 Hz, 1 H), 
4.07 – 3.96 (m, 2 H), 4.65 – 3.56 (m, 2 H), 2.59 – 2.49 (m, 1 H), 2.36 – 2.10 (m, 2 H), 2.18 (s, 3 
H), 1.89 – 0.53 (m, 6 H), 0.69 and 0.67 (2 d,  J = 6.8 Hz, 3 H, CH3 of two diastereomers);
 13
C 
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NMR 163.42, 163.30, 162.78, 162.75, 161.48, 161.44, 140.88, 140.86, 138.99, 134.50, 133.41, 
133.18, 125.31, 125.20, 124.58, 123.75, 123.19, 123.12, 122.99, 122.95, 108.74, 108.67, 100.02, 
99.97, 97.55, 97.36, 79.84, 79.28, 58.33, 58.25, 53.94, 40.40, 36.42, 36.34, 35.76, 35.56, 34.36, 
32.62, 32.10, 31.44, 26.07, 20.28, 20.26, 13.73, 13.49; MS  (electrospray ionization) m/z 568.5 
(M+H
+
). 
(5aS,7S)-3-Methyl-7-(1H-imidazol-4-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (23A) and (5aS,7S)-3-Methyl-7-(bis(1H-
imidazol-4-ylmethyl)amino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-
b][1]benzopyran (23B) 
23A 23B
O
O
O
H
N
N
NH
H
O
O
O
N
N
NH
N
NH
H
            
From 217 mg (0.79 mmol) of amine 39 and 83 mg (0.86 mmol) of aldehyde 66, 112 mg (40% 
yield) of compound 23A and 75 mg (22% yield) of compound 23B were obtained as solids. 
Compound 23A: 
1
H NMR  7.56 (s, 1 H), 6.89 (s, 1 H), 6.02 (s, 1 H), 5.70 (s, 1 H), 5.06 – 4.98 
(m, 1 H), 3.77 (s, 2 H), 2.64 (dd, J = 11.1, 4.9 Hz, 1 H), 2.51 – 2.43 (m, 1 H), 2.40 (d, J = 14.1 
Hz, 1 H), 2.17 (s, 3 H), 2.11 – 1.86 (m, 2 H), 1.72 – 1.42 (m, 4 H), 1.41 – 1.02 (m, 1 H), 0.88 (d, 
J = 6.4 Hz, 3 H);
 13
C NMR   163.54, 163.53, 162.84, 161.73, 135.39, 132.95, 117.85, 109.17, 
104.93, 100.03, 97.47, 79.74, 79.64, 53.09, 53.00, 46.14, 39.26, 38.80, 38.69, 37.57, 37.50, 
36.85, 32.48, 32.34, 31.09, 28.45, 20.24, 14.81, 14.71; MS (electrospray ionization) m/z 356.5 
(M+H
+
). Compound 23B: 
1
H NMR  9.09 (br. s, 2 H, NH), 7.62 (s, 2 H), 6.91 (s, 2 H), 5.97 (s, 1 
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H), 5.70 and 5.69 (2 s, 1 H, two diastereomers), 5.07 – 4.93 (m, 1 H), 3.64 – 3.42 (m, 4 H), 2.46 
– 2.26 (m, 2 H), 2.19 – 2.09 (m, 1 H), 2.15 and 2.14 (2 s, 3 H), 2.04 – 1.82 (m, 2 H), 1.81 – 0.85 
(m, 5 H), 0.77 (d, J = 6.0 Hz, 3 H);
 13
C NMR   163.76, 163.72, 163.04, 161.72, 161.67, 135.12, 
133.45, 132.51, 121.36, 108.81, 100.19, 97.44, 97.40, 80.04, 79.82, 58.29, 58.14, 49.10, 39.62, 
37.88, 37.72, 35.93, 35.11, 35.01, 32.62, 32.42, 31.45, 27.49, 20.22, 14.42, 14.26; MS 
(electrospray ionization) m/z 458.5 (M+Na
+
, 100%), 436.5 (M+H
+
).  
(5aS,7S)-3-Methyl-7-(thiazol-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-
oxopyrano[4,3-b][1]benzopyran (24) 
O
O
O
H
N
S
N
H
 
From 80 mg (0.29 mmol) of amine 39 and 33 mg (0.29 mmol) of aldehyde 67, 44 mg (41% 
yield) of compound 24 was obtained as a solid. 
1
H NMR (200 MHz)  7.72 (d, J = 3.3 Hz, 1 H), 
7.28 (d, J = 3.3 Hz, 1 H), 6.06 (s, 1 H), 5.71 (s, 1 H), 5.14 - 5.00 (m, 1 H), 4.13 (s, 2 H), 2.77 – 
2.52 (m, 2 H), 2.52 – 2.39 (m, 1 H), 2.19 (s, 3 H), 2.13 – 1.89 (m, 2 H), 1.79 – 1.42 (m, 4 H), 
1.36 – 1.07 (m, 1 H), 0.92 (d, J = 6.6 Hz, 3 H); 13C NMR   172.38, 163.41, 163.39, 162.72, 
161.65, 142.63, 132.87, 119.03, 109.27, 99.93, 97.50, 79.79, 79.67, 53.51, 53.42, 51.30, 39.38, 
38.60, 38.47, 37.97, 37.90, 36.82, 32.53, 32.29, 31.18, 28.42, 20.27, 14.69, 14.58; MS 
(electrospray ionization) m/z 373.5 (M+H
+
), 100%). 
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(5aS,7S)-3-Methyl-7-(1-(pyridin-3-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-
1-oxopyrano[4,3-b][1]benzopyran (25) 
O
O
O
H
N N
H
 
From 85 mg (0.31 mmol) of amine 39 and 33 mg (0.31 mmol) of aldehyde 68, 68 mg (60% 
yield) of compound 25 was obtained as a solid.
 1H NMR δ 8.57 (s, 1 H), 8.51 (d, J = 4 Hz, 1 H), 
7.70 (d, J = 7.5 Hz, 1 H), 7.28 (dd, J = 7.5, 4 Hz, 1 H), 6.05 (s, 1 H), 5.71 (s, 1 H), 5.11 – 4.98 
(m, 1 H), 3.81 (s, 2 H), 2.67 – 2.57 (m, 1 H), 2.53 – 2.38 (m, 2 H), 2.19 (s, 3 H), 2.08 – 1.91 (m, 
2 H), 1.74 – 1.46 (m, 4 H), 1.29 – 1.06 (m, 1 H), 0.91 (d, J = 5.0 Hz, 3 H); 13C NMR δ 163.3, 
162.6, 161.6, 149.7, 148.5, 136.0, 135.6, 132.8, 123.5, 109.1, 99.9, 97.4, 79.7, 79.5, 53.1, 53.05, 
51.5,  39.2, 38.7, 38.5, 37.7, 37.6, 36.7, 32.4, 32.3, 31.0, 28.4, 20.2, 14.7, 14.6;  MS (electrospray 
ionization) m/z 367.2 (M+H
+
); HRMS calcd for C22H27N2O3
+
 (M+H
+
) 367.2022, found 367.2017 
(100%). 
(5aS,7S)-3-Methyl-7-(1-(pyridin-4-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-
1-oxopyrano[4,3-b][1]benzopyran (26) 
O
O
O
H
N
N
H
 
From 85 mg (0.31 mmol) of amine 39 and 33 mg (0.31 mmol) of aldehyde 69, 72 mg (64% 
yield) of compound 26 was obtained as a solid.  
1H NMR δ 8.54 (d, J = 4.5 Hz, 2 H), 7.26 (d, J = 
4.7 Hz, 2 H), 6.06 (s, 1 H), 5.70 (s, 1 H), 5.11 – 4.98 (m, 1 H), 3.80 (s, 2 H), 2.63 – 2.55 (m, 1 
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H), 2.50 – 2.39 (m, 2 H), 2.18 (s, 3 H), 2.09 – 1.91 (m, 2 H), 1.75 – 1.47 (m, 4 H), 1.35 – 1.05 
(m, 1 H), 0.92 (d, J = 6.6 Hz, 3 H); 
13C NMR δ 163.3, 163.3, 162.6, 161.6, 149.8, 132.8, 123.1, 
109.3, 99.9, 97.4, 79.7, 79.6, 53.4, 53.3, 53.0, 39.3, 38.8, 38.7, 38.0, 37.9, 36.9, 32.5, 32.4, 31.1, 
28.6, 20.2, 14.8, 14.7;  MS (electrospray ionization) m/z 367.2 (M+H
+
), 139.0, 121.2; HRMS 
calcd for C22H26N2O3Na
+
 (M+Na
+
) 389.1841, found 389.1844 (100%). 
(5aS,7S)-3-Methyl-7-(1-(quinolin-2-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (27A) 
O
O
O
H
N
N
H
 
From 60 mg (0.22 mmol) of amine 39 and 35 mg (0.22 mmol) of aldehyde 70A, 54 mg (60% 
yield) of 27A was obtained as a solid. 
1H NMR δ 8.11 (d, J = 8.6 Hz, 1 H), 8.04 (d, J = 8.2 Hz, 1 
H), 7.79 (d, J = 8.2 Hz, 1 H), 7.69 (t, J = 7.4 Hz, 1 H), 7.50 (t, J = 7.4 Hz, 1 H), 7.43 (d, J = 8.6 
Hz, 1 H), 6.04 (s, 1 H), 5.67 (s, 1 H), 5.08 – 5.00 (m, 1 H), 4.09 (s, 2 H), 2.69 (dd, J = 11.7, 5.8 
Hz, 1 H), 2.59 – 2.50 (m, 1 H), 2.41 (d, J = 14 Hz, 1 H), 2.16 (s, 3 H), 2.10 – 1.91 (m, 2 H), 1.78 
– 1.45 (m, 4 H), 1.27 – 1.04 (m, 1 H), 0.93 and 0.92 (2 d, J = 6.2 Hz, 3 H, CH3 of diastereomers 
at C12); 
13C NMR δ 163.4, 163.4, 162.7, 161.6, 160.1, 147.8, 136.6, 133.0, 132.9, 129.7, 129.0, 
127.7, 127.5, 126.3, 120.7, 109.2, 99.9, 97.5, 79.8, 79.7, 55.9, 53.7, 53.6, 39.3, 38.7, 38.6, 37.9, 
37.8, 36.8, 32.5, 32.4, 31.1, 28.5, 20.2, 14.8, 14.7;  MS (electrospray ionization) m/z 417.3 
(M+H
+
);  HRMS calcd for C26H29N2O3
+
 (M+H
+
) 417.2178, found 417.2164 (100%). 
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(5aS,7S)-3-Methyl-7-(1-((4-methylquinolin-2-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (27B) 
O
O
O
H
N
N
H
 
From 43 mg (0.15 mmol) of amine 39 and 26 mg (0.15 mmol) of aldehyde 70B, 35 mg (53% 
yield) of compound 27B was obtained as a solid. Note: Ethanol was used as solvent in the 
reaction.  
1
H NMR δ 8.03 (d, J = 8.1 Hz, 1 H), 7.96 (d, J = 8.2 Hz, 1 H), 7.67 (t, J = 7.4 Hz, 1 H), 
7.51 (t, J = 7.4 Hz, 1 H), 7.27 (s, 1 H),  6.03 (s, 1 H), 5.67 (s, 1 H), 5.12 – 4.97 (m, 1 H), 4.02 (s, 
2 H), 2.75 - 2.60 (m, 1 H), 2.68 (s, 3 H), 2.59 – 2.31  (m, 2 H), 2.16 (s, 3 H), 2.11 – 1.86 (m, 2 
H), 1.78 – 1.39 (m, 4 H), 1.31 – 1.04 (m, 1 H), 0.92 and 0.91 (2 d, J = 6.4, Hz, 3 H, CH3 of two 
diastereomers at C12);  
13
C NMR δ 163.4, 162.7, 161.6, 156.0, 147.7, 144.7, 133.0, 129.6, 129.3, 
127.5, 126.0, 123.9, 121.4, 109.2, 99.9, 97.5, 79.9, 79.7, 56.0, 53.8, 53.7, 39.4, 38.7, 38.5, 38.0, 
37.8, 36.8, 32.6, 32.4, 31.2, 28.5, 20.2, 18.9, 14.9, 14.7;  MS (electrospray ionization) 429.1 (M-
1); HRMS calcd for C27H31N2O3
+
 (M+H
+
) 431.2335, found 431.2308 (100%). 
(5aS,7S)-3-Methyl-7-(1-((6-methylquinolin-2-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (27C) 
O
O
O
H
N
N
H
 
From 43 mg (0.15 mmol) of amine 39 and 26 mg (0.15 mmol) of aldehyde 70C, 37 mg of 
compound 27C (56% yield) was obtained as a solid.  Note: Ethanol was used as a solvent in the 
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reaction.
  1H NMR δ 8.04 (d, J = 8.2 Hz, 1 H), 7.94 (d, J = 8.6 Hz, 1 H), 7.57 (s, 1 H), 7.53 (dd, J 
= 8.6, 1.6 Hz, 1 H), 7.40 (d, J = 8.6 Hz, 1 H), 6.05 (s, 1 H), 5.69 (s, 1 H), 5.10 – 5.02 (m, 1 H), 
4.08 (s, 2 H), 2.73 – 2.65 (m, 1 H), 2.59 – 2.49 (m, 1 H), 2.53 (s, 3 H), 2.43 (d, J = 14.4 Hz, 1 H), 
2.18 (s, 3 H), 2.10 – 1.93 (m, 2 H), 1.77 – 1.46 (m, 4 H), 1.29 – 1.07 (m, 1 H), 0.94 and 0.93 (2 
d, J = 6.6 Hz, 3 H, CH3, 2 diastereomers at C12); 
13C NMR δ 163.5, 163.4, 162.8, 161.6, 159.1, 
146.4, 136.2, 136.1, 133.0, 132.99, 132.0, 128.7, 127.5, 126.7, 120.7, 109.2, 100.0, 97.5, 79.9, 
79.7, 55.9, 53.7, 53.6, 39.4, 38.7, 38.5, 37.9, 37.8, 36.8, 32.6, 32.4, 31.2, 28.4, 21.7, 20.3, 14.9, 
14.7;  MS (electrosprary ionization) 431.4 (M+1), 156.1, 129.2;  HRMS calcd for C27H31N2O3
+
 
(M+H
+
) 431.2335, found 431.2309 (100%). 
(5aS,7S)-3-Methyl-7-(1-(quinolin-4-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (28A) 
O
O
O
H
N
N
H
 
From 1.28 g (4.65 mmol) of amine 39 and 0.73 g (4.65 mmol) of aldehyde 71A, 1.25 g (65% 
yield) of 28A was obtained as a solid. 
 1H NMR δ 8.88 (d, J = 4.3 Hz, 1 H), 8.14 (d, J = 7.4 Hz, 1 
H), 8.12 (d, J = 7.0 Hz, 1 H), 7.73 (t, J = 7.6 Hz, 1 H), 7.58 (t, J = 7.8 Hz, 1 H), 7.45 (d, J = 4.3 
Hz, 1 H), 6.07 (s, 1 H), 5.70 (s, 1 H), 5.06 – 4.95 (m, 1 H), 4.27 (s, 2 H), 2.75 – 2.67 (m, 1 H), 
2.63 – 2.55 (m, 1 H), 2.44 (d, J = 14.4 Hz, 1 H), 2.19 (s, 3 H), 2.07 – 1.88 (m, 2 H), 1.75 – 1.47 
(m, 4 H), 1.30 – 1.08 (m, 1 H), 0.94 and 0.93 (2 d, J = 6.6 Hz, 3 H, CH3, 2 diastereomers at C12); 
13C NMR δ 163.4, 163.37, 162.7, 161.7, 150.4, 148.4, 146.0, 132.8, 130.3, 129.3, 127.3, 126.6, 
123.6, 120.1, 109.3, 99.9, 97.5, 79.8, 79.7, 53.9, 53.8, 50.7, 50.7, 39.3, 38.8, 38.6, 38.0, 37.9, 
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36.9, 32.5, 32.4, 31.1, 28.6, 20.3, 14.9, 14.8;  MS (electrospray ionization) m/z 417.5 
(M+H
+
),139.1;  HRMS calcd for C26H29N2O3
+
 (M+H
+
) 417.2178, found 417.2162 (100%). 
(5aS,7S)-3-Methyl-7-(1-((2-methylquinolin-4-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (28B) 
O
O
O
H
N
N
H
 
From 43 mg (0.15 mmol) of amine 39 and 26 mg (0.15 mmol) of aldehyde 71B, 40 mg (60% 
yield) of 28B was obtained as a solid. 
 1
H NMR δ 8.01 (d, J = 8.6 Hz, 2 H), 7.65 (t, J = 7.6 Hz, 1 
H), 7.47 (t, J = 7.6 Hz, 1 H), 7.31 (s, 1 H), 6.03 (s, 1 H), 5.68 (s, 1 H), 5.04 – 4.94 (m, 1 H), 4.18 
(s, 2 H), 2.73 – 2.63 (m, 1 H), 2.71 (s, 3 H), 2.59 – 2.52 (m, 1 H), 2.41 (d, J = 14.5 Hz, 1 H), 2.16 
(s, 3 H), 2.05 – 1.86 (m, 2 H), 1.75 – 1.44 (m, 4 H), 1.26 – 1.05 (m, 1 H), 0.91 and 0.90 (2 d, J = 
6.6 Hz, 3 H, CH3, two diastereomers); 
13C NMR δ 163.4, 163.3, 162.7, 161.6, 158.9, 148.0, 
145.8, 132.81, 132.80, 129.3, 129.3, 125.7, 125.4, 123.3, 120.9, 109.2, 99.9, 97.4, 79.7, 79.6, 
53.8, 53.79, 50.64, 50.61, 39.3, 38.7, 38.5, 37.9, 37.8, 36.8, 32.5, 32.3, 31.1, 28.5, 25.5, 20.2, 
14.9, 14.7;  MS (electrospray) m/z 431.4 (M+H
+
), 144.2;  HRMS calcd for C27H31N2O3
+
 (M+H
+
) 
431.2335, found 431.2320 (100%). 
 
 
 
(5aS,7S)-7-(1-((2-(Hydroxymethyl)quinolin-4-yl)methylamino)propan-2-yl)-3-methyl-
6,7,8,9-hexahydropyrano[4,3-b]chromen-1(5aH)-one (28C) 
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O
O
O
H
N
N
OH
H
 
From 43 mg (0.15 mmol) of amine 39 and 29 mg (0.15 mmol) of aldehyde 71C, 42 mg (61% 
yield) of 28C was obtained as a solid.  Note: Ethanol was used as a solvent in the reaction.  
1
H 
NMR δ 8.09 (d, J = 8.2 Hz, 1 H), 8.07 (d, J = 7.8 Hz, 1 H), 7.72 (t, J = 7.6 Hz, 1 H), 7.56 (t, J = 
7.6 Hz, 1 H), 7.35 (s, 1 H), 6.06 (s, 1 H), 5.70 (s, 1 H), 5.06 – 4.97 (m, 1 H), 4.91 (s, 2 H), 4.25 
(s, 2 H), 2.76 – 2.66 (m, 1 H), 2.63 – 2.54 (m, 1 H), 2.43 (d, J = 14.0 Hz, 1 H), 2.19 (s, 3 H), 2.08 
– 1.88 (m, 2 H), 1.77 – 1.47 (m, 4 H), 1.33 – 1.06 (m, 1 H), 0.94 and 0.93 (2 d, J = 6.6 Hz, 3 H, 
CH3, two diastereomers);  
13C NMR δ 163.4, 163.37, 162.7, 161.7, 159.0, 146.9, 146.7, 132.8, 
132.79, 129.6, 129.5, 126.5, 126.4, 123.5, 117.1, 109.3, 99.9, 97.5, 79.8, 79.6, 64.3, 53.9, 53.86, 
50.7, 50.65, 39.3, 38.8, 38.6, 38.0, 37.9, 36.8, 32.5, 32.4, 31.1, 29.9, 28.6, 20.3, 14.9, 14.8;  MS 
(electrospray ionization) m/z 469.3 (M+Na
+
), 447.3 (M+H
+
), 142; HRMS calcd for C27H31N2O4
+
 
(M+H
+
) 447.2284, found 447.2284. 
 
4-((2-((5aS,7S)-Methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl)propylamino)methyl)quinolin-2-yl)methyl  acetate (28D) 
O
O
O
H
N
N
OAc
H
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  From 43 mg (0.15 mmol) of amine 39 and 34 mg (0.15 mmol) of aldehyde 71D, 50 mg (66% 
yield) of 28D was obtained as a solid.  A mixture of ethanol and THF (2:1) was used as a solvent 
in the reaction. 
1H NMR δ 8.09 (dd, J = 8.2, 3.1 Hz, 2 H), 7.71 (t, J = 7.6 Hz, 1 H), 7.56 (t, J = 
7.6 Hz, 1 H), 7.52 (s, 1 H), 6.05 (s, 1 H), 5.70 (s, 1 H), 5.37 (s, 2 H), 5.06 – 4.96 (m, 1 H), 4.25 
(s, 2 H), 2.75 – 2.67 (m, 1 H), 2.61 – 2.54 (m, 1 H), 2.43 (d, J = 14.0 Hz, 1 H), 2.19 (s, 3 H), 2.18 
(s, 3 H), 2.07 – 1.88 (m, 2 H), 1.73 – 1.48 (m, 4 H), 1.31 – 1.06 (m, 1 H), 0.94 and 0.93 (2 d, J = 
6.6 Hz, 3 H, CH3, 2 diastereomers at C12);  
13C NMR δ 170.9, 163.4, 163.4, 162.7, 161.7, 156.0, 
147.9, 147.0, 132.8, 130.1, 129.7, 126.8, 126.5, 123.5, 118.5, 109.3, 99.9, 97.5, 79.8, 79.6, 67.8, 
53.9, 53.9, 50.8, 50.8, 39.3, 38.8, 38.7, 38.0, 37.9, 36.9, 32.5, 32.4, 31.1, 28.6, 21.2, 20.3, 15.0, 
14.8;  MS (electrospray ionization) 511.2 (M+Na
+
), 489.2 (M+H
+
);  HRMS calcd for 
C29H32N2O5Na
+
 (M+Na
+
) 511.2209, found 511.2184 (100%). 
(5aS,7S)-7-(1-((2-(1,3,5-Trioxan-2-yl)quinolin-4-yl)methylamino)propan-2-yl)-3-methyl-
6,7,8,9-tetrahydropyrano[4,3-b]chromen-1(5aH)-one (28E) 
O
O
O
H
N
N
O
O
O
H
 
From 102 mg (0.37 mmol) of amine 39 and 91 mg (0.37 mmol) of aldehyde 71E, 88 mg (47% 
yield) of compound 28E was obtained as a solid.  Note: Ethanol was used as a solvent in the 
reaction. 
 1H NMR δ 8.16 (d, J = 8.2 Hz, 1 H), 8.14 (d, J = 7.6 Hz, 1 H), 7.84 (d, J = 1.6 Hz, 1 
H), 7.72 (t, J = 7.6 Hz, 1 H), 7.59 (t, J = 8.1 Hz, 1 H), 6.11 (s, 1 H), 6.05 (s, 1 H), 5.69 (s, 1 H), 
5.46 – 5.39 (m, 4 H), 5.07 – 4.98 (m, 1 H), 4.27 (s, 2 H), 2.75 – 2.66 (m, 1 H), 2.63 - 2.54 (m, 1 
H), 2.43 (d, J = 14.1 Hz, 1 H), 2.18 (s, 3 H), 2.07 – 1.87 (m, 2 H), 1.78 – 1.46 (m, 4 H), 1.33 – 
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1.06 (m, 1 H), 0.92 and 0.92 (2 d, J = 6.8 Hz, 3 H, CH3, 2 diastereomers at C12);  
13C NMR δ 
163.4, 163.37, 162.7, 161.7, 155.2, 147.7, 147.5, 133.0, 130.5, 129.7, 127.5, 127.3, 123.7, 117.3, 
117.2, 109.3, 102.3, 99.9, 97.5, 93.9, 79.8, 79.7, 54.0, 53.9, 51.0, 51.0, 39.4, 38.6, 38.5, 38.0, 
37.9, 36.8, 32.6, 32.4, 31.2, 28.5, 20.3, 14.9, 14.8;  MS (electrospray ionization) 527.4 (M+Na
+
), 
505.6 (M+H
+
), 445.1, 199.3, 139.0;  HRMS calcd for C29H33N2O6
+
 (M+H
+
) 505.2339, found 
505.2340. 
(5aS,7S)-3-Methyl-7-(1-((6-methylquinolin-4-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (28F) 
O
O
O
H
N
N
H
 
From 85 mg (0.31 mmol) of amine 39 and 53 mg (0.31 mmol) of aldehyde 71F, 82 mg (62% 
yield) of compound 28F was obtained as a solid.  Note: A mixture of ethanol and THF (2:1) was 
used as a solvent in the reaction.  
1H NMR δ 8.78 (d, J = 4.3 Hz, 1 H), 8.01 (d, J = 8.6 Hz, 1 H), 
7.85 (s, 1 H), 7.53 (d, J = 8.6 Hz, 1 H), 7.39 (d, J = 4.3 Hz, 1 H), 6.05 (s, 1 H), 5.69 (s, 1 H), 5.05 
– 4.94 (m, 1 H), 4.21 (s, 2 H), 2.75 – 2.66 (m, 1 H), 2.62 – 2.54 (m, 1 H), 2.56 (s, 3 H), 2.43 (d, J 
= 14.0 Hz, 1 H), 2.17 (s, 3 H), 2.07 – 1.88 (m, 2 H), 1.74 – 1.47 (m, 4 H), 1.31 – 1.07 (m, 1 H), 
0.94 and 0.93 (2 d, J = 7.0 Hz, 3 H, CH3, 2 diastereomers at C12); 
13C NMR δ 163.4, 163.35, 
162.7, 161.6, 149.5, 147.0, 145.2, 136.5, 132.8, 131.5, 130.0, 127.2, 122.4, 120.0, 109.3, 99.9, 
97.5, 79.8, 79.7, 53.9, 53.8, 50.7, 39.3, 38.8, 38.7, 38.0, 37.9, 36.9, 32.5, 32.4, 31.2, 28.6, 22.1, 
20.2, 14.9, 14.8;  MS (electrospray ionization) 431.4 (M+1), 156.2, 144.3; HRMS calcd for 
C27H30N2O3Na
+
 (M+Na
+
) 453.2154, found 453.2151. 
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(5aS,7S)-3-Methyl-7-(1-(quinolin-6-ylmethylamino)propan-2-yl)-6,7,8,9-
tetrahydropyrano[4,3-b]chromen-1(5aH)-one (29) 
O
O
O
H
N
N
H
 
From 0.15 g (0.53 mmol) of amine 39 and 83 mg (0.53 mmol) of aldehyde 72, 104 mg (47% 
yield) of 29 was obtained as a solid.  
1H NMR 8.87 δ (d, J = 3.9 Hz, 1 H), 8.12 (d, J = 8.2 Hz, 1 
H), 8.06 (d, J = 8.6 Hz, 1 H), 7.76 (s, 1 H), 7.71 (d, J = 9.0 Hz, 1 H), 7.38 (dd, J = 8.4, 4.1 Hz, 1 
H), 6.02 (s, 1 H), 5.66 (s, 1 H), 5.01 (dd, J = 10.9, 4.7 Hz, 1 H), 3.99 (s, 2 H), 2.70 – 2.62 (m, 1 
H), 2.55 – 2.46 (m, 1 H), 2.40 (d, J = 14.1 Hz, 1 H), 2.15 (s, 3 H), 2.05 – 1.88 (m, 2 H), 1.74 – 
1.42 (m, 4 H), 1.26 – 1.01 (m, 1 H), 0.90 and 0.89 (2 d, J = 6.3 Hz, 3 H, CH3, 2 diastereomers at 
C12); 
13C NMR δ 163.4, 163.36, 162.7, 161.6, 150.3, 147.7, 137.4, 136.2, 132.7, 132.7, 130.4, 
129.6, 128.3, 126.9, 121.5, 109.2, 99.9, 97.4, 97.4, 79.7, 79.5, 53.5, 52.7, 52.7, 39.2, 38.7, 38.5, 
37.4, 37.3, 36.7, 32.4, 32.3, 31.0, 28.4, 20.2, 14.7, 14.6;  MS (electrospray ionization) m/z 417.5 
(M+H
+
), 142.0;  HRMS calcd for C26H29N2O3
+
 (M+H
+
) 417.2178, found 417.2174 (100%). 
(5aS,7S)-3-Methyl-7-(1-(quinolin-8-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (30) 
O
O
O
H
N
N  
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From 43 mg (0.15 mmol) of amine 39 and 24 mg (0.15 mmol) of aldehyde 73, 34 mg (53% 
yield) of 30 was obtained as a solid.  Note: A mixture of ethanol and THF (2:1) was used as a 
solvent in the reaction.  In the column chromatographic separation, the column was deactivated 
with 2% triethylamine in hexane prior to the loading of the crude product.  
1H NMR δ 8.87 – 
8.83 (m, 1 H), 8.12 (d, J = 8.2 Hz, 1 H), 7.69 (d, J = 8.2 Hz, 1 H), 7.61 (d, J = 7.0 Hz, 1 H), 7.44 
(t, J = 7.4 Hz, 1 H), 7.37 (dd, J = 8.2, 3.9 Hz, 1 H), 5.99 (s, 1 H),  5.65 (s, 1 H), 5.01 – 4.91 (m, 1 
H), 4.30 (s, 2 H), 2.58 (dd, J = 11.7, 5.8 Hz, 1 H), 2.50 – 2.42 (m, 1 H), 2.35 (d, J = 12.9 Hz, 1 
H), 2.13 (s, 3 H), 2.02 – 1.82 (m, 2 H), 1.69 – 1.38 (m, 4 H), 1.30 – 0.99 (m, 1 H), 0.82 (d, J = 
6.2 Hz, 3 H);  
13C NMR δ 163.4, 163.35, 162.7, 161.6, 149.5, 147.0, 136.8, 133.0, 132.9, 129.6, 
128.6, 127.5, 126.5, 121.3, 109.2, 109.14, 99.9, 97.5, 79.8, 79.7, 53.1, 53.0, 51.7, 51.67, 39.4, 
38.5, 38.45, 37.5, 37.4, 36.7, 32.5, 32.4, 31.1, 28.2, 20.3, 14.7, 14.63;  MS (electrospray 
ionization) 439.5 (M+Na
+
), 417.3 (M +H
+
), 142.1;  HRMS calcd for C26H29N2O3
+
 (M+H
+
) 
417.2178, found 417.2173 (100%). 
5aS,7S)-7-(1-(Benzo[h]quinolin-4-ylmethylamino)propan-2-yl)-3-methyl-1H,7H-5a,6,8,9-
tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (31) 
O
O
O
H
N
N
H
 
From 51 mg (0.18 mmol) of amine 39 and 38 mg (0.18 mmol) of aldehyde 74, 54 mg (62% 
yield) of compound 31 was obtained as a solid.  Note: Ethanol was used as a solvent in the 
reaction.  
1H NMR δ 9.32 (d, J = 7.4 Hz, 1 H), 8.96 (d, J = 4.3 Hz, 1 H), 8.03 (d, J = 9.0 Hz, 1 
H), 7.92 (d, J = 7.4 Hz, 1 H), 7.85 (d, J = 9.4 Hz, 1 H), 7.78 – 7.68 (m, 2 H), 7.56 (d, J = 4.7 Hz, 
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1 H), 6.05 (s, 1 H), 5.64 (s, 1 H), 5.05 – 4.94 (m, 1 H), 4.30 (s, 2 H),  2.76 – 2.66 (m, 1 H), 2.64 – 
2.56 (m, 1 H), 2.43 (d, J = 14.4 Hz, 1 H), 2.18 (s, 3 H), 2.04 – 1.89 (m, 2 H), 1.76 – 1.46 (m, 4 
H), 1.43 – 1.06 (m, 1 H), 0.95 and 0.93 (2 d, J = 7.0 Hz, 3 H, CH3, two diastereomers);  
13
C NMR 
δ 163.4, 162.8, 161.6, 148.8, 146.7, 145.7, 133.4, 132.9, 132.0, 128.3, 127.9, 127.8, 127.3, 125.1, 
124.9, 121.3, 121.1, 109.2, 99.9, 97.5, 79.8, 79.6, 53.8, 53.7, 51.1, 39.2, 38.8, 38.6, 38.0, 37.8, 
36.8, 32.5, 32.4, 31.1, 28.7, 20.3, 15.0, 14.8;  MS (electrospray ionization) m/z 467.6 (M+H
+
), 
192.3;  HRMS calcd for C30H31N2O3
+
 (M+H
+
) 467.2335, found 467.2335 (100%). 
N-(2-((5aS,7S)-3-Methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl)propyl)quinolie-4-carboxamide (32) 
O
O
O
H
N
N
O
H
 
A mixture of 43 mg (0.15 mmol) of amine 39, 42 mg (0.24 mmol) of acid 75, 56 mg (0.36 
mmol) of EDC.HCl, and 2 mg (0.02 mmol) of DMAP in 5 mL of dry dichloromethane was 
stirred under argon, at 25 
o
C, for 12 h.  The reaction mixture was diluted with 100 mL of 
dichloromethane, washed with water and brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a gradient mixture of hexane and ethyl acetate as eluant to 
give 43 mg (65% yield) of compound 32 as a solid.  
1H NMR δ 8.82 (d, J = 4.3 Hz, 1 H), 8.16 (d, 
J = 8.6 Hz, 1 H), 8.08 (d, J = 8.6 Hz, 1 H), 7.73 (t, J = 7.6 Hz, 1 H), 7.57 (t, J = 7.6 Hz, 1 H), 
7.34 (d, J = 4.3 Hz, 1 H), 6.72 (br. s, 1 H, NH), 5.97 (s, 1 H), 5.68 (s, 1 H), 5.09 – 4.98 (m, 1 H), 
3.63 – 3.52 (m, 1 H), 3.42 – 3.29 (m, 1 H), 2.43 (d, J = 13.3 Hz, 1 H), 2.14 (s, 4 H), 2.06 – 1.90 
(m, 1 H), 1.87 – 1.71 (m, 2 H), 1.71 – 1.51 (m, 2 H), 1.43 – 1.11 (m, 1 H), 0.99 and 0.98 (2 d, J = 
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6.6 Hz, 3 H, CH3, 2 diastereomers at C12); 
13C NMR δ 167.7, 163.5, 162.7, 161.8, 149.9, 148.7, 
142.4, 132.4, 130.2, 129.9, 127.8, 125.4, 124.6, 118.5, 109.4, 99.9, 97.4, 79.6, 79.4, 43.9, 39.2, 
38.8, 38.7, 38.0, 36.9, 32.4, 32.3, 31.1, 28.6, 20.2, 14.5, 14.4;  MS (electrospray ionization) m/z 
453.3 (M + Na
+
), 431.1 (M+H
+
);  HRMS calcd for C26H27N2O4
+
 (M+H
+
) 431.1971, found 
431.1957 (100%). 
N-(2-((5aS,7S)-3-Methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl)propyl)quinolie-4-carboxylate (33) 
O
O
O
O
N
O
H
 
A mixture of 50 mg (0.18 mmol) of alcohol 40, 32 mg (0.18 mmol) of acid 75, 47.7 mg (0.3 
mmol) of EDC.HCl, and 5 mg (0.04 mmol) of DMAP in 5 mL of dry dichloromethane was 
stirred for 24 h. The mixture was dilute with 120 mL of dry dichloromethane, washed with 0.5N 
HCl followed by brine, dried with MgSO4, concentrated, and purified through a silica gel column 
using a mixture of hexanes and ethyl acetate (1:2) to get 27 mg (57% yield) of compound 33, as 
a solid. 20 mg of alcohol 40 was also recovered. 
1
H NMR  9.08 – 9.04 (m, 1 H), 8.78 – 8.74 (m, 
1 H), 8.51 (d, J = 6.2 Hz, 1 H), 7.96 (d, J = 6.6 Hz, 1 H), 7.83 – 7.73 (m, 2 H), 6.09 (s, 1 H), 5.70 
(s, 1 H), 5.11 – 5.03 (m, 1 H), 4.44 – 4.38 (m, 1 H), 4.32 – 4.23 (m, 1 H), 2.54 – 2.46 (m, 1 H), 
2.18 (s, 4 H), 2.10 – 1.92 (m, 2 H), 1.89 – 1.55 (m, 3 H), 1.43 – 1.17 (m, 1 H), 1.06 and 1.07 (2 
d, J = 6.6 Hz, 3 H, CH3, two diastereomers); 
13C NMR δ 164.78, 163.35, 163.33, 162.60, 161.86, 
142.53, 134.57, 132.18, 130.63, 130.40, 128.84, 126.90, 124.35, 123.10, 120.02, 109.73, 99.85, 
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97.51, 79.40, 79.30, 68.57, 68.55, 39.10, 38.36, 38.28, 37.44, 37.25, 37.20, 32.36, 32.27, 30.90, 
29.10, 20.29, 14.14, 14.05; MS (electrospray ionization) m/z 470.3 (M+K
+
). 
N-(2-((5aS,7S)-3-Methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-yl)propyl)4-
hydroxy benzoate (34) 
O
O
O
O
O
OH
H
 
A mixture of 100 mg (0.36 mmol) of alcohol 40 and 91.5 mg (0.36 mmol) of acid 76, 96 mg 
(0.61 mmol) of EDC.HCl, and 6 mg (0.05 mmol) of DMAP in 7 mL of dry dichloromethane was 
stirred for 20 h. The mixture was diluted with 250 mL of dichloromethane and washed with 0.5N 
HCl and brine, dried (MgSO4), and concentrated. To this crude in 10 mL of THF was added 1.1 
mL (1.1 mmol) of TBAF (1M in THF), and the mixture was stirred for 2 h. The mixture was 
diluted with dichloromethane (200 mL), washed with water and brine, dried with MgSO4, 
concentrated, and purified through silica gel column to get 60 mg (53% yield) of compound 34 
as a solid. 21 mg of alcohol 40 was also recovered.
 1
H NMR  7.93 (d, J = 8.9 Hz, 2 H), 6.92 (d, 
J = 8.6 Hz, 2 H), 6.08 (s, 1 H), 5.75 (s, 1 H), 5.12 – 5.03 (m, 1 H), 4.29 - 4.21 (m, 1 H), 4.21 - 
4.13 (m, 1 H), 2.48 (d, J = 14.0 Hz, 1 H), 2.20 (s, 4 H), 2.08 – 1.88 (m, 2 H), 1.87 - 1.55 (m, 3 
H), 1.35 - 1.14 (m, 1 H), 1.01 (d, J = 7.0 Hz, 3 H); 
13
C NMR  166.83, 164.00, 163.97, 163.38, 
161.97, 161.09, 132.90, 131.97, 122.20, 115.61, 109.24, 100.32, 97.62, 79.74, 79.65, 65.50, 
67.47, 39.11, 38.34, 38.21, 37.44, 37.21, 37.21, 32.48, 32.40, 30.95, 29.20, 20.28, 14.05, 13.90; 
MS (electrospray ionization) m/z 419.3 (M+Na
+ 
, 100% ). 
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(5aS,7S)-3-Methyl-7-{(1R) and (1S)-1-[3-imino-2(4-methoxyphenyl)propanal]propan-2-yl}-
1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (35) 
O
O
O
N
H
HO
OMe  
A mixture of 85 mg (0.31 mg) of amine 39 and 64.8 mg (0.36 mmol) of dialdehyde 77, in 5 mL 
of dry MeOH was stirred for 12 h. Diluted with dichloromethane, washed with brine, dried 
(MgSO4), concentrated, and purified through silica gel column to get 63 mg (47% yield) of 
compound 35 as a solid. (NOTE: The attempt to reduce imine 35 with NaBH3CN in the presence 
of acetic acid was not successful and the product was obtained as a mixture of E and Z 
conformational isomers). 
1
H NMR  (200 MHz) 10.59 - 10.35 and 5.57 – 5.28 (2 m, 1 H, CHO, E 
and Z isomers), 9.42 (d, J = 3.7 Hz, 0.5 H, CHO-aldehyde), 9.06 (s, 0.5 H, CHO-aldehyde), 7.24 
– 7.10 (m, 2 H), 7.07 and 7.00 (2 d, J = 3.8 Hz, 1 H, imine), 6.99 – 6.82 (m, 2 H),  6.07 (s, 1 H), 
5.71 (s, 1 H) 5.06 (br. s, 1 H), 3.80 (s, 3 H), 3.46 – 3.23 (m, 1 H), 3.23 – 1.96 (m, 1 H), 2.47 (d, J 
= 13.6 Hz, 1 H), 2.18 (s, 3 H), 2.15 – 1.88 (m, 2 H), 1.83 – 1.42 (m, 4 H), 1.36 – 1.08 (m, 1 H), 
0.96 and 0.91 (2 d, J = 6.6 Hz, 3 H, CH3 of two diastereomers); 
13
C NMR 189.25, 163.41, 
163.36, 162.69, 161.95, 161.85, 157.99, 153.41, 132.20, 132.18, 130.72, 130.68, 127.46, 114.81, 
114.37, 109.85, 109.68, 99.91, 99.85, 97.47, 79.35, 79.22, 77.44, 55.56, 55.54, 53.64, 39.17, 
39.14, 39.10, 38.50, 38.18, 37.01, 32.28, 32.18, 30.98, 28.48, 20.32, 14.29, 14.20; MS 
(electrospray ionization) m/z 458.6 (M+Na
+
, 100%). 
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2-{(5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-yl}propanal 
(78) 
O
O
O
H
H
O  
To a solution of 500 mg (1.81 mmol) of TP alcohol 40 in 10 mL of DMSO was added 608.7 mg 
(2.17 mmol) of IBX. After stirring for 3 h, the mixture was diluted with water (100 mL), and 
extracted in dichloromethane (75 x 3 mL). The organic layer was washed with brine, dried 
(MgSO4), and concentrated to get 380 mg (77% yield) of aldehyde 78 as a solid. 
1
H NMR  9.68 
and 9.67 (2 s, 1 H, 2 diastereomers), 6.10 (s, 1 H), 5.70 (s, 1 H), 5.14 – 5.05 (m, 1 H), 2.53 – 2.44 
(m, 1 H), 2.40 – 2.28 (m, 1 H), 2.19 (s, 3 H), 2.16 – 1.98 (m, 2 H), 1.81 – 1.52 (m, 3 H), 1.35 – 
1.15 (m, 1 H), 1.11 (d, J = 6.8 Hz, 3 H);
 13C NMR δ 204.15, 204.11, 163.24, 163.21, 162.44, 
161.77, 131.69, 109.70, 99.74, 78.95, 78.78, 50.69, 50.64, 39.11, 37.16, 36.15, 36.01, 32.08, 
31.96, 31.11, 29.05, 20.16, 10.08, 9.96; MS (electrospray ionization) m/z 297.3 (M+Na
+
), 275.2 
(M+H
+
).   
2-{(5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-yl}propanoic 
acid (79) 
O
O
O
OH
H
O  
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To a solution of 200 mg (0.73 mmol) of aldehyde 78 in 7 mL of DMF was added 278 mg (1.82 
mmol) of oxone, and the mixture was stirred for 5 h.  Basified with K2CO3 (aq) and some 
impurities are extracted in dichloromethane. Acidified with 2N HCl and extracted in 
dichloromethane. The dichloromethane layer was washed with brine, dried (MgSO4), and 
concentrated to get 170 mg (80% yield) of carboxylic acid 79, as a solid. 
1
H NMR  6.09 (s, 1 
H), 5.71 (s, 1 H), 5.12 – 5.04 (m, 1 H), 2.52 – 2.38 (m, 2 H), 2.27 - 2.13 (m, 1 H), 2.19 (s, 3 H), 
2.11 – 1.52 (m, 4 H), 1.28 – 1.12 9 (m, 1 H), 1.19 and 1.18 (2 d, J = 7.2 Hz, 3 H, two 
diastereomers); 
13C NMR δ 181.36, 181.29, 163.48, 163.46, 162.80, 161.90, 132.01, 132.00, 
109.72, 109.71, 99.94, 97.50, 79.17, 79.01, 44.47, 44.32, 39.22, 38.64, 38.56, 37.70, 32.10, 
32.03, 31.11, 29.62, 20.30, 13.96, 13.65; MS (electrospray ionization) m/z (negative mode) 
289.3 (M-1, 100%).  
(S)-methyl 2-{2-{(5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl}proanamido}propanoate (81) 
O
O
O
H
N
H
O
OMe
O
 
A mixture of 175 mg (0.6 mmol) tricyclic pyrone acid 79, 110 mg (0.78 mmol) of alanine methyl 
ester (80), 186 mg (1.2 mmol) of EDC.HCl, and 80 mg of DMAP (0.6 mmol) in 8 mL of dry 
dichloromethane was stirred for 12 h. The mixture was diluted with dichloromethane (250 mL) 
and washed with 0.5N HCl followed by brine, dried with MgSO4, concentrated, and purified 
through silica gel column eluting with a gradient mixture of DCM and MeOH to get 150 mg 
(66%) of compound 81, as a solid. 
1
H NMR 6.27 and 6.17 (2 d, J = 7.6 Hz, 1 H, two 
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diastereomers), 6.06 (s, 1 H), 6.71 – 5.68 (m, 1 H),  5.10 – 5.05 (m, 1 H), 4.63 – 4.52 (m, 1 H), 
3.75 and 3.74 (2 s, 3 H), 2.49 – 2.37 (m, 1 H), 2.28 – 1.94 (m, 3 H), 2.18 and 2.17 (2 s, 3 H), 
1.93 – 1.77 (m, 2 H), 1.57 – 1.44 (m, 1 H), 1.43 and 1.40 (2 d, J = 7.6 Hz, 3 H), 1.15 (d, J = 6.4 
Hz, 3 H), 1.13 – 1.00 (m, 1 H); 13C NMR δ 175.15, 174.92, 173.69, 163.46, 163.43, 162.76, 
162.71, 161.74, 161.71, 132.64, 132.32, 109.42, 109.26, 99.96, 97.43, 97.40, 79.33, 79.00, 52.66, 
52.59, 48.06, 47.99, 46.51, 46.39, 39.52, 39.08, 39.06, 38.20, 32.08, 31.65, 30.14, 20.25, 18.65, 
18.29, 15.18, 15.10; MS (electrospray ionization) m/z 376.1 (M+H
+
, 100%).    
(S)-2-{2-{(5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl}proanamido}propanoic acid (82)  
 
O
O
O
H
N
H
O
OH
O
 
To a solution of 90 mg (0.32 mmol) of compound 81 in a mixture of 5 mL of MeOH and THF 
(1:1), at 0 °C was added 6 mL of 0.1 N (aq) LiOH solution. After stirring for 5 h at 0 °C, 
acidified with 0.1 N HCl and extracted in dichloromethane (50 mL x 3). The organic layer was 
washed with brine, dried (MgSO4), and concentrated to get 78 mg (90% yield) of compound 82 
as a solid. 
1
H NMR 8.05 – 7.39 (br. s, 1 H, COOH), 7.05 and 6.65 (2 d, J = 7.2 Hz, 1 H, NH, 
two diastereomers), 6.08 and 6.06 (2 s, 1 H), 5.74 and 5.72 (2 s, 1 H), 5.10 – 5.00 (m, 1 H), 4.63 
– 4.51 (m, 1 H), 2.52 – 2.31 (m, 1 H), 2.29 – 1.70 (m, 5 H), 2.19 and 2.18 (2 d, 3 H), 1.60 – 1.34 
(m, 1 H), 1.47 and 1.45 (2 d, J = 7.2 Hz, 3 H), 1.30 – 0.81 (m, 1 H), 1.15 and 1.14 (2 d, J = 6.8 
Hz, 3 H); 
13C NMR δ 176.53, 176.51, 176.11, 175.97, 175.81, 163.91, 163.82, 163.30, 163.29, 
163.09, 161.91, 161.89, 133.23, 133.21, 132.57, 109.17, 108.83, 100.29, 100.18, 97.41, 97.33 
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79.49, 79.05, 48.29, 48.24, 46.21, 39.48, 39.14, 38.94, 38.44, 32.02, 31.80, 30.08, 20.20, 18.16, 
17.64, 15.36, 15.34, 15.01; MS (electrospray ionization) m/z (negative mode) 260.4 (M-1, 
100%).   
(S)-methyl 2- 2-((S)-2-(2-((5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-
b]chromen-7-yl)proanamido)-3-((S)-2-oxopyrrolidin-3-yl)propanoate (84) 
O
O
O
H
N
H
O
N
H
O
O
OMe
NH
O
 
A mixture of mixture of 60 mg (0.16 mmol) of compound 82, 48 mg (0.216 mmol) of glutamine 
surrogate salt 83, 51.5 mg (0.33 mmol) of EDC.HCl, and 41 mg (0.33 mmol) of DMAP in dry 
dichloromethane was stirred for 12 h. The mixture was diluted with dichloromethane (100 mL), 
washed with 0.5N HCl followed by brine, dried (MgSO4), concentrated, and purified through 
silica gel column to get 59 mg (67% yield) of compound 84 (solid) as a mixture of four isomers. 
Note: indication of further two isomers may be from rotational conformations. 
1
H NMR 8.21 – 
8.09 (m, 1 H, NH), 6.56 (br. s, 2 H, NHs), 6.04 (s, 1 H), 5.71 – 5.67 (m, 1 H), 5.10 – 4.99 (m, 1 
H), 4.65 – 4.52 (m, 1 H), 4.51 – 4.40 (m, 1 H), 3.74 – 3.69 (m, 3 H), 3.41 – 3.29 (m, 2 H), 2.54 – 
2.33 (m, 3 H), 2.32 – 1.68 (m, 10 H), 1.65 – 1.32 (m, 5 H), 1.31 – 0.98 (m, 4 H); 13C NMR δ 
180.03, 179.87, 179.81, 175.20, 175.16, 175.11, 175.04, 173.21, 173.10, 173.07, 172.34, 172.30, 
172.24, 163.48, 163.46, 163.44, 163.42, 162.73, 161.78, 161.76, 161.72, 132.49, 132.43, 132.33, 
109.42, 109.37, 109.32, 109.29, 99.96, 99.93, 97.44, 97.41, 79.28, 79.25, 79.10, 79.00, 52.65, 
51.91, 51.78, 48.73, 48.70, 48.67, 48.65, 46.49, 46.40, 40.76, 40.70, 39.57, 39.51, 39.18, 39.13, 
39.02, 38.96, 38.77, 38.75, 38.65, 38.61, 38.30, 38.11, 33.30, 33.15, 33.12, 33.06, 32.08, 32.04, 
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31.74, 31.64, 31.55, 30.19, 29.57, 28.59, 28.51, 22.81, 20.27, 19.34, 19.16, 19.08, 18.85, 15.17, 
15.06, 15.03; MS (electrospray ionization) m/z 552.3 (M+Na
+
, 100%).   
(S)-2-((S)-2-(2-((5aS, 7S)-3-methyl-1-oxo-1,5a,6,7,8,9-hexahydropyrano[4,3-b]chromen-7-
yl)proanamido)propanamido)-3-((S)-2-oxopyrrolidin-3-yl)propanal (36) 
O
O
O
H
N
H
O
N
H
O
O
NH
O
H
 
To 30 mg (0.06 mmol) of compound 84 in a mixture of THF and DCM (1:1), at 0 °C was added 
12.5 mg (0.6 mmol) of LiBH4 and stirred for 3 h. The reaction was quenched with sat. NH4Cl 
solution (1 mL), diluted with brine (20 mL), and extracted with dichloromethane (30 x 3 mL). 
The combined organic layer was dried (MgSO4) and concentrated. To 20 mg (0.04 mmol) of this 
residue in 5 mL of dry dichloromethane, under argon was added 25.4 mg (0.06 mmol) of Dess-
Martin periodinane (solid). After stirring for 2 h, 3 drops of water were added and stirred for 5 
min and filtered. The filtrate was concentrated and purified through silica gel column using a 
gradient mixture of  dichloromethane and acetone as eluent to get 10 mg of tricyclic pyrone-
dipeptidyl aldehyde 36 (solid), as a mixture of four isomers. 
1
H NMR 9.57 and 9.49 (2d, J = 
3.2 Hz, 1 H, aldehyde),  8.79 – 8.44 (m, 1 H, NH), 6.85 – 6.39 (m, 2 H, NHs), 6.05 and 6.04 (2d, 
1 H, two diastereomers), 5.83 – 5.66 (m, 1 H), 5.04 (br. s, 1 H), 4.71 – 4.41 (m, 2 H), 4.32 (br. s, 
1 H), 4.50 – 4.22 (m, 3 H), 2.72 – 0.95 (m, 17 H), 2.18 (s, 3 H); MS (electrospray ionization) m/z 
522.1 (M+Na
+
, 100%), 500.2 (M+H
+
).  
 
Pyrrole-2-corboxaldehyde (61) and pyrrole-3-carboxaldehyde (62)  
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N
H O
H
N
H
O
H
61 62  
Step 1: To a slurry of 357 mg (14.9 mmol) of NaH in 15 mL of dry DMF, at 0 °C was added 1 g 
(14.9 mmol) of pyrrole (85) dropwise. After stirring for 30 min at 0 °C, 3.18 mL (14.9 mmol) of 
triisopropylsilyl chloride was added. After stirring for 1.5 h at 0 °C to room temperature, the 
mixture was concentrated to get 3.2 g (99% yield) of viscous oil 86. 
Step 2: To a solution of 1.3 g (17.8 mmol) of DMF in 5 mL of dichloromethane, at 0 °C, under 
argon was added 2.3 g (17.8 mmol) of oxalyl chloride. After stirring for 0.5 h, at 25 °C, a 
solution of 3.2 g (14.3 mmol) of compound 86 in 7 mL of dichloromethane was added dropwise 
at 0 °C. After stirring for 45 min, 40 ml of 5% NaOH was added and stirring was continued at 
room temperature for 4 h. Extracted in dichloromethane (125 x 3), washed with brine, dried 
(MgSO4), concentrated, and purified through silica gel column using a gradient mixture of 
hexane and ethyl acetate to get 410 mg (29% yield) of 2-formylpyrrole 61
76
 and 530 mg (37% 
yield) of 3-formylpyrrole 62
77
 as solids. 
1
H NMR spectra of both aldehydes were in agreement 
with reported in corresponding literatures.
76,77
 
General procedure for the syntheses of aldehydes 70B, 70C, 71B, 71F, and 74  
4-Methylquinoline-2-carboxaldehyde (70B)
 
 
N
H
O
 
To a mixture of 0.95 g (8.4 mmol) of trifluoroacetic acid and 1.0 g (7.0 mmol) of 4-
methylquinoline (87) were added 3.6 mL (28 mmol) of 70% tert-butyl hydroperoxide, 78 mg 
(0.28 mmol) of FeSO4•7H2O, 20 mL of acetonitrile, and 20 g of trioxane.  The reaction mixture 
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was heated to reflux for 12 h, cooled to 25 °C, basified with 5% NaOH, and extracted three times 
with diethyl ether.  The combined organic layer was washed with brine, and concentrated.  The 
residue was diluted with 100 mL of 10% H2SO4, heated to reflux for 5 h, cooled to 25 °C, 
basified with 10% NaOH, and extracted three times with diethyl ether.  The combined organic 
layer was washed with brine, dried (MgSO4), concentrated, and column chromatographed on 
silica gel using a gradient mixture of hexane and ethyl acetate as eluant to give 0.38 g (50% yield 
based on recovered 87) of 70B as a solid. 0.37 g of 87 was also recovered.  
1
H NMR δ 10.19 (s, 1 
H), 8.24 (d, J = 8.2 Hz, 1 H), 8.06 (d, J = 8.2 Hz, 1 H), 7.86 (s, 1 H), 7.81 (ddd, J = 8.4, 6.8, 1.2 
Hz, 1 H), 7.70 (ddd, J = 8.2, 7.0, 1.2 Hz, 1 H), 2.78 (s, 3 H);  
13
C NMR δ 194.3, 152.4, 147.9, 
146.2, 131.2, 130.3, 130.25, 129.1, 124.2, 118.1, 19.1;  MS (electrospray ionization) m/z 172.0 
(100%) (M+H
+
). 
6-Methylquinoline-4-carboxaldehyde (71F) and 6-methylquinoline-2-carboxaldehyde (70C) 
          
N
O H
N
O
H
70C71F  
 From 1.5 g (10.5 mmol) of 6-methylquinoline (88), 0.24 g (17% yield, based on recovered 88) 
of 71F and 0.23 g (16% yield, based on recovered 88) of 70C
80
 were obtained as solids, and 0.31 
g of 88 was also recovered. Compound 71F:  
1
H NMR δ 10.51 (s, 1 H), 9.14 (d, J = 4.3 Hz, 1 H), 
8.83 (s, 1 H), 8.12 (d, J = 8.6 Hz, 1 H), 7.77 (d, J = 4.3 Hz, 1 H), 7.67 (dd, J = 8.6, 1.9 Hz, 1 H), 
2.63 (s, 3 H); 
13C NMR δ 192.8, 149.2, 147.7, 139.6, 135.8, 132.2, 129.4, 125.8, 123.7, 123.1, 
22.0;  MS (electrospray ionization) m/z 172.0 (100%) (M+H
+
), 144.1. Compound 70C:  
1
H 
NMR δ 10.21 (s, 1 H), 8.21 (d, J = 8.2 Hz, 1 H), 8.14 (d, J = 9.4 Hz, 1 H), 8.00 (d, J = 8.6 Hz, 1 
H), 7.67 (s, 1 H), 7.66 (dd, J = 8.0, 2.0 Hz, 1 H), 2.59 (s, 3 H);
 13C NMR δ 194.0, 152.2, 146.8, 
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139.9, 136.8, 133.1, 130.4, 130.3, 126.9, 117.7, 22.1;  MS (electrospray ionization) m/z 172.0 
(100%) (M+H
+
). 
2-Methylquinoline-4-carboxaldehyde (71B)
  
N
O H
 
 From 0.50 g (2.2 mmol) of 2-methylquinoline (89), 0.29 g (50% yield) of 71B was obtained as a 
solid.  
1
H NMR δ 10.49 (s, 1 H), 8.97 (dd, J = 8.6, 1.2 Hz, 1 H), 8.13 (d, J = 8.6 Hz, 1 H), 7.80 
(ddd, J = 8.3, 7.0, 1.6 Hz, 1 H), 7.70 (s, 1 H), 7.68 (ddd, J = 8.5, 6.8, 1.2 Hz, 1 H), 2.88 (s, 3 H); 
13C NMR δ 193.0, 159.2, 149.0, 137.0, 130.2, 129.2, 128.3, 127.2, 124.3, 122.2, 25.3; MS 
(electrospray ionization) m/z 172.0 (100%) (M+H
+
). 
Benzo[h]quinoline-4-carboxaldehyde (74) 
N
O H
 
From 0.50 g (2.79 mmol) of benzo[h]quinoline (90), 90 mg (18% yield based on recovered 90) 
of 74 was obtained as a solid and 85 mg of 90 was also recovered. Note: 10% of 2-formylated 
analog 91 was also formed. 
1
H NMR δ 10.50 (s, 1 H), 9.26 (d, J = 7.8 Hz, 1 H), 9.16 (d, J = 4.3 
Hz, 1 H), 8.74 (d, J = 9.4 Hz, 1 H), 7.94 – 7.84 (m, 2 H), 7.80 – 7.68 (m, 3 H); 13C NMR δ 192.9, 
148.9, 147.8, 136.5, 133.3, 131.2, 130.9, 129.0, 127.9, 127.7, 125.0, 124.9, 122.9, 120.8; MS 
(electrospray ionization) m/z 208 (M+H
+
), 186.2. 
 
Syntheses of intermediates 92 and 94  
4-Methyl-2-(1,3,5-trioxan-2-yl)quinoline (92)  
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N
O
O O  
To a mixture of 5.0 g (35 mmol) of 4-methylquinoline (87) and 4.75 g (42 mmol) of TFA was 
added 18 mL (140 mmol) of 70% tert-butyl hydroperoxide, 390 mg (1.4 mmol) of FeSO4•7H2O, 
80 mL of acetonitrile, and 80 g of trioxane.  The reaction mixture was heated to reflux for 12 h, 
cooled to 25 °C, basified with 5% NaOH, and extracted three times with diethyl ether. The 
combined organic layer was washed with brine, concentrated, and purified through silica gel 
column using a gradient mixture of hexanes and ethyl acetate  to get 3.0 g (43% yield based on 
recovered 87) of 92 and 0.18 g (3% yield) of 70B as solids. 0.70 g of starting material 87 was 
also recovered.  
1H NMR δ 8.11 (d, J = 8.2 Hz, 1 H), 7.92 (d, J = 8.5 Hz, 1 H), 7.67 (t, J = 7.6 
Hz, 1 H), 7.61 (s, 1 H), 7.52 (t, J = 7.6 Hz, 1 H), 6.04 (s, 1 H), 5.41 – 5.33 (m, 4 H), 2.66 (s, 3 
H);
 13C NMR δ 154.9, 147.0, 145.9, 130.1, 129.5, 128.4, 127.0, 123.7, 118.9, 102.2, 93.7, 18.9;  
MS (electrospray ionization) m/z 270.2 (M+K
+
), 254.1 (M+Na
+
), 232.2 (M+H
+
), 172.0. 
2-Methyl-4-(1,3,5-trioxan-2-yl)quinoline (94)  
N
O
O
O
 
From 10.0 g (70 mmol) of 2-methylquinoline (89), 5.3 g (51% yield based on recovered 89) of 
94 was obtained as a solid. 3.5 g of starting material 89 was recovered.  
1
H NMR δ 8.05 (d, J = 
8.6 Hz, 2 H), 7.66 (t, J = 7.8 Hz, 1 H), 7.55 (s, 1 H), 7.49 (t, J = 7.8 Hz, 1 H), 6.33 (s, 1 H), 5.44 
– 5.36 (m, 4 H), 2.73 (s, 3 H); 13C NMR δ 159.0, 148.4, 140.4, 129.4, 129.39, 126.1, 123.6, 
123.3, 119.5, 98.8, 93.8, 25.5;   MS (electrospray ionization) m/z 232.2 (M+H
+
), 172.0, 144.1. 
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General procedure for the syntheses of compounds 71A, 71E, 72, and 95 
Quinoline-4-carboxaldehyde (71A)  
N
O H
 
A solution of 5.0 g (35 mmol) of 4-methylquinoline (87) and 5.0 g (45 mmol) of SeO2 in toluene, 
under argon, was heated to reflux for 24 h.  The reaction mixture was diluted with 
dichloromethane, washed with brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a gradient mixture of hexanes and ethyl acetate as eluent to 
give 4.0 g (73% yield) of compound 71A, as a solid.  
1H NMR δ 10.54 (s, 1 H), 9.22 (d, J = 4.3 
Hz, 1 H), 9.04 (d, J = 8.6 Hz, 1 H), 8.24 (d, J = 8.2 Hz, 1 H), 7.84 (t, J = 7.6 Hz, 1 H), 7.81 (d, J 
= 4.3 Hz, 1 H), 7.76 (t, J = 8.0 Hz, 1 H); 
13C NMR δ 193.1, 150.7, 149.5, 137.0, 130.4, 130.3, 
129.6, 126.0, 124.7, 124.1;  MS (electrospray ionization) m/z 158.0 (100%) (M+H
+
), 130.2. 
Quinoline-6-carboxaldehyde (72)  
N
O
H
 
  The benzylic oxidation of 6-methylquinoline 88 with SeO2 was found to be reluctant; only trace 
amount of product 72 was obtained while refluxing in toluene. But the use of xylene as a solvent 
gave satisfactory yield. From 0.50 g (3.5 mmol) of 6-methylquinoline (88), 0.12 g (54% yield 
based on recovered compound 88) of 72 was obtained as a solid. 0.30 g of starting material 88 
was also recovered. 
1H NMR δ 10.20 (s, 1 H), 9.05 (dd, J = 4.3, 1.6 Hz, 1 H), 8.35 (s, 1 H), 8.32 
(dd, J = 8.2, 1.9 Hz, 1 H), 8.23 – 8.17 (m, 2 H), 7.52 (dd, J = 8.2, 4.3 Hz, 1 H); 13C NMR δ 
  108  
 
191.6, 153.3, 151.1, 137.6, 134.5, 133.8, 131.0, 127.9, 126.9, 122.4; MS (electrospray 
ionization) m/z 157.9 (100%) (M+H
+
). 
2-(1,3,5-Trioxan-2-yl)quinoline-4-carboxaldehyde (71E)  
N
O
O O
OH
 
  From 0.30 g (1.3 mmol) of 92, 130 mg (50% yield based on recovered 92) of compound 71E 
was obtained as a solid and 40 mg of 92 was also recovered.  
1
H NMR δ 10.53 (s, 1 H), 9.08 (dd, 
J = 8.0, 1.2 Hz, 1 H), 8.26 (dd, J = 7.8, 0.8 Hz, 1 H), 8.25 (s, 1 H), 7.86 (ddd, J = 7.8, 7.0, 1.6 
Hz, 1 H), 7.78 (ddd, J = 7.8, 7.0, 1.6 Hz, 1 H), 6.21 (s, 1 H), 5.49 – 5.45 (m, 4 H);  13C NMR δ 
193.0, 155.8, 148.3, 138.0, 130.7, 130.2, 130.1, 124.7, 124.3, 124.0, 101.3, 93.8;  MS 
(electrospray ionization) m/z 268.3 (100%) (M+Na
+
). 
4-(1,3,5-Trioxan-2-yl)quinoline-2-carboxaldehyde (95)  
N
O
O
O
H
O
  
From 0.70 g (3.0 mmol) of 94, 0.60 g (81% yield) of 95 was obtained as a solid.  Note: the 
reaction was conducted at 80 °C for 15 h.  
1
H NMR δ 10.24 (s, 1 H),  8.32 (d, J = 9.0 Hz, 2 H), 
8.31 (s, 1 H), 7.85 (ddd, J = 8.5, 7.1, 1.2 Hz, 1 H), 7.75 (ddd, J = 8.4, 6.6, 1.2 Hz, 1 H), 6.47 (s, 1 
H), 5.51 – 5.46 (m, 4 H);  13C NMR δ 193.5, 152.5, 148.6, 142.1, 131.3, 130.6, 129.8, 127.0, 
124.6, 115.5, 99.1, 93.9;  MS (electrospray ionization) m/z 267.9 (100%) (M+Na
+
), 245.9 
(M+H
+
).   
Quinoline-2,4-dicarboxaldehyde (93) 
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N
O H
O
H
 
 Hydrolysis of 0.60 g (3.0 mmol) of 95 by refluxing with 2N hydrochloric acid provided 0.38 g 
(98% yield) of dialdehyde 93, as a solid. 
1H NMR δ 10.53 (s, 1 H), 10.28 (s, 1 H), 9.11 (dd, J = 
8.2, 1.2 Hz, 1 H), 8.40 (s, 1 H), 8.35 (dd, J = 8.0, 1.4 Hz, 1 H), 7.92 (ddd, J = 8.2, 7.0, 1.6 Hz, 1 
H), 7.87 (ddd, J = 8.4, 7.0, 1.6 Hz, 1 H);
 13C NMR δ 192.9, 192.7, 153.0, 149.2, 138.1, 132.3, 
131.3, 131.2, 125.6, 125.2, 122.8;  MS (electrospray ionization) m/z 186.1 (M+H
+
), 172.0. 
2-(Hydroxymethyl)quinoline-4-carboxaldehyde (71C), 4-(Hydroxymethyl)quinoline-2-
carboxaldehyde (96), and 2,4-dihydroxymethylquinoline (97) 
           
N
HO
HO
N
HO
O
H
N
HO
HO
71C 96 97  
To a solution of 0.30 g (1.62 mmol) of dialdehyde 93 in a mixture of 15 mL of dichloromethane 
and ethanol (3:1) at 0 °C, under argon, was added 15 mg (0.40 mmol) of NaBH4, and the mixture 
was stirred for 1 h.  The reaction mixture was diluted with 50 mL of brine, extracted twice with 
dichloromethane, dried (MgSO4), concentrated, and column chromatographed on silica gel using 
a gradient mixture of hexane and ethyl acetate as eluant to give 73 mg (32% yield) of 71C, 81 
mg (35% yield) of 96, and 38 mg (16% yield) of 97 along with 72 mg of recovered 93.  
Compound 71C:  
1H NMR δ 10.53 (s, 1 H), 9.00 (dd, J = 8.4, 1.0 Hz, 1 H), 8.20 (d, J = 8.2 Hz, 1 
H), 7.84 (ddd, J = 8.6, 7.0, 1.6 Hz, 1 H), 7.75 (s, 1 H), 7.73 (ddd, J = 8.6, 7.0, 1.6 Hz, 1 H), 5.06 
(s, 2 H); 
13
C NMR δ 192.8, 159.7, 148.1, 137.8, 130.7, 129.4, 129.1, 124.7, 123.8, 123.5, 64.5;  
MS (electrospray ionization) m/z 188.3 (M+H
+
), 128.2, 115.2. Compound 96:  
1
H NMR δ 10.24 
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(s, 1 H), 8.30 (d, J = 8.6 Hz, 1 H), 8.19 (s, 1 H), 8.05 (dd, J = 8.2, 0.8 Hz, 1 H), 7.85 (ddd, J = 
8.5, 6.9, 1.4 Hz, 1 H), 7.73 (ddd, J = 8.4, 7.0, 1.4 Hz, 1 H), 5.29 (d, J = 0.8 Hz, 2 H); 
13
C NMR δ 
(CDCl3 and DMSO-d6) δ 193.1, 151.6, 148.9, 146.7, 130.1, 129.2, 128.3, 126.8, 122.5, 113.4, 
59.7;  MS (electrospray ionization) m/z 188.3 (100%) (M+H
+
), 115.1. Compound 97:  
1
H NMR 
δ 8.12 (d, J = 9.0 Hz, 1 H), 7.94 (d, J = 8.2 Hz, 1 H), 7.75 (ddd, J = 8.4, 6.8, 1.2 Hz, 1 H), 7.58 
(ddd, J = 8.4, 7.0, 1.2 Hz, 1 H), 7.46 (s, 1 H), 5.25 (d, J = 3.5 Hz, 2 H), 4.93 (d, J = 3.9 Hz, 2 H); 
13
C NMR (DMSO-d6) δ 162.2, 148.0, 146.5, 129.1, 128.9, 125.8, 124.6, 123.3, 115.7, 65.0, 59.8;  
MS (electrospray ionization) m/z 190.2 (100%) (M+H
+
). 
(4-Formylquinolin-2-yl)methyl acetate (71D)
83
 
N
HO
AcO
 
 To a mixture of 50 mg (0.27 mmol) of 71C and 5 mg (0.05 mmol) of ZnO in 8 mL of 
dichloromethane, under argon, was added 0.28 g (2.7 mmol) of acetic anhydride.  The reaction 
mixture was stirred at 25 
o
C for 2 h, diluted with 100 mL of dichloromethane, washed with brine, 
dried (MgSO4), concentrated, and column chromatographed on silica gel to get 52 mg (85% 
yield) of compound 71D as a solid.  
1
H NMR δ 10.53 (s, 1 H), 8.99 (d, J = 8.2 Hz, 1 H), 8.18 (d, 
J = 8.6 Hz, 1 H), 7.87 (s, 1 H), 7.82 (t, J = 7.6 Hz, 1 H), 7.73 (t,  J = 8.2 Hz, 1 H), 5.48 (s, 2 H), 
2.23 (s, 3 H); 
13
C NMR δ 192.9, 170.8, 156.8, 149.0, 137.8, 130.7, 130.0, 129.6, 124.5, 124.5, 
123.5, 67.2, 21.1;  MS (electrospray ionization) m/z 230.1 (M+H
+
), 216.5. 
Quinoline-8-carboxaldehyde (73), 8-hydroxymethylquinoline (99) 
N
OH
N
OH
73 99         
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 A solution of 0.50 g (3.5 mmol) of 8-methylquinoline (98), 1.87 g (10.5 mmol) of N-
bromosuccinamide (NBS), and 50 mg (0.3 mmol) of azobisisobutyronitrile (AIBN) in 25 mL of 
dry dichloroethane was refluxed, under argon, for 30 h.  The reaction mixture was diluted with 
150 mL of dichloromethane, washed three times with 2 N NaOH followed by brine, dried 
(MgSO4), and concentrated. The residue was refluxed in 50 mL of water for 4 h, cooled to 25 °C, 
diluted with 50 mL of 2 N NaOH, and extracted three times with diethyl ether. The combined 
organic layer was washed with brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a gradient mixture of hexane and diethyl ether as eluant to 
give 205 mg (37% yield) of 73 and 298 mg (54% yield) of 99 as solids.  Compound 99 was 
converted to compound 73 in 79% yield by treating with IBX and DMSO.  Compound 73: 
1
H 
NMR δ 11.45 (s, 1 H), 9.04 (dd, J = 4.3, 1.9 Hz, 1 H), 8.32 (dd, J = 7.0, 1.6 Hz, 1 H), 8.24 (dd, J 
= 8.4, 1.8 Hz, 1 H), 8.08 (dd, J = 8.2, 1.6 Hz, 1 H), 7.67 (t, J = 7.6 Hz, 1 H), 7.51 (dd, J = 8.4, 
4.1 Hz, 1 H); 
13
C NMR δ 192.8, 151.5, 147.8, 136.5, 134.4, 131.9, 129.5, 128.5, 126.4, 122.0;  
MS (electrospray ionization) m/z 158.0 (M+H
+
), 128.1.Compound 99:  
1
H NMR δ 8.77 (dd, J = 
3.9, 1.2 Hz, 1 H), 8.07 (dd, J = 8.2, 1.2 Hz, 1 H), 7.65 (d, J = 8.2 Hz, 1 H), 7.55 (d, J = 7.0 Hz, 1 
H), 7.40 (t, J = 7.6 Hz, 1 H), 7.32 (dd, J = 8.2, 4.3 Hz, 1 H), 5.20 (s, 2 H);  
13
C NMR δ 149.0, 
146.8, 138.2, 136.7, 128.3, 127.5, 127.3, 126.4, 121.1, 64.2;  MS (electrospray ionization) m/z 
160.3 (M+H
+
), 142.0, 141.1. 
6-(t-butyldimethylsilyloxy)benzoic acid (76)  
O OH
OTBS  
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To a mixture 200 mg (1.45 mmol) of p-hydroxybenzoicacid (100) and 295.8 mg (4.35 mmol) of 
imidazole in 6 mL of dry DMF was added 437.1 mg (2.9 mmol) of t-butyldimethylsilylchloride, 
under argon. After stirring for 5 h, diluted with dichloromethane (200 mL), washed with 0.1N 
HCl followed by brine, and concentrated to get viscous oil. To this oil, in a mixture 6 mL of 
MeOH and THF (1:1), was added a solution of 2 mL of 1M K2CO3 (aq) and stirred for 3 hours. 
Then the mixture was acidified with 1N HCl, filtered, and the residue was washed with water to 
get 220 mg (60 % yield) of compound 76, whose 
1
H NMR was in agreement with that of 
reported.
85
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Chapter 2 - Design, synthesis, and anti-norovirus activity of 
thiouridine nucleosides  
 2.1 Introduction 
RNA dependent RNA polymerase (RdRp) is one of the non-structural proteins present in 
viruses.
1
 Because of its unique nature and essentiality for the replication of viral particles,
2
 it has 
been an attractive and selective target for antiviral drugs development.
3
 Several nucleosides have 
been reported as strong inhibitors of viral RdRp polymerase, and some are progressing at 
different levels of clinical trials mainly for the treatment of hepatitis C virus (HCV).
4
 Use of 
nucleosides for the treatment of norovirus has been less explored, yet few of the nucleosides 
tested against norovirus had shown effective inhibition.
5,6
 The severity of norovirus infection and 
the problems associated with its treatments are explained in chapter one (1.2.2). In this chapter, 
the design, synthesis, and anti-norovirus activity of 2’-C-methylthiouridine (101) and a reported 
2’-amino-2’-deoxythiouridine (102)7 (Figure 2.1) along with the proposed future work of 
making phosphoramidate derivatives of these nucleosides is described. 
 2.2 Background  
Two main categories of RdRp inhibitors: nucleosides inhibitors (NIs) and non-
nucleosides inhibitors (NNIs) have been used for viral inhibition.
8
 The nucleosidic analogs 
substitute natural nucleoside in polymerase substrate terminating the RNA elongation, while the 
non-nucleosidic analogs bind to the allosteric site of the polymerase converting it inactive.
9,10
 
Modification of nucleosides by establishing the methyl substituent at C2’ led to the enhancement 
of potency against hepatitis C virus (HCV).
11,12 
Many of such 2’-C-methyl analogs (Figure 2.2) 
are at different levels of clinical trials.
4 
Like other viral RdRps, the structural features of finger,  
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Figure 2.1: Thiouridine nucleosides synthesized as anti-norovirus agents. 
 
palm, and thumb (Figure 2.3 B) are also common in norovirus, but the C-terminus active site is 
highly specific.
13
 Moreover, the active form of norovirus RdRp was found to exist as 
homodimer.
14
 Binding of  5-nitrocytidine triphosphate, a norovirus inhibitor, with NV RdRp 
revealed the possibility using nucleosides as NV RdRp inhibitors.
15
 2’-C-methyl cytidine (106) 
and ribavirin (107) (Figure 2.4) were found to effectively inhibit the replication of murine NV 
and human NV, respectively.
5,6
 Similarly, the triphosphate derivative of amino analog 2’-C-
amino-2’-C-deoxy-cytidine (108) was effective to cause rearrangement of the active site in NV 
RdRp.
16
 The practice of substituting natural base pairs with thiolated analogs while modifying 
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Figure 2.2: Nucleosides effective for the inhibition of HCV virus. 
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nucleosides was found beneficial; significant enhancement in the potency of nucleosides with 
thiolated uracil was observed as P2Y2 receptors.
7,17
 Crystal structures of murine NV RdRp with 
ribavirin and thiouridine have been revealed and stronger inhibition of murine NV was observed 
by thiouridine.
18
 All these studies encourage for the exploration of synthetic nucleosides as NV 
RdRp inhibitors towards the development potent anti-noroviral agents.  
 
VP1 VP2
Non-structural proteins
ORF1
p48 NTPase p22 VPg 3CLpro RdRp
RdRp (NS7) CN
A
B
 
Figure 2.3: A- Schematic representation of NV genome (RdRp encoding is highlighted). B- 
X-ray structure of NV RdRp.
13  
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Figure 2.4: Nucleosides effective for the inhibiton of norovirus.  
Taken from  ref 13 with permission 
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 2.3 Design and synthesis of thiouridine nucleosides 
Based on above literature studies, the modification of natural nucleosides by establishing 
2’-C-methyl or 2’-amino as well as the substitution with thio analogs in base pairs can provide 
potential anti-norovirus compounds. Therefore, a novel 2’-C-methylthiouridine (101) and a 
reported 2’-amino-2’-deoxythiouridine (102)7 were synthesized to evaluate the norovirus 
inhibition activity. 
2.3.1 Synthesis of 2’-C-methylthiouridine (101) 
The synthesis of 2’-C methylated thiouridine 101 was accomplished through a series 
reactions (Scheme 2.1) reported in different literatures starting from dextrose (109). Thus, the 
isopropylidene protection of diols in compound 109 was easily achieved by treating with a 
catalytic amount of conc. H2SO4 in acetone to get 110.
19
  The oxidation of hydroxyl in 
compound 110 with a mixture of acetic anhydride and dimethyl sulfoxide gave ketone 111 in 
45% yield.
20
 Then the treatment of compound 111 with methylmagnesisum bromide in ether 
provided compound 112 in 76% yield.
21
 The benzyl protection of hydroxyl in compound 112 
followed by selective removal of less hindered isopropylidene with 70% (aq) acetic acid 
provided dihydroxy analog 113 in 87% overall yield.
22
 Selective benzoylation of primary 
hydroxyl in compound 113 was achieved by treating with benzoyl cyanide in acetonitrile using 
triethylamine as a base to get quantitative yield of compound 114. Compound 115 was obtained 
as a mixture of epimers at C1 through a series of of hydrolysis, oxidative cleavage, cyclization, 
and acetylation reactions from compound 114. Thus, after the removal of isopropylidene in the 
compound 114 with 90% (aq) TFA, the oxidation with NaIO4 in a mixture of dioxane and water 
followed by cyclization using sodium methoxide as a base in methanol gave 5’-O-benzoylated-
2’-C-methylribofuranose. Then the treatment of this 1’,3’ dihydroxyl intermediate with acetic  
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Scheme 2.1: Synthesis of 2’-C-methylthiouridine. 
 
anhydride in pyridine gave compound 115 in 56% overall yield, as a mixture of epimers (4:1) at 
C1.
23
 Attempt to remove C-2’-O-benzyl with Pd/C at 1 atmospheric pressure of H2 at 25 °C did 
not work well, and the reaction at 50 °C gave a mixture of 2’-hydroxyl, 3’,4’-dihydroxyl, and C1 
methoxy substituted analogs. Then the acetylation with acetic anhydride in dichloromethane by 
treating with acetic anhydride in the presence of Et3N and DMAP gave compound 116 in 53% 
overall yield. Treatment of compound 116 with silylated uracil 117 in dichloroethane in the 
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presence of tin-tetrachloride provided compound 118, in 10% yield.
24,25
 The α-anomer was only 
detected in trace amount. The methyl substituent at C2 must have caused some steric hindrance 
to upcoming thiouracil nucleophile leading to low yield. Similar Lewis acid catalyzed 
condensations of silylated thiouracil 117 were found to be very sensitive to reaction conditions 
and suffered with low yields.
26,27
 The silylated thiouracil 117 was made by following the 
literature reported procedure.
17,24
 The treatment of compound 118 with methanolic ammonia 
provided desired compound 101 in 75% yield. An attempt to make compound 101 by treating 
compound 118 with sodium methoxide in methanol followed by the neutralization with acidic 
resin was not fruitful.
28
  
 2.3.2 Synthesis of 2’-amino-2’-deoxythiouridine (102) 
Motivated from the results that 2’-amino analog was effective to cause rearrangement of 
NV RdRp,
16
 a reported 2’-amimo analog compound 1027 was synthesized (Scheme 2.2) by using 
literature methods, starting from D-arabinose (119). Hence, the treatment of compound 119 with 
cyanamide in methanol at reflux in the presence of concentrated ammonia provided compound 
120
29
 in 88% yield.
30
 Then the stirring of compound 120 with methyl propiolate (121) in ethanol, 
at 78 °C, provided compound 122
31
 in 92% yield.
30,32
 Nucleophilic substitution at C2 was 
achieved by refluxing compound 122 with excess amount of sodium azide in DMF to get 
compound 123 in 48% yield.
31
 Selective mesylation of the 5’-hydroxyl was achieved by treating 
compound 123 with methanesulfonyl chloride in pyridine at 0 °C providing 57% yield of 
compound 124.
7
 The mesylated analog 124 was refluxed in ethanol in the presence of excess 
sodium bicarbonate to give compound 125 in 50% yield, which then was heated to 70 °C in 
pyridine, saturated with hydrogen sulfide, to get desired product 102 in 63% yield.
7
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Scheme 2.2: Synthesis of 2’-amino-2’-deoxythiouridine. 
 
 2.4 Anti-norovirus activity of thiouridine nucleosides 
Anti-norovirus activity of thiouridine nucleosides was performed by Yungeong Kim and 
Kyeong-Ok, Chang at the Department of Diagnostic Medicine and Pathology, College of 
Vetenary Medicine, Kansas State University. The same protocol of quantitative reverse 
transcription-PCR (qRTPCR) that was used to evaluate anti-norovirus activity of tricyclic 
pyrones, mentioned in chapter one, was also used for the evaluation of thiouridine nucleosides.  
Both the thiouridine nucleosides were found ineffective up to 50 μM for the inhibition of 
norovirus replication in HG23 cells (Table 2.1). Because of inactivity of these analogs the 
cytotoxicity was not measured. One of the reasons for their low efficacy may be inabitility of 
cellular kinase to initiate phosphorylation inside the cells.
10
 Therefore, in this project, we have 
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planned to make phosphoramidate derivatives of these analogs hoping to get increased potency 
against norovirus.  
 
Table 2.1: Anti-norovirus activity of thiouridine nucleosides. 
Compounds EC50 (µM) 
2’-deoxy-2’-C-methylthiouridine (101)    > 50 
2’-amino-2’-deoxythiouridine (102)    > 50 
 
 
 2.5 Future works 
As both the nucleosides were found ineffective to inhibit norovirus, the future work of 
this project is to modify them to phosphoramide derivatives. The phosphoramidate analogs were 
found more effective and less toxic as anti-viral compounds to their corresponding free 
nucleosides, probably due to the increased lipophilicity and avoidance of kinase-mediated 
activation.
33,34,35
  Sub-micromolar to nanomolar efficacy against HCV was achieved (Figure 2.5) 
by converting inactive nucleosides to corresponding phosphoramidate derivatives
.12,36,37
 In vivo 
bioavailability of active triphosphate derivatives of nucleosides in liver was high when the 
compounds were administered as their phosphoramidates.
38
 In this regard, the synthesis of 
phosphoramidate derivatives 128 and 129 (Figure 2.6) of nucleosides 101 and 102 has been 
proposed. The synthesis of compounds 128 and 129 will be executed (Scheme 2.3) by following 
the methods reported in literatures. Acetyl protection of amino group in nucleoside 102 will 
allow phosphorylation at O-5’. Therefore, the compound 102 will be treated with ethyl 
trifluoroacetate in DMF in the presence of N,N-di-isopropylethylamine (DIEA) to get compound 
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130.
7
 Then the phosphorylation of compounds 101 and 130 will be achieved by treating them 
separately with compound 133 in THF in the presence of Et3N.
33
 Compound 133 will be 
prepared by reacting alanine methyl ester (131) with phenyl phosphoryl chloride (132) in THF 
using Et3N as a base.
38
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Figure 2.5: Increased efficacy of phosphoramidate analogs compared to corresponding free 
nucleosides against HCV.
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Scheme 2.3: Proposed synthesis of phosphoramidate analogs 128 and 129.
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 2.6 Conclusions 
 Nucleosides 2’-C-methylthiouridine and 2’-amino-2’-deoxythiouridine were synthesized 
and found ineffective for the inhibition of norovirus replication in cell based assay. The 
inactivity may be due to low cell permeability or inability of cellular kinase to convert the 
nucleosides into active triphosphates inside the cells. Derivatization of these nucleosides to their 
corresponding phosphoramidate analogs may enhance anti-norovirus activity. 
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 2.8 Experimental 
General Methods.  NMR spectra were obtained from a 400-MHz spectrometer (Varian Inc.), in 
CDCl3, unless otherwise indicated, and reported in ppm. Low-resolution mass spectra were taken 
from an API 2000-triple quadrupole ESI-MS/MS mass spectrometer (from Applied Biosystems).  
Chemicals were purchased from Fisher Scientific, Aldrich Chemical Co., Chem-Impex 
International, and VWR. 
Anti-norovirus activity of thiouridines: The anti-noroviral effects of each compound were 
examined in NV replicon-harboring cells (HG23 cells) using Real-time qRT-PCR method as 
described in chapter one.  
1,2;5,6-Di-O-isopropylidene-α-D-glucofuranose (110) 
O
O
O
O
O
HO  
To 50 g (277 mmol) of dextrose (109) in 500 mL of acetone was added 6 drops of conc. H2SO4 
and the mixture was stirred for 30 h. 40 g of the unreacted dextrose was recovered as residue by 
filtering the mixture. The filtrate was concentrated to 150 mL, diluted with dichloromethane (500 
mL), washed with brine, dried with MgSO4, and concentrated to get 9 g (62% yield) of 
compound 110  as a solid. 
1
H NMR   5.95 (d, J = 3.5 Hz, 1 H), 4.54 (d, J = 3.5 Hz, 1 H), 4.37 – 
4.31 (m, 2 H), 4.18 (dd, J = 8.6, 6.3 Hz, 1 H), 4.08 (dd, J = 7.4, 2.7 Hz, 1 H), 3.99 (dd, J = 8.6, 
5.5 Hz, 1 H), 2.56 (d, J = 3.9 Hz, 1 H, OH), 1.51 (s, 3 H), 1.45 (s, 3 H), 1.37 (s, 3 H), 1.33 (s, 3 
H);
 13
C NMR    111.94, 109.73, 105.37, 85.27, 81.37, 75.00, 73.28, 67.75, 26.97, 26.92, 26.32, 
25.31; MS (electrospray ionization) 543.2 (dimer + Na
+
, 100%), 283.2 (M + Na
+
).  
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1,2;5,6-Di-O-isopropylidene-α-D-ribo-hexofuranos-3-ulose (111) 
O
O
O
O
O
O  
8.5 g (32.7 mmol) of compound 110, in a mixture of 50 mL of DMSO and 25 mL of Ac2O was 
stirred for 20 h. The mixture was diluted with diethyl ether (500 mL), washed with water 
followed by brine, dried (MgSO4), concentrated, and purified through silica gel column using a 
gradient mixture of hexanes and ether as eluent to obtain  3.8 g (45% yield) of compound 111. 
1
H NMR  6.14 (d, J = 4.30 Hz, 1 H), 4.43 – 4.31 (m, 3 H), 4.03 (d, J = 6.3 Hz, 2 H), 1.46 (s, 3 
H), 1.44 (s, 3 H), 1.34 (s, 6 H);
 13
C NMR    209.02, 114.46, 110.54, 103.28, 79.12, 77.43, 76.54, 
64.46, 27.73, 27.33, 26.15, 25.46; MS (electrospray ionization) 381.4 (M + Na
+
). 
1,2;5,6-Di-O-isopropylidene-3-C-methyl-α-D-allofuranose (112) 
O
O
O
O
O
HO  
To 3.5 g (13.56 mmol) of ketone 111, in 110 mL of dry diethyl ether at 0 °C was added 6 mL 
(17.63 mmol) methyl magnesium bromide (3M in diethyl ether). After stirring the mixture at 
room temperate for 4 h, diluted with water (100 mL), and extracted with diethyl ether. The ether 
layer was washed with brine, dried (MgSO4), and concentrated to get 2.8 g (76% yield) of 
compound 112 as a solid. 
1
H NMR  5.71 (d, J = 3.9 Hz, 1 H), 4.18 (d, J = 3.5 Hz, 1 H), 4.14 – 
4.08 (m, 2 H), 3.97 – 3.90 (m, 1 H), 3.79 (d, J = 7.8 Hz, 1 H), 2.68 (s, 1 H, OH), 1.60 (s, 3 H), 
1.46 (s, 3 H), 1.37 (s, 3 H), 1.36 (s, 3 H), 1.29 (s, 3 H); 
13
C NMR    113.05, 109.80, 103.81, 
84.96, 81.63, 77.63, 73.97, 68.00, 26.97, 26.95, 26.64, 25.50, 19.73; MS (electrospray 
ionization) 297.2 (M + Na
+
, 100%).  
3-O-Benzyl-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose (113)  
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O
O
O
HO
HO
BnO  
Step 1: 2.8 gm (10.2 mmol) of alcohol 112, in 50 mL of DMSO was transferred to a slurry of 
294 (12.26 mmol) NaH in 15 mL of DMSO. After stirring for 1 h, 1.8 mL (15.31 mmol) of BnBr 
was added dropwise. After stirring for 2 more hours, the mixture was diluted with water (300 
mL) and extracted in diethyl ether. The ether layer was washed with brine, dried with MgSO4, 
concentrated, and purified through silica gel column using a gradient mixture of hexanes and 
ether to get 2.8 g (91% yield) of benzylated analog and 0.5 g of recovered alcohol 112.  
Step 2: 2.8 g (7.7 mmol) of the benzylated product obtained from earlier step was stirred in 100 
mL of 70% CH3COOH (aq) for 18 h. Then the mixture was diluted with brine (100 mL) and 
extracted in dichloromethane (150 mL x 3). The organic layer was dried with MgSO4 and 
concentrated to get 2.4 g (96% yield) of compound 113 as a solid. 
1
H NMR  7.42 – 7.28 (m, 5 
H), 5.75 (d, J = 3.9 Hz, 1 H), 4.69 – 4.61 (m, 2 H), 4.40 (d, J = 3.9 Hz, 1 H), 4.05 (d, J = 8.6 Hz, 
1 H), 3.85 (dt, J = 8.6, 4.3 Hz, 1 H), 3.79 (dd, J = 12.0, 4.3 Hz, 1 H), 3.68 (dd, J = 12.0, 4.3 Hz, 1 
H), 1.62 (s, 3 H), 1.41 (s, 3 H), 1.37 (s, 3 H); 
13
C NMR    137.99, 128.61, 127.98, 113.53, 
104.52, 83.58, 82.76, 78.58, 70.18, 67.40, 64.70, 27.00, 26.84, 16.64;  MS (electrospray 
ionization) 346.9 (M + Na
+
, 100%).  
3-O-Benzyl-1,2-di-O-isopropylidene-3-C-methyl-6-O-benzoyl-α-D-allofuranose (114) 
O
O
O
HO
BzO
BnO  
To a mixture of 2.4 g (7.4 mmol) of compound 113, and 1380 mg (10.52 mmol) of benzoyl 
cyanide in 60 mL of dry acetonitrile was added 2 drops of triethylamine and the mixture was 
stirred for 16 h. The mixture was dilute with dichloromethane, washed with water followed by 
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brine, dried (MgSO4), and concentrated to provide 3.2 g (100% yield) of compound 114 as a 
solid. 
1
H NMR 8.13 – 8.05 (m, 2 H), 7.59 – 7.51 (m, 1 H), 7.49 – 7.28 (m, 7 H), 5.77 (d, J = 
3.5 Hz, 1 H), 4.70 – 4.63 (m, 3 H), 4.42 (d, J = 3.5 Hz, 1 H), 4.36 (dd, J = 11.7, 5.1 Hz, 1 H), 
4.17- 4.08 (m, 2 H), 1.61 (s, 3 H), 1.43 (s, 3 H), 1.38 (s, 3 H); 
13
C NMR    166.76, 138.11, 
133.08, 129.92, 128.55, 128.46, 127.93, 127.85, 113.46, 104.44, 83.58, 82.88, 78.06, 68.82, 
67.33, 67.09, 26.95, 26.86, 16.41; MS (electrospray ionization) 451.8 (M + Na
+
, 100%).   
1,3-Di-O-acetyl-2-O-benzyl-2-C-methyl-5-O-benzoyl-β-D-ribofuranose (115)  
O OAc
OBn
BzO
AcO  
Step 1: 3 g (7.0 mmol) of compound 114 in 30 mL of 90% trifluoroacetic acid (aq), at 0 °C to 25 
°C, was stirred for 0.5 h. The mixture was diluted with 300 mL of dichloromethane, washed with 
water, 10% NaHCO3 followed by brine, dried with MgSO4, and concentrated.   
Step 2: To the residue obtained in step 1, in a mixture of 50 mL of dioxane and 20 mL of water, 
was added a solution of 10 mL of 1M NaIO4 and the mixture was stirred for 12 h. Diluted with 
30 mL of EtOH, filtered, the filtrate was concentrated in reduced vacuum. To this residue was 
added 30 mL of CHCl3 and concentrated again in reduced pressure. 
Step 3: To the residue obtained in step 2, in 50 mL of dry MeOH, was added 0.2 mL of 1M 
NaOMe in MeOH. After stirring for 45 min at 25 °C, the mixture was neutralized with Dowex 
resin, filtered, and the filtrate was concentrated under reduced pressure.  
Step 4: To the residue obtained in step 3, in 30 mL of dry pyridine, was added 5 mL of acetic 
anhydride. After stirring for 5 h at 25 °C, the mixture was acidified with 2N HCl and extracted in 
dichloromethane. The organic layer was washed with brine, dried with MgSO4, concentrated, 
and purified through silica gel column using a gradient mixture of hexanes and ethyl acetate to 
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get 1.75 g (56%  overall yield in 4 steps) of compound 115 as a mixture of two epimers (4:1) at 
C1 center.  
1
H NMR 8.13 - 8.03 (m, 2 H), 7.62 – 7.54 (m, 1 H), 7.50 – 7.26 (m, 7 H), 7.32 and 
6.28 (2 s, 1 H), 5.54 and 5.42 (2 d, J = 8.2, 1 H), 4.69 – 4.33 (m, 5 H), 2.13 (s, 3 H), 1.98 and 
1.96 (2 s, 3 H), 1.47 and 1.43 (2 s, 3 H);
 13
C NMR  170.60, 169.72, 166.28, 160.32, 138.49, 
133.38, 129.96, 128.59, 127.81, 127.24, 98.51, 98.47, 98.07, 83.38, 78.81, 75.95, 75.30, 66.23, 
64.00, 63.61, 21.37, 21.29, 21.05, 15.72, MS (electrospray ionization) 465.1 (M + Na
+
, 100%). 
1,2,3-Tri-O-acetyl-2-C-methyl-5-O-benzoyl-β-D-ribofuranose (116)  
O OAc
OAc
BzO
AcO  
Step 1: A mixture of 1 g (2.26 mmol) of compound 115, 300 mg of (5%) Pd/C in 30 mL of 
MeOH was stirred at 50 °C for 18 h. The mixture was filtered through celite and concentrated to 
get a mixture of 2’-hydroxy, 2’,3’-dihydroxy, and C1 methoxy substituted analogs.  
Step 2: To the crude mixture obtained in first step, in 25 mL of dry DCM, was added 100 mg 
(0.82 mmol) of DMAP and 1.2 mL of triethylamine followed by 2.5 mL of acetic anhydride. 
After stirring for 12 h, diluted with water (30 mL), acidified with 1N HCl, and extracted in 
dichloromethane (80 x3). The combined organic layer was washed with brine, dried with 
MgSO4, concentrated, and purified through silica gel column to get 472 mg (53% yield in two 
steps) of compound 116. 
1
H NMR  8.14 – 7.97 (m, 2 H), 7.63 – 7.53 (m, 1 H), 7.50 – 7.40 (m, 2 
H), 6.53 (s, 1 H), 5.45 (d, J = 8.2 Hz, 1 H), 4.61 (dd, J = 11.7, 3.5 Hz, 1 H), 4.47 – 4.41 (m, 1 H), 
4.40 – 4.34 (m, 1 H), 2.13 (s, 3 H), 2.11 (s, 3 H), 2.00 (s, 3 H), 1.64 (s, 3 H); 13C NMR    
170.33, 169.80, 169.09, 166.23, 133.47, 129.93, 128.64, 97.45, 78.38, 75.21, 64.01, 22.02, 21.18, 
20.91, 16.52; MS (electrospray ionization) 416.9 (M + Na
+
, 100%).   
1-(2,3-Di-O-acetyl-2-C-methyl-5-O-benzoyl-β-D-ribofuranosyl)thiouracil (118)  
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O N
OAc
BzO
AcO
H
N
O
S
 
To a solution of 200 mg (0.5 mmol) comound 116
 
in 6 mL of dichloroethane was added silylated 
thiouracil 117. After stirring for 5 min, 145 mg (0.55 mmol) of tin tetrachloride was added and 
the mixture was stirred for 4h. 5 mL of sat. NaHCO3 solution was added, stirred for 1 h, and left 
to stand for 3h. The mixture was filtered through silica pad; the filtrate was diluted with 15 mL 
of water and extracted in dichloromethane. The organic layer was washed with brine, dried with 
MgSO4, concentrated, and purified through silica gel column to get 31 mg (10% yield) of 
compound 118. 
1
H NMR  8.08 – 8.00 (m, 2 H), 7.91 (d, J = 6.6 Hz, 1 H), 7.62 – 7.54 (m, 1 H), 
7.50 – 7.40 (m, 2 H), 6.75 (s, 1 H), 6.26 (d, J = 6.6 Hz, 1 H), 5.23 (d, J = 3.9 Hz, 1 H), 4.71 – 
4.56 (m, 2 H), 4.54 – 4.49 (m, 1 H), 2.16 (s, 3 H), 2.09 (s, 3 H), 1.85 (s, 3 H); 13C NMR    
169.85, 169.12, 166.31, 164.19, 160.07, 154.99, 133.52, 129.90, 129.66, 128.69, 112.15, 92.31, 
82.24, 81.28, 75.71, 63.37, 22.86, 21.57, 20.93; MS (electrospray ionization) 485.3 (M + Na
+
, 
100%).  
2’-C-methylthiouridine (101) 
O N
OH
HO
HO
H
N
O
S
 
20 mg (0.04 mmol) of compound 118 in 5 mL of 7M methanolic ammonia was stirred for 
overnight. The mixture was concentrated and purified through silica gel column using a gradient 
mixture of dichloromethane and methanol as eluent to get 8.9 mg (75% yield) of compound 101. 
1
H NMR (D2O)  7.82 (d, J = 8.2 Hz, 1 H), 5.9 (d, J = 7.8 Hz, 1 H), 5.16 (s, 1 H, H-1), 3.94 – 
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3.87 (m, 2 H), 3.75 – 3.68 (m, 1 H), 3.44 (d, J = 8.2 Hz, 1 H), 1.07 (s, 3 H, Me); MS 
(electrospray ionization) negative mode, 273.4  (M - 1). 
2-Amino-β-D-arabinofurano[1’,2’;4,5]-2-oxazoline (120)  
O N
HO
HO
NH2
O
 
2 mL of ammonia (28% aqueous) was added to a mixture of 5 g (33.3 mmol) of D-arabinose 
(119) and 2.8 g (66.6 mmol) of cyanamide in 20 mL of MeOH. After stirring for 4.5 h at 45 °C, 
the mixture was concentrated to 15 mL, cooled to 0 °C, and filtered to get 5.1 g (88% yield) of 
compound 120 as a white solid. 
1
H NMR (DMSO-d6)  6.30 (br. s., 2 H), 5.66 (d, J = 5.5 Hz, 1 
H), 5.40 (br. s., 1 H), 4.70 (br. s., 1 H), 4.52 (d, J = 5.5 Hz, 1 H), 4.00 (d, J = 3.1 Hz, 1 H), 3.71 – 
3.58 (m, 1 H), 3.32 – 3.20 (m, 2 H); 13C NMR (DMSO-d6)  162.21, 99.95, 88.05, 84.61, 75.61, 
61.54; MS (electrospray ionization) 174.9 (M + Na
+
, 100%).   
2,2’-Anhydro-1-(D-arabinofuranosyl)uracil (122)  
O
N
HO
HO
N
OO
 
A mixture of 1 g (5.7 mmol) of compound 120 and 1 mL (11.5 mmol) of methyl propiolate (121) 
in 12 mL of 96% EtOH was refluxed for 2 h. Then the mixture was diluted with dichloromethane 
(50 mL), cooled to 0 °C, and filtered to get 1.2 g (92% yield) of compound 122 as a white solid. 
1
H NMR (DMSO-d6)  7.83 (d, J = 7.4 Hz, 1 H), 6.30 (d, J = 5.9 Hz, 1 H), 5.88 (d, J = 4.3 Hz, 1 
H), 5.84 (d, J = 7.4 Hz, 1 H), 5.20 (d, J = 5.5 Hz, 1 H), 4.97 (t, J = 5.1 Hz, 1 H), 4.38 (d, J = 3.5 
Hz, 1 H), 4.07 (t, J = 5.1 Hz, 1 H), 3.32 – 3.24 (m, 1 H), 3.23 – 3.15 (m, 1 H); 13C NMR 
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(DMSO-d6) 171.18, 159.79, 136.83, 108.61, 90.01, 89.21, 88.75, 74.73, 60.83; MS 
(electrospray ionization) 249.0 (M + Na
+
, 100%).   
2’-Azido-2’-deoxyuridine (123)  
O N
N3HO
HO
H
N
O
O
 
A mixture of 0.7 g (3.1 mmol) of compound 122 and 1.6 g (24.77 mmol) of sodium azide was 
stirred in 20 mL of DMF at 115 °C for 16 h. The mixture was diluted with 150 mL of a mixture 
of dichloromethane and methanol (15:1) and filtered. The filtrate was concentrated, and purified 
through silica gel column using a gradient mixture of dichloromethane and methanol to get 0.4 g 
(48% yield) of compound 123, as a solid. 
1
H NMR (DMSO-d6)  11.40 (br. s, 1 H), 7.87 (dd, J = 
8.2, 1.2 Hz, 1 H), 5.95 (d, J = 5.5 Hz, 1 H), 5.88 (d, J = 5.5 Hz, 1 H), 5.67 (d, J = 8.20 Hz, 1 H), 
5.17 (t, J = 4.7 Hz, 1 H), 4.30 (q, J = 4.7 Hz, 1 H), 4.05 (t, J = 5.5 Hz, 1 H), 3.92 – 3.87 (m, 1 H), 
3.70 – 3.62 (m, 1 H), 3.61 – 3.54 (m, 1 H); 13C NMR (DMSO-d6) 163.00, 150.43, 140.01, 
102.06, 85.57, 85.22, 70.44, 64.58, 60.21; MS (electrospray ionization) 292.0 (M + Na
+
, 100%).    
   2’-Azido-2’-deoxy-5’-O-methanesulfonyluridine (124)  
O N
N3HO
MsO
H
N
O
O
 
To a mixture of 0.4 g (1.49 mmol) of compound 123 in 8 mL of pyridine at -30 °C was added 
0.15 mL (1.63 mmol) of methanesulfonyl chloride and temperature was increased to 0 °C and 
stirred for 1 h. Reaction was quenched with sat. NaHCO3 (20 mL) and extracted with 
dichloromethane. The organic layer was washed with brine, dried with MgSO4, concentrated, 
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and purified through silica gel column using a gradient mixture of dichloromethane and 
methanol as eluent to get 295 mg (57% yield) of compound 124, as a solid. 
1
H NMR (DMSO-d6) 
 11.46 (s, 1 H), 7.62 (d, J = 8.2 Hz, 1 H), 6.19 (d, J = 5.5 Hz, 1 H), 5.82 (d, J = 5.1 Hz, 1 H), 
5.68 (d, J = 7.8 Hz, 1 H), 4.54 – 4.20 (m, 4 H), 4.13 – 4.00 (m, 1 H), 3.23 (s, 3 H); 13C NMR 
(DMSO-d6)    162.92, 150.33, 140.43, 102.36, 86.77, 81.20, 70.20, 68.70, 63.51, 36.86.  
2’-Azido-2’-deoxy-2-O-ethyluridine (125)  
O N
N3HO
HO
N
O
EtO
 
A mixture of 160 mg (0.46 mmol) of compound 124 and 386 mg (4.6 mmol) of NaHCO3 in 10 
mL of absolute ethanol was refluxed for 36 h. Diluted with ethyl acetate (100 mL), and filtered. 
The filtrate was concentrated and purified through silica gel column using a gradient mixture of 
dicholoromethane and methanol as eluent to get 69 mg (50% yield) of compound 125, as a solid. 
1
H NMR DMSO-d6)  7.97 (d, J = 7.6 Hz, 1 H), 6.01 (d, J = 5.9 Hz, 1 H), 5.86 (d, J = 7.6 Hz, 1 
H), 5.84 (d, J = 4.9 Hz, 1 H), 5.24 (t, J = 5.1 Hz, 1 H), 4.43 – 4.25 (m, 3 H), 4.12 (t, J = 5.2 Hz, 1 
H), 3.95 – 3.88 (m, 1 H), 3.74 – 3.66 (m, 1 H), 3.63 – 3.56 (m, 1 H), 1.33 (t, J = 7.2 Hz, 3 H); 13C 
NMR (DMSO-d6)   169.52, 154.72, 137.62, 107.94, 87.27, 85.44, 70.05, 65.29, 64.49, 59.86, 
13.84; MS (electrospray ionization) 320.1 (M + Na
+
, 100%).   
2’-Amino-2’-deoxythiouridine (102)  
O N
NH2HO
HO
H
N
O
S
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H2S gas was bubbled into a solution of 40 mg (0.13 mmol) compound 125 in 8 mL of pyridine, 
at 0 °C for 0.5 h in a sealed tube, and the tube was closed. After stirring at 75 °C for 3 days, the 
solution was concentrated, and purified through silica gel column using a gradient mixture of 
dichloromethane and methanol as eluent to get 20 mg (63% yield) of compound 102, as a solid. 
1
H NMR (DMSO-d6)  8.09 (d, J = 8.2 Hz, 1 H), 6.56 (d, J = 6.3 Hz, 1 H), 6.00 (d, J = 8.2 Hz, 1 
H), 5.24 (br. s., 1 H), 4.05 – 3.87 (m, 2 H), 3.69 – 3.54 (m, 2 H), 3.43 – 3.26 (m, 4 H); 13C NMR 
(DMSO-d6)     176.90, 159.51, 140.97, 106.67, 92.43, 85.90, 70.08, 60.65, 58.80; MS 
(electrospray ionization) 260.1 (M + Na
+
, 100%).  
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Appendix:
 1
H and 
13
C spectra 
Acquisition Time (sec) 2.0487 Comment Std proton Date Dec 23 2009 Date Stamp Dec 23 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-3-VANILINEALDEHYDE-AMINE.FID\FID Frequency (MHz) 399.75
Nucleus 1H Number of Transients 44 Original Points Count 13103 Points Count 16384
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.5376 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
OMe
OH
LP-3-51.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.141.244.442.343.051.021.041.061.672.911.061.171.000.951.031.01
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Acquisition Time (sec) 1.3005 Comment Std proton Date Dec 23 2009 Date Stamp Dec 23 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-3-51C13.FID\FID Frequency (MHz) 100.53
Nucleus 13C Number of Transients 472 Original Points Count 31375 Points Count 32768
Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10528.0313 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
OMe
OH
LP-3-51-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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rm
a
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z
e
d
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n
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n
s
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE
lp-3-21fr7-21 Date Nov  1 2009
Date Stamp Nov  1 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-21FR7-21.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 80 Original Points Count 5984
Points Count 16384 Pulse Sequence s2pul Receiver Gain 16.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1002.8743 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
NO2
OH
LP-3-21.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.991.754.462.522.932.031.072.011.111.531.070.880.890.960.85
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE
lp-3-21fr7-21 Date Nov  1 2009
Date Stamp Nov  1 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-21FR7-21-C13.FID\FID
Frequency (MHz) 50.29 Nucleus 13C Number of Transients 4320 Original Points Count 18720
Points Count 65536 Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4876.9170 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
NO2
OH
LP-3-21-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
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z
e
d
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n
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n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Apr 14 2011
Date Stamp Apr 14 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-78.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 40 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 28.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.3633 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
Br
OH
LP-5-78.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.814.445.893.173.822.471.312.872.651.081.071.001.221.271.19
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Apr 14 2011
Date Stamp Apr 14 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-78-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 21208 Original Points Count 31413
Points Count 65536 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10557.7637 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
Br
OH
LP-5-78-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
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z
e
d
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Apr 10 2011
Date Stamp Apr 10 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-74.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 28 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 28.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
F
OH
LP-5-74.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
3.722.274.662.573.030.800.930.962.001.020.810.692.90
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Apr 10 2011
Date Stamp Apr 10 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-74-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 8804 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10558.3594 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
F
OH
LP-5-74-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
0.055
0.060
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a
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z
e
d
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Acquisition Time (sec) 2.0487 Comment Std proton Date Dec 13 2009 Date Stamp Dec 13 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-42COLUMN.FID\FID
Frequency (MHz) 399.75 Nucleus 1H Number of Transients 48 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.9280 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
OH
OMe
LP-3-42.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
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y
3.121.554.792.333.310.971.071.061.873.281.001.221.032.081.05
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Acquisition Time (sec) 1.3005 Comment Std proton Date Dec 13 2009 Date Stamp Dec 13 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-42C13.FID\FID
Frequency (MHz) 100.53 Nucleus 13C Number of Transients 2540 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10542.0205 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
OH
OMe
LP-3-42-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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a
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z
e
d
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n
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Acquisition Time (sec) 2.0487 Comment Std proton Date Dec  3 2009 Date Stamp Dec  3 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-3-36COLUMN.FID\FID Frequency (MHz) 399.75
Nucleus 1H Number of Transients 72 Original Points Count 13103 Points Count 16384
Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.3184 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
OBn
OBn
LP-3-36.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
3.412.365.232.332.791.771.041.991.191.731.760.300.340.992.101.185.293.42
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Acquisition Time (sec) 1.3005 Comment Std proton Date Dec  3 2009 Date Stamp Dec  3 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-36-C13.FID\FID
Frequency (MHz) 100.53 Nucleus 13C Number of Transients 4804 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10536.1299 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
OBn
OBn
LP-3-36-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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a
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z
e
d
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 31 2011
Date Stamp Mar 31 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-69.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 24 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2402.9727 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
O
LP-5-69.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
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y
4.493.016.223.534.622.761.392.721.001.022.560.952.401.21
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 31 2011
Date Stamp Mar 31 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-69-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 956 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.9355 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
O
LP-5-69-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE
lp-3-43 Date Dec 16 2009
Date Stamp Dec 16 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-43.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 68 Original Points Count 5984
Points Count 16384 Pulse Sequence s2pul Receiver Gain 16.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1003.7899 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
OMe
OH
OMe
LP-3-43.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
2.991.284.072.252.761.730.821.865.391.430.800.751.75
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Dec 16 2009 Date Stamp Dec 16 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-43-C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 2976 Original Points Count 18720 Points Count 65536
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4876.7261 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
OMe
OH
OMe
LP-3-43-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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z
e
d
 I
n
te
n
s
it
y
 
  153  
 
Acquisition Time (sec) 2.0487 Comment Std proton Date Sep  2 2010 Date Stamp Sep  2 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-69.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 52 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
OH
LP-4-69.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
4.143.055.372.733.991.111.181.012.001.181.001.012.261.261.10
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Acquisition Time (sec) 1.3005 Comment Std proton Date Sep  2 2010 Date Stamp Sep  2 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-69-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 16832 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10545.5117 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
OH
LP-4-69-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
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Acquisition Time (sec) 2.0487 Comment Std proton Date Dec 23 2010 Date Stamp Dec 23 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-146.FID\FID
Frequency (MHz) 399.73 Nucleus 1H Number of Transients 32 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2413.9363 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-146.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.642.234.822.433.330.981.000.982.001.600.950.901.031.871.01
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Dec 23 2010
Date Stamp Dec 23 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-146-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 24948 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.9365 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-146-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Aug 21 2011
Date Stamp Aug 21 2011 File Name F:\NMR-MERCURY-02012\TP70-08-22.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 80 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 38.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-21.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.681.224.382.543.242.141.252.000.910.820.841.791.84
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul 26 2011
Date Stamp Jul 26 2011 File Name F:\TP70-07-25-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 1904 Original Points Count 31413 Points Count 65536
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.7100 Spectrum Type STANDARD Sweep Width (Hz) 24154.59
Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-21-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Aug  9 2011
Date Stamp Aug  9 2011 File Name F:\NMR-MERCURY-02012\LP-4-114-2.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 44 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 24.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.3633 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-114.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.802.565.853.884.932.371.132.502.921.121.121.004.80
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Aug  9 2011
Date Stamp Aug  9 2011 File Name F:\NMR-MERCURY-02012\LB-4-114-2-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 15228 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10555.4111 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-4-114-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 16 2011
Date Stamp Mar 16 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-60.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 12 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 12.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
OH
LP-5-60.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.552.256.923.544.114.242.293.153.293.261.141.241.042.952.89
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 16 2011
Date Stamp Mar 16 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-60-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 16396 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10544.3525 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
OH
LP-5-60-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
 
  163  
 
Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Sep 14 2010
Date Stamp Sep 14 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-105.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 84 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2402.5823 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
LP-4-105HNMR.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.773.446.933.895.282.461.372.401.001.150.866.03
 
  164  
 
Date Stamp Sep 14 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-105-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 23628 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10550.9873 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
LP-4-105-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Dec 28 2010
Date Stamp Dec 28 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-149.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 36 Original Points Count 12783
Points Count 32768 Pulse Sequence s2pul Receiver Gain 18.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.4763 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
LP-4-149.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.102.026.023.364.282.621.362.643.751.000.990.962.312.01
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Dec 28 2010
Date Stamp Dec 28 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-149-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 23844 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10550.2510 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
LP-4-149-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 31 2011
Date Stamp Mar 31 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-68.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 48 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.3633 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
H
O
LP-5-68.ESP
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.372.565.442.693.502.161.472.180.960.960.832.052.091.00
 
  168  
 
Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 31 2011
Date Stamp Mar 31 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-68-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 4036 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10555.4111 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
H
O
LP-5-68-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 25 2011
Date Stamp Mar 25 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-64.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 20 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
O
LP-5-64.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.831.985.793.304.262.561.382.023.551.000.950.882.342.26
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 25 2011
Date Stamp Mar 25 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-64-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 880 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.4619 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
O
LP-5-64-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 30 2011
Date Stamp Mar 30 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-58.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 44 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 24.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2401.8013 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-58.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.002.632.912.832.603.190.991.101.216.962.131.000.920.832.242.60
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 30 2011
Date Stamp Mar 30 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-58-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 10432 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10555.4102 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-58-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jul  1 2011 Date Stamp Jul  1 2011
File Name F:\NMR-NOVA-02-12\LP-5-57-2.FID\FID Frequency (MHz) 399.73 Nucleus 1H Number of Transients 44
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2414.7563 Spectrum Type STANDARD
Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
NH
H
Cl
LP-5-57.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.972.085.243.434.422.381.322.431.001.010.934.71
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jul  1 2011 Date Stamp Jul  1 2011
File Name F:\NMR-NOVA-02-12\LP-5-57-2-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 22968 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10553.6523
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
Cl
LP-5-57-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 17 2011
Date Stamp Mar 17 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-56.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 28 Original Points Count 12783
Points Count 32768 Pulse Sequence s2pul Receiver Gain 16.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.2573 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
CN
LP-5-56.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.552.085.212.573.642.131.172.161.001.000.902.152.26
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 17 2011
Date Stamp Mar 17 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-56-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 828 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10548.0381 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
CN
LP-5-56-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar  6 2012
Date Stamp Mar  6 2012 File Name F:\MERCURY03-2-2012\LP-6-71-LAST.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 112 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 26.00 Solvent acetone Spectrum Offset (Hz) 2399.0100
Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
LP-6-71.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.471.533.181.826.293.580.840.960.921.800.900.980.970.911.021.070.910.931.00
O
O
O
NH
H
OH
CF3COOH
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar  1 2012
Date Stamp Mar  1 2012 File Name F:\MERCURY03-2-2012\LP-6-71-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 20136 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent acetone Spectrum Offset (Hz) 10633.4824
Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
LP-6-71-C13.ESP
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
O
O
O
NH
H
OH
CF3COOH
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Acquisition Time (sec) 2.0487 Comment Std proton Date Mar 25 2010 Date Stamp Mar 25 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-106.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 28 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2417.1301 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-3-106.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.361.525.002.423.560.971.131.102.200.880.810.801.001.331.151.151.131.14
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul 11 2011
Date Stamp Jul 11 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\TP61-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 376 Original Points Count 31413
Points Count 65536 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10541.1777 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-3-106-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Feb  5 2010 Date Stamp Feb  5 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-71-2.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 52 Original Points Count 13103
Points Count 32768 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.4619 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
OMe
LP-3-71.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.391.874.902.793.710.921.171.003.511.960.780.830.721.101.002.211.071.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Feb  5 2010 Date Stamp Feb  5 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-71-2C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 628 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10542.5674 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
OMe
LP-3-71-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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a
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z
e
d
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n
te
n
s
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 17 2010 Date Stamp Aug 17 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-71.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 44 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 32.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2418.5090 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
OH
LP-4-71.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.883.765.293.223.081.041.201.052.361.020.990.880.870.890.980.941.081.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 17 2010 Date Stamp Aug 17 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-71-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 7800 Original Points Count 31375
Points Count 65536 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.2803 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
OH
LP-4-71-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar  1 2012
Date Stamp Mar  1 2012 File Name F:\MERCURY03-2-2012\LP-6-72-LAST.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 52 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.5349 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-6-72.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.182.726.133.274.491.321.361.352.021.071.000.951.931.041.082.10
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 29 2012
Date Stamp Feb 29 2012 File Name F:\MERCURY03-2-2012\LP-6-72-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 500 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.4619 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OH
LP-6-72-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Aug 16 2012
Date Stamp Aug 16 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\LP-7-95.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 100 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.3528 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
OHO
LP-7-95.esp
12 11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
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n
s
it
y
2.572.125.891.393.830.971.000.941.000.880.931.030.870.861.870.72
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Aug 15 2012
Date Stamp Aug 15 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\LP-7-95-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 2000 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.1475 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OHO
LP-7-95-C13.esp
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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rm
a
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z
e
d
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Aug 15 2012
Date Stamp Aug 15 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\LP-7-96.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 40 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.3528 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
OAcO
LP-7-96.esp
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.722.677.381.955.383.961.381.271.181.111.001.041.151.171.821.151.05
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Aug 15 2012
Date Stamp Aug 15 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\LP-7-96-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 14984 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10557.6221 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
OAcO
LP-7-96-C13.esp
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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e
d
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jul 11 2011
Date Stamp Jul 11 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\LP-2-25.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 44 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
O
H
LP-2-25.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.091.574.694.003.372.091.062.000.940.830.790.800.860.79
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul 11 2011
Date Stamp Jul 11 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKH\.TRASH-LAXMAN\LP-2-25-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 16224 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.3525 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
O
H
LP-2-25-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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rm
a
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z
e
d
 I
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jul  7 2011
Date Stamp Jul  7 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\LP-2-29-2.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 24 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.9622 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
S
H
LP-2-29.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.792.045.923.644.112.441.162.191.011.050.910.900.970.89
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul  7 2011
Date Stamp Jul  7 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\LP-2-29-2-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 824 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.1475 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
S
H
LP-2-29-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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z
e
d
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE
lp-2-120fr22-24 Date Oct  4 2009
Date Stamp Oct  4 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-2-120FR22-24.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 48 Original Points Count 5984
Points Count 8192 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1001.9926 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
S
Ph
LP-2-120.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.982.917.654.694.905.902.911.101.101.001.241.314.702.70
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Oct  7 2009 Date Stamp Oct  7 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-2-120-C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 4928 Original Points Count 18720 Points Count 65536
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4879.2056 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
S
Ph
LP-2-120-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE Date Oct 21 2009
Date Stamp Oct 21 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-3-16PURE.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 64 Original Points Count 5984
Points Count 8192 Pulse Sequence s2pul Receiver Gain 18.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1003.4878 Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
H
LP-3-16.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.242.297.835.636.761.662.792.330.931.733.401.682.601.00
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE
lp-3-16pure-c13 Date Oct 21 2009
Date Stamp Oct 21 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-3-16-C13.FID\FID
Frequency (MHz) 50.29 Nucleus 13C Number of Transients 5024 Original Points Count 18720
Points Count 32768 Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4877.7900 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
H
LP-3-16-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
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0.45
0.50
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jul 21 2011
Date Stamp Jul 21 2011 File Name F:\LP-3-18.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 40 Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul
Receiver Gain 22.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 2404.3528 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
N
H
LP-3-18.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
5.162.568.134.945.813.071.583.061.001.251.051.302.701.11
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul 21 2011 Date Stamp Jul 21 2011
File Name F:\LP-3-18-C13.FID\FID Frequency (MHz) 100.58 Nucleus 13C Number of Transients 2800
Original Points Count 31413 Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 10552.4619 Spectrum Type STANDARD
Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
H
LP-3-18-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
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z
e
d
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Acquisition Time (sec) 2.0487 Comment Std proton Date Oct 12 2009 Date Stamp Oct 12 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKH\LAXMAN POKHREL\400 MHZ\LP-3-06PURE.FID\FID Frequency (MHz) 399.75
Nucleus 1H Number of Transients 100 Original Points Count 13103 Points Count 16384
Pulse Sequence s2pul Receiver Gain 54.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1362 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
N
H
LP-3-6.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.144.254.761.632.831.080.991.011.780.460.420.300.340.781.740.850.860.840.99
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Acquisition Time (sec) 1.3005 Comment Std proton Date Oct 12 2009 Date Stamp Oct 12 2009
File Name C:\USERS\LAXMAN\DESKTOP\NMR\LAXMAN POKHREL\400 MHZ\LP-3-6-C13.FID\FID Frequency (MHz) 100.53
Nucleus 13C Number of Transients 3032 Original Points Count 31375 Points Count 32768
Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10551.5918 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
N
H
LP-3-6-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 11 2009 Date Stamp Aug 11 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-2-93-FR41.FID\FID Frequency (MHz) 399.75
Nucleus 1H Number of Transients 50 Original Points Count 13103 Points Count 16384
Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.9280 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
O
LP-2-93-2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
4.022.286.413.394.881.301.311.181.881.001.060.930.832.581.030.98
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 11 2009 Date Stamp Aug 11 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-2-93-FR40-C13.FID\FID Frequency (MHz) 100.53
Nucleus 13C Number of Transients 21284 Original Points Count 31375 Points Count 32768
Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10550.8555 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
O
LP-2-93-2-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
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Acquisition Time (sec) 1.4976 Comment lp-2-93-fr2 Date Aug 10 2009 Date Stamp Aug 10 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKH\LAXMAN POKHREL\200MHZ\LP-2-93-FR2.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 13080 Original Points Count 18720 Points Count 32768
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 4880.4604
Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
N
H
O
O
LP-2-93-1-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE Date Jul 27 2009
Date Stamp Jul 27 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-2-81-2.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 200 Original Points Count 5984
Points Count 8192 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1003.1215 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
S
LP-2-81-2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
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6.184.258.425.076.806.482.961.081.391.004.382.72
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Jul 27 2009 Date Stamp Jul 27 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN 
POKHREL\200MHZ\LP-2-81-2-C13.FID\FID
Frequency (MHz) 50.29
Nucleus 13C Number of Transients 5720 Original Points Count 18720 Points Count 32768
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4878.9351 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT 
TEMPERATURE
O
O
O
NH
H
S
LP-2-81-2-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jul 29 2009 Date Stamp Jul 29 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-2-81-1.FID\FID
Frequency (MHz) 399.75 Nucleus 1H Number of Transients 100 Original Points Count 9357
Points Count 16384 Pulse Sequence s2pul Receiver Gain 42.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1900.3818 Spectrum Type STANDARD Sweep Width (Hz) 4567.25 Temperature (degree C) 25.000
O
O
O
N
H
S
S
LP-2-81-1.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.194.697.114.981.000.411.892.030.390.750.830.741.804.871.792.34
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug  2 2009 Date Stamp Aug  2 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-2-81-1-1-C13.FID\FID
Frequency (MHz) 100.53 Nucleus 13C Number of Transients 22288 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.0645 Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
N
H
S
SLP-2-81-1C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
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z
e
d
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n
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n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Aug  9 2011
Date Stamp Aug  9 2011 File Name G:\TP36-08-10-11 Frequency (MHz) 399.96
Nucleus 1H Number of Transients 100 Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul
Receiver Gain 22.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 2402.9727 Sweep Width (Hz) 6397.95
Temperature (degree C) 25.000
O
O
O
NH
H
NH
N
LP-3-50-2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.852.106.854.034.361.131.241.222.501.001.421.591.481.37
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Aug  9 2011 Date Stamp Aug  9 2011
File Name G:\TP36-08-10-11-C13 Frequency (MHz) 100.58 Nucleus 13C Number of Transients 30000
Original Points Count 31413 Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 10553.9365 Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
NH
N
LP-3-50-2-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jun 17 2011 Date Stamp Jun 17 2011
File Name F:\LAXMAN POKHREL\TP36-DI2.FID\FID Frequency (MHz) 399.73 Nucleus 1H Number of Transients 28
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 30.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2414.5737 Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
N
H
NH
N
N
NH
LP-3-50-1.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.642.736.902.385.752.404.851.001.211.012.472.503.22
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jun 17 2011 Date Stamp Jun 17 2011
File Name F:\LAXMAN POKHREL\TP36DI2.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 20000 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10549.7402
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
N
H
NH
N
N
NH
LP-3-50-1-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
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n
s
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE
lp-2-121fr4-6 Date Oct  4 2009
Date Stamp Oct  4 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-2-121FR4-6.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 100 Original Points Count 5984
Points Count 8192 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1006.0217 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
S
N
LP-2-121.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.641.745.153.114.571.471.001.122.091.000.820.830.770.73
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Oct  4 2009 Date Stamp Oct  4 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-2-121FR4-6-C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 5532 Original Points Count 18720 Points Count 32768
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4878.9351 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
S
N
LP-2-121-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
 
  217  
 
Acquisition Time (sec) 2.0487 Comment Std proton Date Oct  9 2009 Date Stamp Oct  9 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-5PURE.FID\FID
Frequency (MHz) 399.75 Nucleus 1H Number of Transients 50 Original Points Count 13103
Points Count 32768 Pulse Sequence s2pul Receiver Gain 36.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2424.8154 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-3-5.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.542.346.183.304.922.531.622.631.001.220.961.341.181.131.18
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Oct  9 2009 Date Stamp Oct  9 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-05PURE-C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 3848 Original Points Count 18720 Points Count 32768
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4875.5015 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
LP-3-5-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 25 2011
Date Stamp Mar 25 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\NEW FOLDER\LP-5-66-REC.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 48 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2406.2129 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-66.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.052.054.662.273.461.931.232.000.700.750.632.001.77
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 24 2011
Date Stamp Mar 24 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-66-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 544 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10551.7246 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-66-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
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z
e
d
 I
n
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n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jul  7 2011
Date Stamp Jul  7 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\LP-2-117-2.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 40 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.9622 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-2-117.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.212.264.832.593.621.151.221.341.762.111.000.880.860.920.981.020.980.961.01
 
  222  
 
Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jul  7 2011
Date Stamp Jul  7 2011 File Name F:\LAXMAN POKHREL\LAXMAN-MERCURY-07-15-2011\LP-2-117-2-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 324 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10551.7246 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-2-117-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
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s
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE
lp-3-44fr2 Date Dec 16 2009
Date Stamp Dec 16 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-44.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 56 Original Points Count 5984
Points Count 16384 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1001.2827 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
LP-3-44.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.481.745.442.993.701.591.335.362.211.000.880.910.991.181.172.22
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Dec 16 2009 Date Stamp Dec 16 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LPOKHREL\LP-3-44C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 1008 Original Points Count 18720 Points Count 65536
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4878.8242 Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
LP-3-44-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 27 2010 Date Stamp Aug 27 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-91FR3.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 64 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
N
LP-4-91.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.482.695.472.873.471.595.701.491.950.950.730.720.911.160.880.990.96
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 27 2010 Date Stamp Aug 27 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-91-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 20000 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.1387 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
N
LP-4-91-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Sep 29 2011
Date Stamp Sep 29 2011 File Name F:\NMR-MERCURY-02012\TP63-HCL-CON-2.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 100 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 39.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.5349 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-108.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.671.848.612.533.531.011.090.962.330.950.930.921.131.091.102.151.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jun 29 2011 Date Stamp Jun 29 2011
File Name F:\LP-5-108-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C Number of Transients 1628
Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 10551.2129 Spectrum Type STANDARD
Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-108-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 2.0487 Comment Std proton Date May 14 2010 Date Stamp May 14 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-28.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 48 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 40.000
O
O
O
NH
H
N
LP-4-28.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
4.282.295.733.584.361.471.304.802.291.000.860.881.041.121.172.09
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Acquisition Time (sec) 1.3005 Comment Std proton Date May 14 2010 Date Stamp May 14 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-28C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 5400 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10546.9844 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 40.000
O
O
O
NH
H
N
LP-4-28-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
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Acquisition Time (sec) 2.0487 Comment Std proton Date Dec 19 2010 Date Stamp Dec 19 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-120COL.FID\FID
Frequency (MHz) 399.73 Nucleus 1H Number of Transients 20 Original Points Count 13103
Points Count 32768 Pulse Sequence s2pul Receiver Gain 38.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2414.2439 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
N
OH
LP-4-120.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.151.764.512.423.541.091.231.192.002.010.950.860.800.961.031.051.99
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Oct  5 2010
Date Stamp Oct  5 2010 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-4-120-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 22992 Original Points Count 31413
Points Count 65536 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.6035 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
OH
LP-4-120-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Oct  1 2010 Date Stamp Oct  1 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-108FR2.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 32 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 32.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
O
O
O
NH
H
N
OAc
LP-4-108.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.262.085.722.893.112.970.971.071.011.970.972.020.910.860.951.091.041.99
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Acquisition Time (sec) 1.3005 Comment Std proton Date Oct  1 2010 Date Stamp Oct  1 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-108FR1-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 20000 Original Points Count 31375
Points Count 65536 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10550.8076 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
N
OAc
LP-4-108-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jun 15 2011 Date Stamp Jun 15 2011
File Name F:\LAXMAN POKHREL\LP-4-22.FID\FID Frequency (MHz) 399.73 Nucleus 1H Number of Transients 32
Original Points Count 13102 Points Count 32768 Pulse Sequence s2pul Receiver Gain 34.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2414.6738 Spectrum Type STANDARD
Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
NH
H
N
O
O
O
LP-4-22.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.261.715.802.573.160.961.071.001.950.824.240.820.731.081.001.041.011.95
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jun 15 2011 Date Stamp Jun 15 2011
File Name F:\LAXMAN POKHREL\LP-4-22-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 2396 Original Points Count 31375 Points Count 65536 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10551.7217
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
H
N
O
O
O
LP-4-22-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 21 2010 Date Stamp Aug 21 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-86FR2.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 100 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2417.5210 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
N
LP-4-86.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.852.537.374.754.981.566.081.603.031.251.051.001.291.281.421.181.22
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 21 2010 Date Stamp Aug 21 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-86-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 20912 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.1377 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
O
O
O
NH
H
N
LP-4-86-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date May 25 2010 Date Stamp May 25 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-34.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 44 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 40.000
O
O
O
NH
H
N
LP-4-34.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.801.875.833.683.651.181.271.242.501.040.730.821.081.211.171.181.241.01
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Acquisition Time (sec) 1.3005 Comment Std proton Date May 25 2010 Date Stamp May 25 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-34C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 1816 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10547.7207 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 40.000
O
O
O
NH
H
N
LP-4-34-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan 21 2011 Date Stamp Jan 21 2011
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-5-11.FID\FID
Frequency (MHz) 399.73 Nucleus 1H Number of Transients 56 Original Points Count 13102
Points Count 16384 Pulse Sequence s2pul Receiver Gain 24.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2414.7561 Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-21.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.222.894.553.273.780.981.151.092.051.001.031.090.930.960.900.840.891.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 22 2011
Date Stamp Jan 22 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-11C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 25900 Original Points Count 31413
Points Count 65536 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.6035 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
N
LP-5-21-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan 14 2010 Date Stamp Jan 14 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\400 MHZ\LP-3-59COL2FR1.FID\FID Frequency (MHz) 399.74
Nucleus 1H Number of Transients 44 Original Points Count 13103 Points Count 16384
Pulse Sequence s2pul Receiver Gain 48.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2416.7397 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
O
O
O
NH
H
N
LP-3-59.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.893.217.052.493.410.941.141.122.090.820.720.761.072.311.141.191.021.031.00
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Acquisition Time (sec) 1.4976 Comment 13C OBSERVE Date Jan 14 2010 Date Stamp Jan 14 2010
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-3-59C13.FID\FID Frequency (MHz) 50.29
Nucleus 13C Number of Transients 5004 Original Points Count 18720 Points Count 32768
Pulse Sequence s2pul Receiver Gain 40.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 4878.9346 Spectrum Type STANDARD Sweep Width (Hz) 12500.00 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
NH
H
N
LP-3-59-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 2.0487 Comment Std proton Date Dec 30 2011 Date Stamp Dec 30 2011
File Name F:\LP-6-36FR1.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 16
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 42.00 Solvent CHLOROFORM-
d
Spectrum Offset (Hz) 2407.6953 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
NH
N
H
O
LP-6-36-1.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.702.683.022.792.204.761.101.321.101.171.041.061.131.011.081.020.970.981.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Dec 30 2011 Date Stamp Dec 30 2011
File Name F:\LP-6-36FR1-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C Number of Transients 2088
Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 10549.6133 Spectrum Type STANDARD
Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
NH
N
H
O
LP-6-36-1-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb  7 2011
Date Stamp Feb  7 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-30.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 100 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
O
H
N
OLP-5-30.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.352.162.521.603.024.761.071.151.091.000.950.952.191.051.020.950.99
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb  7 2011
Date Stamp Feb  7 2011 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN-MERCURY04-15-11\LPOKHREL\LP-5-30-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 3820 Original Points Count 31413
Points Count 65536 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10555.9209 Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
O
H
N
OLP-5-30-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jun 14 2011 Date Stamp Jun 14 2011
File Name F:\LAXMAN POKHREL\LP-5-26.FID\FID Frequency (MHz) 399.73 Nucleus 1H Number of Transients 28
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 10.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2413.4968 Spectrum Type STANDARD
Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
O
H
OH
OLP-5-26.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.171.363.612.474.241.041.051.060.990.930.972.012.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jun 14 2011 Date Stamp Jun 14 2011
File Name F:\LAXMAN POKHREL\LP-5-26-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 5776 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10554.1582
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
O
H
OH
O
LP-5-26-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9945 Comment STANDARD 1H OBSERVE Date Nov 15 2009
Date Stamp Nov 15 2009 File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\200MHZ\LP-3-27FR18-19.FID\FID
Frequency (MHz) 199.98 Nucleus 1H Number of Transients 76 Original Points Count 5984
Points Count 8192 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1003.4805 Spectrum Type STANDARD Sweep Width (Hz) 3000.30 Temperature (degree C) AMBIENT TEMPERATURE
O
O
O
N
H
O H
H
OMeLP-3-27.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.992.565.683.184.161.291.121.103.611.060.501.051.012.510.662.040.380.360.41
 
  252  
 
Acquisition Time (sec) 1.3005 Comment Std proton Date Dec  4 2009 Date Stamp Dec  4 2009
File Name C:\USERS\LAXMAN\DESKTOP\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-3-27C13.FID\FID
Frequency (MHz) 100.53 Nucleus 13C Number of Transients 6504 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10549.3828 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
N
H
O H
H
OMeLP-3-27-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Mar 19 2012 Date Stamp Mar 19 2012
File Name C:\USERS\LAXMAN\DESKTOP\INOVA-03-27-2013\MARCH\LP-6-81.FID\FID Frequency (MHz) 399.72
Nucleus 1H Number of Transients 48 Original Points Count 13102 Points Count 16384
Pulse Sequence s2pul Receiver Gain 44.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2407.6824 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
O
H
H
LP-6-81.ESP
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.561.663.403.823.901.291.191.051.070.951.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 19 2012
Date Stamp Mar 19 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-81-C13
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 500 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10546.5645 Sweep Width (Hz) 24154.59 Temperature (degree C) 20.000
O
O
O
H
H
O
LP-6-81-C13.ESP
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Mar 21 2012 Date Stamp Mar 21 2012
File Name C:\USERS\LAXMAN\DESKTOP\INOVA-03-27-2013\MARCH\LP-6-82.FID\FID Frequency (MHz) 399.72
Nucleus 1H Number of Transients 52 Original Points Count 13102 Points Count 16384
Pulse Sequence s2pul Receiver Gain 44.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2406.9146 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
O
H
OH
LP-6-82.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
5.691.893.021.605.392.281.051.051.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Mar 21 2012 Date Stamp Mar 21 2012
File Name C:\USERS\LAXMAN\DESKTOP\INOVA-03-27-2013\MARCH\LP-6-82C13.FID\FID Frequency (MHz) 100.52
Nucleus 13C Number of Transients 19844 Original Points Count 31375 Points Count 32768
Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10550.3496 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
O
O
O
O
H
OH
LP-6-82C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Mar 22 2012 Date Stamp Mar 22 2012
File Name C:\USERS\LAXMAN\DESKTOP\INOVA-03-27-2013\MARCH\LP-6-85.FID\FID Frequency (MHz) 399.72
Nucleus 1H Number of Transients 40 Original Points Count 13102 Points Count 16384
Pulse Sequence s2pul Receiver Gain 42.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2408.8535 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
O
O
O
NH
H
O
OMe
O
LP-6-85.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.294.472.456.791.093.121.001.000.930.970.510.48
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 22 2012
Date Stamp Mar 22 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\LP-6-85-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 5944 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.9365 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
OMe
O
LP-6-85-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 27 2012
Date Stamp Mar 27 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-90-2
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 100 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
OH
O
LP-6-90.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.884.353.615.320.951.000.930.900.920.500.441.17
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 27 2012
Date Stamp Mar 27 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-90-C13
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 20000 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.4619 Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
OH
O
LP-6-90-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Mar 29 2012
Date Stamp Mar 29 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-93FR2-2
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 100 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
NH
O
O
OMe
N
HO
LP-6-93.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.065.385.3811.073.612.363.651.101.211.020.991.032.241.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Mar 29 2012
Date Stamp Mar 29 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-93FR2C13
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 30000 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10553.9365 Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
NH
H
O
NH
O
O
OMe
N
HO
LP-6-93C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date May 24 2012
Date Stamp May 24 2012 File Name E:\LAXMAN POKHREL-NMRS\LP-NMR-02-15-2013-MERCURY\LP-6-104-PURE
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 100 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 28.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
NH
H
O
NH
O
O
N
HO
H
LP-6-104-PURE.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 26 2012
Date Stamp Jan 26 2012 File Name F:\NMR-MERCURY-02012\LP-3-40.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 40 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 22.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
H
O
LP-3-40.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.361.131.190.791.471.211.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 26 2012
Date Stamp Jan 26 2012 File Name F:\NMR-MERCURY-02012\LP-3-40C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 17788 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10557.6221 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
H
O
LP-3-40-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan  9 2012 Date Stamp Jan  9 2012
File Name F:\NMR-NOVA-02-12\LP-6-41FR1.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 32
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 50.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2408.0728 Spectrum Type STANDARD
Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
N
H
O
LP-6-41FR1.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.212.551.171.201.381.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jan  9 2012 Date Stamp Jan  9 2012
File Name F:\NMR-NOVA-02-12\LP-6-41FR1-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 400 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10554.0303
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
N
H
O
LP-6-41FR1-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 15 2012
Date Stamp Jan 15 2012 File Name F:\NMR-MERCURY-02012\QUIN-4-ALD.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 24 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 39.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.5349 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
O H
QUIN-4-ALD.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.192.120.961.050.971.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 15 2012
Date Stamp Jan 15 2012 File Name F:\NMR-MERCURY-02012\QUINOLINE-4-ALD-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 10000 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10559.8330 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
O H
QUIN-4-ALD-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 31 2012
Date Stamp Jan 31 2012 File Name F:\NMR-MERCURY-02012\LP-6-55.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 36 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 38.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2405.5242 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
H O
LP-6-55.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.562.281.131.011.061.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 31 2012
Date Stamp Jan 31 2012 File Name F:\NMR-MERCURY-02012\LP-6-55C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 100 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10549.5137 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
H O
LP-6-55-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Dec 26 2011
Date Stamp Dec 26 2011 File Name F:\NMR-MERCURY-02012\LP-4-82.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 16 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 16.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.9253 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
O
O
O
LP-4-82.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.384.280.991.020.941.001.89
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Dec 26 2011
Date Stamp Dec 26 2011 File Name F:\NMR-MERCURY-02012\LP-4-82-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 72 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10547.3018 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
O
O
O
LP-4-82-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 23 2010 Date Stamp Aug 23 2010
File Name C:\USERS\LAXMAN\DESKTOP\NMR\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-88FR1.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 52 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 50.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2417.1301 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 30.000
N
O
O
O
H
O
LP-4-88.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.951.141.000.982.470.61
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 26 2010 Date Stamp Aug 26 2010
File Name C:\USERS\LAXMAN\DESKTOP\NMR\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-88-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 984 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10552.1377 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
N
O
O
O
H
OLP-4-88-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan  1 2012 Date Stamp Jan  1 2012
File Name F:\NMR-NOVA-02-12\LP-6-34.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 24
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 48.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2405.3401 Spectrum Type STANDARD
Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
N
HO
H
O
LP-6-34.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.110.980.980.980.831.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jan  1 2012 Date Stamp Jan  1 2012
File Name F:\NMR-NOVA-02-12\LP-6-34C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 252 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10551.8213
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
N
HO
H
O
LP-6-34-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-35FR3.FID\FID Frequency (MHz) 399.96 Nucleus 1H Number of Transients 16
Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul Receiver Gain 39.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
O
OH
H
LP-6-35FR3.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.881.870.901.000.870.88
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan  2 2012
Date Stamp Jan  2 2012 File Name F:\LP-6-35FR3-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 632 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10558.3594 Spectrum Type STANDARD Sweep Width (Hz) 24154.59
Temperature (degree C) 25.000
N
O
OH
H
LP-6-35FR3-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-35FR2.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 32
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 60.00 Solvent CHLOROFORM-
d
Spectrum Offset (Hz) 2408.0728 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
N
OH
O
H
LP-6-35FR2.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.571.621.171.281.171.121.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan  5 2012
Date Stamp Jan  5 2012 File Name F:\LP-6-35FR2-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 22480 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 9976.0010 Spectrum Type STANDARD Sweep Width (Hz) 24154.59
Temperature (degree C) 25.000
N
OH
O
H
LP-6-35FR2-C13.ESP
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-35FR4.FID\FID Frequency (MHz) 399.96 Nucleus 1H Number of Transients 72
Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul Receiver Gain 39.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
OH
OH
LP-6-35FR4.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
0.951.022.332.301.031.041.071.091.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-35FR4-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C Number of Transients 4020
Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent DMSO-d6
Spectrum Offset (Hz) 10486.9805 Spectrum Type STANDARD Sweep Width (Hz) 24125.45
Temperature (degree C) 25.000
N
OH
OH
LP-6-35FR4-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 2.0487 Comment Std proton Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-40.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 56
Original Points Count 13102 Points Count 16384 Pulse Sequence s2pul Receiver Gain 48.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2408.4761 Spectrum Type STANDARD Sweep Width (Hz) 6395.40 Temperature (degree C) 25.000
N
O
OAc
H
LP-6-40.ESP
11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.202.191.211.151.001.030.991.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jan  2 2012 Date Stamp Jan  2 2012
File Name F:\LP-6-40-C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C Number of Transients 1168
Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 10551.8213 Spectrum Type STANDARD
Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
N
O
OAc
H
LP-6-40-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 2.0500 Comment Std proton Date Jan 25 2012 Date Stamp Jan 25 2012
File Name F:\NMR-NOVA-02-12\LP-4-72.FID\FID Frequency (MHz) 399.72 Nucleus 1H Number of Transients 40
Original Points Count 20485 Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2409.0603 Spectrum Type STANDARD
Sweep Width (Hz) 9992.51 Temperature (degree C) 25.000
N
O
O O
LP-4-72.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.104.220.971.000.881.091.061.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Jan 25 2012 Date Stamp Jan 25 2012
File Name F:\NMR-NOVA-02-12\LP-4-72C13.FID\FID Frequency (MHz) 100.52 Nucleus 13C
Number of Transients 108 Original Points Count 31375 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 30.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 10535.6240
Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 25.000
N
O
O O
LP-4-72-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 2.0487 Comment Std proton Date Aug 19 2010 Date Stamp Aug 19 2010
File Name C:\USERS\LAXMAN\DESKTOP\NMR\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-85FR3.FID\FID
Frequency (MHz) 399.74 Nucleus 1H Number of Transients 76 Original Points Count 13103
Points Count 16384 Pulse Sequence s2pul Receiver Gain 52.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2417.1301 Spectrum Type STANDARD Sweep Width (Hz) 6395.91 Temperature (degree C) 25.000
N
O H
O
O O
LP-4-85.ESP
11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
5.371.071.121.131.950.921.00
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Acquisition Time (sec) 1.3005 Comment Std proton Date Aug 26 2010 Date Stamp Aug 26 2010
File Name C:\USERS\LAXMAN\DESKTOP\NMR\LAXMAN POKHREL\LAXMAN(NOVA)-03-15-11\LPOKHREL\LP-4-85-C13.FID\FID
Frequency (MHz) 100.52 Nucleus 13C Number of Transients 300 Original Points Count 31375
Points Count 32768 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10546.2480 Spectrum Type STANDARD Sweep Width (Hz) 24125.45 Temperature (degree C) 30.000
N
O H
O
O O
LP-4-85-C13.ESP
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-6-41FR5.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 10 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 12.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.5349 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
O H
LP-6-41FR5.ESP
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.641.061.021.161.011.051.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-6-41FR5-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 216 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10536.9814 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
O H
LP-6-41FR5-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 26 2012
Date Stamp Jan 26 2012 File Name F:\NMR-MERCURY-02012\LP-6-53.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 20 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
H
O
LP-6-53.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.012.031.041.050.981.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 26 2012
Date Stamp Jan 26 2012 File Name F:\NMR-MERCURY-02012\LP-6-53C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 252 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.8848 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
H
O
LP-6-53C13.ESP
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
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z
e
d
 I
n
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n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-6-52.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 8 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 24.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
HO
LP-6-52.ESP
11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.301.321.301.291.201.231.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-6-52C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 316 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.1475 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
HO
LP-6-52-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-4-158FR2.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 20 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 12.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
OH
LP-4-158FR2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.240.981.091.031.071.001.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 24 2012
Date Stamp Jan 24 2012 File Name F:\NMR-MERCURY-02012\LP-4-158FR2C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 56 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10535.5068 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
OH
LP-4-158FR2-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Jan 27 2012
Date Stamp Jan 27 2012 File Name F:\NMR-MERCURY-02012\LP-6-54FR4-DP.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 40 Original Points Count 12783 Points Count 16384
Pulse Sequence s2pul Receiver Gain 24.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.7432 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
N
O H
LP-6-54FR4.ESP
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.991.062.141.000.911.000.92
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Jan 27 2012
Date Stamp Jan 27 2012 File Name F:\NMR-MERCURY-02012\LP-6-54FR4-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 848 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10554.6738 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
N
O H
LP-6-54FR4-C13.ESP
200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
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z
e
d
 I
n
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n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Oct 17 2012
Date Stamp Oct 17 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-38DP.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 32 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 28.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
OH
O
O
LP-8-38.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.874.473.914.001.111.371.331.432.421.141.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Oct 17 2012
Date Stamp Oct 17 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-38C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 100 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 9243.8975 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
OH
O
O
LP-8-38-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
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n
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n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Oct 21 2012
Date Stamp Oct 21 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-39FR3.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 32 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 28.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.3633 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
O
O
O
LP-8-39.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
5.723.553.212.773.721.01
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Oct 21 2012
Date Stamp Oct 21 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-39FR3C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 248 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.8848 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
O
O
O
LP-8-39-C13.ESP
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
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a
li
z
e
d
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Oct 23 2012
Date Stamp Oct 23 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-41.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 36 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 34.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
OH
O
O
LP-8-41.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
3.907.765.064.951.011.271.422.601.290.99
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Apr  7 2013
Date Stamp Apr  7 2013 File Name G:\LP-8-41AGAINC13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 3244 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10559.8340 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
O
O
OH
LP-8-41-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
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n
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Nov  1 2012
Date Stamp Nov  1 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-44.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 52 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2399.7554 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
OBn
OH
OH
LP-8-44.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.993.403.391.601.471.501.151.101.851.005.84
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Apr  7 2013
Date Stamp Apr  7 2013 File Name G:\LP-8-44AGAINC13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 4484 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10559.8330 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
OH
OH
OBn
LP-8-44-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Nov  2 2012
Date Stamp Nov  2 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-46.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 28 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.5349 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
O
O
OBn
OBz
OH
LP-8-46.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.482.432.121.480.850.762.220.626.580.881.38
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Nov  2 2012
Date Stamp Nov  2 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-46-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 440 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10556.8848 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
O
O
OBn
OBz
OH
LP-8-46-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date May 24 2013
Date Stamp May 24 2013 File Name G:\LP-8-49-2FR7.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 100 Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul
Receiver Gain 39.00 Solvent CHLOROFORM-d Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OAc
OBn
OBz
OAc
LP-8-49-2FR7.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.860.850.782.182.788.471.000.290.880.267.583.161.502.88
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date May 24 2013
Date Stamp May 24 2013 File Name G:\LP-8-49-2FR7-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 30816 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10559.8418 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OAc
OBn
OBz
OAc
LP-8-49-2FR7-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Nov 24 2012
Date Stamp Nov 24 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-55DP2.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 28 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2404.1443 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OAc
OAc
OAc
OBz
LP-8-55-2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.843.344.094.542.441.711.621.650.994.462.124.21
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Nov 24 2012
Date Stamp Nov 24 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-55DP2C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 2724 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10559.8330 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OAc
OAc
OAc
OBz
LP-8-55-2-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Nov 25 2012
Date Stamp Nov 25 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-60DP1.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 60 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 30.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2403.7539 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OAc
N
OAc
OBz
N
H
O
S
LP-8-60DP1.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.692.182.411.442.380.950.980.882.361.461.002.43
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Nov 25 2012
Date Stamp Nov 25 2012 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-60DP1-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 2160 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 10558.3594 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OAc
N
OAc
OBz
N
H
O
S
LP-8-60DP1-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date May 30 2013
Date Stamp May 30 2013 File Name G:\THIOURIDINE.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 192 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 39.00 Solvent DEUTERIUM OXIDE
Spectrum Offset (Hz) 2460.8940 Spectrum Type STANDARD Sweep Width (Hz) 6397.95
Temperature (degree C) 25.000
O
N
OH
OH
OH
N
H
O
S
LP-8-111.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.201.181.211.641.081.001.00
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 12 2013
Date Stamp Feb 12 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-78-DMSO.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 24 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 32.00 Solvent DMSO-d6
Spectrum Offset (Hz) 2405.9915 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
N
OH
OH
NH2
O
LP-8-78.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.831.071.020.870.880.810.821.68
 
  318  
 
Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 12 2013
Date Stamp Feb 12 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-78C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 2172 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent DMSO-d6
Spectrum Offset (Hz) 10490.8350 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
N
OH
OH
NH2
O
LP-8-78-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
0.055
0.060
N
o
rm
a
li
z
e
d
 I
n
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n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 12 2013
Date Stamp Feb 12 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-ARABINOSE-PROPIOLATE.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 24 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 26.00 Solvent DMSO-d6
Spectrum Offset (Hz) 2406.7725 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OH
N
O
N
OH
O
LP-8-79.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.001.040.890.870.870.850.840.840.900.90
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 12 2013
Date Stamp Feb 12 2013
File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-ARABINOFURANOSE-PROPIOLATE-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 15000 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent DMSO-d6
Spectrum Offset (Hz) 10491.5723 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OH
N
O
N
OH
O
LP-8-79-C13.ESP
192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 16 2013
Date Stamp Feb 16 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-95-DP.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 48 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00 Solvent DMSO-d6
Spectrum Offset (Hz) 2407.5535 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OH
N
O
N
H
OH
O
N3
LP-8-95-DP.ESP
11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1.141.091.031.220.960.960.990.960.901.000.79
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 16 2013
Date Stamp Feb 16 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-95-DP-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 18172 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent DMSO-d6
Spectrum Offset (Hz) 10490.0986 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OH
N
O
N
H
OH
O
N3
LP-8-95-DP-C13.ESP
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
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z
e
d
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n
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 26 2013
Date Stamp Feb 26 2013 File Name G:\LP-8-99-MESYLATE.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 36 Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul
Receiver Gain 26.00 Solvent DMSO-d6 Spectrum Offset (Hz) 2407.1628 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OMs
N
O
N
H
OH
O
N3
LP-8-99.ESP
11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.381.244.670.930.910.871.020.95
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 26 2013
Date Stamp Feb 26 2013 File Name G:\LP-8-99-MESYLATE-C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 18656 Original Points Count 31413 Points Count 32768
Pulse Sequence s2pul Receiver Gain 20.00 Solvent DMSO-d6 Spectrum Offset (Hz) 10491.5723
Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OMs
N
O
N
H
OH
O
N3
LP-8-99-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
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z
e
d
 I
n
te
n
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 13 2013
Date Stamp Feb 13 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-93-ETHOXY.FID\FID
Frequency (MHz) 399.96 Nucleus 1H Number of Transients 32 Original Points Count 12783
Points Count 16384 Pulse Sequence s2pul Receiver Gain 36.00 Solvent DMSO-d6
Spectrum Offset (Hz) 2406.3818 Spectrum Type STANDARD Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
N
N3OH
OH
N
O
OEt
LP-8-93.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.461.311.401.291.523.791.002.170.991.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 13 2013
Date Stamp Feb 13 2013 File Name C:\USERS\LAXMAN\DESKTOP\LP-NMR-02-15-2013-MERCURY\SUGAR ANALOGS\LP-8-93-ETHOXY-C13.FID\FID
Frequency (MHz) 100.58 Nucleus 13C Number of Transients 14468 Original Points Count 31413
Points Count 32768 Pulse Sequence s2pul Receiver Gain 20.00 Solvent DMSO-d6
Spectrum Offset (Hz) 10490.0986 Spectrum Type STANDARD Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
N
N3OH
OH
N
O
OEt
LP-8-93-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
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a
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z
e
d
 I
n
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n
s
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y
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Acquisition Time (sec) 1.9980 Comment Std Proton parameters Date Feb 27 2013
Date Stamp Feb 27 2013 File Name G:\LP-8-94-AGAIN.FID\FID Frequency (MHz) 399.96
Nucleus 1H Number of Transients 60 Original Points Count 12783 Points Count 16384 Pulse Sequence s2pul
Receiver Gain 36.00 Solvent DMSO-d6 Spectrum Offset (Hz) 2405.9915 Spectrum Type STANDARD
Sweep Width (Hz) 6397.95 Temperature (degree C) 25.000
O
OH
N
S
N
H
OH
O
NH2
LP-8-94.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.202.442.211.181.120.991.00
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Acquisition Time (sec) 1.3005 Comment Std Carbon experiment Date Feb 27 2013
Date Stamp Feb 27 2013 File Name G:\LP-8-94C13.FID\FID Frequency (MHz) 100.58
Nucleus 13C Number of Transients 14024 Original Points Count 31413 Points Count 32768 Pulse Sequence s2pul
Receiver Gain 20.00 Solvent DMSO-d6 Spectrum Offset (Hz) 10489.3613 Spectrum Type STANDARD
Sweep Width (Hz) 24154.59 Temperature (degree C) 25.000
O
OH
N
S
N
H
OH
O
NH2
LP-8-94-C13.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
N
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d
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y
 
